🏷

Classifications

Harrison's Part

Channelopathy

👪

Inheritance

1

Autosomal dominant HP:0000006

SSS2 segregates as an autosomal dominant trait. All reported disease variants are heterozygous, and the dominant mechanism is usually dominant-negative suppression of wild-type HCN4 subunits within the heterotetrameric channel rather than simple haploinsufficiency. Penetrance and expressivity vary widely, from asymptomatic sinus bradycardia detected only on screening to syncope requiring pacemaker implantation.

Autosomal dominant inheritance

Show evidence (2 references)

PMID:17646576 SUPPORT Human Clinical

"Electrophysiological testing performed on 2 affected family members confirmed significant isolated sinus node dysfunction. Segregation analysis suggested autosomal-dominant inheritance."

Formal segregation analysis in a 16-member HCN4-G480R family established autosomal dominant transmission of isolated sinus node dysfunction.

PMID:12750403 SUPPORT In Vitro

"Coexpression experiments showed a dominant-negative effect of HCN4-573X subunits on wild-type subunits."

Co-expression of mutant with wild-type subunits demonstrates the dominant-negative mechanism underlying dominant transmission.

◈

Mechanistic Hypotheses

1

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

sinoatrial_automaticity_failure_model CANONICAL

Evidence balance 2 support

The disease-specific specialization of the module-level cardiac_ion_channel_repolarization group of the same name. In SSS2 the depressed current is specifically the hyperpolarization-activated funny current I_f carried by HCN4, so the bradyarrhythmia arises from a slowed diastolic depolarization slope in sinoatrial pacemaker cells rather than from depressed sodium-dependent conduction, and syncope follows from hypoperfusion during pauses rather than from ventricular tachyarrhythmia.

Pathograph links

HCN4 Loss-of-Function Variant -> Reduced Funny Current and Slowed Diastolic Depolarization DIRECT Reduced channel availability, a hyperpolarizing shift of the activation curve, or dominant-negative suppression of wild-type subunits lowers the inward diastolic current carried by I_f.

Reduced Funny Current and Slowed Diastolic Depolarization -> Sinoatrial Node Automaticity Failure DIRECT A slower diastolic depolarization slope lengthens the pacemaker cycle and depresses automaticity of the node as a whole.

Sinoatrial Node Automaticity Failure -> Syncope and Sudden Cardiac Death INDIRECT KNOWN INTERMEDIATES Severe bradycardia or a prolonged pause reduces cerebral perfusion, producing presyncope and syncope. Intermediates: prolonged sinus pauses and asystole; cerebral hypoperfusion

Show evidence (2 references)

PMID:16407510 SUPPORT In Vitro

"These changes, which mimic those of mild vagal stimulation, slow the heart rate by decreasing the inward diastolic current."

Names the funny-current-specific route to bradycardia that distinguishes this specialization from the sodium-channel arm of the module group.

PMID:26835093 SUPPORT Other

"All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia."

Confirms that the HCN4 arm of the model consistently yields bradyarrhythmia rather than tachyarrhythmia.

?

Discussions and Knowledge Gaps

5

By what route does a loss-of-function variant in the sinoatrial pacemaker channel produce dilatation of the ascending aorta?

KNOWLEDGE GAP OPEN q_sss2_aortic_wall_mechanism

Attached to

phenotypes#Dilatation of the Ascending Aorta pathophysiology#Impaired Ventricular Trabecular Compaction

Aortic root and ascending aortic dilatation has now been reported in several independent HCN4 families and in a majority of carriers in the largest series, so the association is replicated. What is missing is any mechanism. HCN4 has no described role in the aortic wall, no HCN4 animal model has been reported with an aortic phenotype, and neither of the two candidate routes has been tested: a direct requirement for HCN4 in neural-crest-derived or second-heart-field-derived outflow tract mesenchyme, or a haemodynamic consequence of lifelong bradycardia acting on the wall through increased stroke volume. The distinction is not academic, because it decides whether pacing a carrier would be expected to slow the aortic course. Until it is resolved, imaging surveillance in carriers rests on the observed association alone.

Show evidence (1 reference)

PMID:35257104 SUPPORT Human Clinical

"Earliest expression of HCN4 has been reported to be a potential marker for the first heart field."

The one developmental fact that makes a direct route plausible: HCN4 marks an early cardiac progenitor population, so a developmental role in outflow structures is not excluded. It is a marker claim rather than a functional one, which is exactly the gap.

Is the ventricular noncompaction of SSS2 a developmental consequence of HCN4 loss in the early myocardium, or a secondary remodelling response to lifelong bradycardia?

OPEN QUESTION OPEN q_sss2_noncompaction_developmental_or_rate_driven

Attached to

pathophysiology#Impaired Ventricular Trabecular Compaction phenotypes#Left Ventricular Noncompaction

Both readings fit the human data. The developmental reading is supported by HCN4 expression in early cardiac progenitors, by noncompaction being present already in fetal and adolescent carriers, and by Hcn4 sitting downstream of a transcriptional cascade rather than being an isolated channel gene: in mouse, loss of Shox2 abolishes Tbx3 and Hcn4 expression and leaves a hypoplastic sinoatrial node. That cascade is characterised for the sinoatrial node and not for ventricular trabeculation, so it shows that HCN4 has a developmental context without showing that it has one in the compacting ventricle. The haemodynamic reading is supported by the observation that HCN4 carriers with noncompaction have preserved ejection fraction and mild ventricular dilatation, a picture that could equally reflect volume loading at a low heart rate. One experiment on the same gene bears on the haemodynamic reading, though only on part of it: a knock-in mouse with a gain-of-function HCN4 allele runs chronically faster and develops no structural cardiomyopathy over twelve months. That speaks to adult remodelling under a sustained rate change, in the opposite direction from the bradycardia at issue and in a species whose baseline rate is an order of magnitude higher; it says nothing about whether lifelong bradycardia perturbs trabecular compaction during development, which is the reading actually in dispute. Settling that needs a loss-of-function HCN4 model examined for trabecular architecture, and a comparison of noncompaction burden between paced and unpaced carriers.

Show evidence (3 references)

PMID:42358349 SUPPORT INDIRECT Model Organism

"Histological analysis did not reveal structural changes consistent with tachycardia-induced cardiomyopathy. Cardiac morphology, fibrosis, and contractility were indistinguishable between genotypes up to 12 months of age."

A sustained HCN4-driven change in heart rate produced no structural cardiomyopathy in the adult mouse heart. It bears on the adult-remodelling reading only, and in the opposite direction from the bradycardia at issue, so it constrains the question rather than answering it.

PMID:19166829 SUPPORT INDIRECT Model Organism

"Genetically, the lack of Tbx3 and Hcn4 expression, along with ectopic activation of Nppa, Cx40, and Nkx2-5 in the Shox2(-/-) SAN region, indicates a failure in SAN differentiation."

Places Hcn4 inside a developmental transcriptional programme rather than treating it as a channel gene expressed only in the mature node, which is what makes a developmental reading of the structural phenotype coherent at all. Two inference steps separate it from the question: it is mouse, and the programme it describes builds the sinoatrial node, not the compacted ventricular wall.

PMID:34088380 SUPPORT INDIRECT Human Clinical

"Ion channel gene mutations should be searched systematically in patients with LVNC associated with either bradycardia or biventricular noncompaction, particularly when LV systolic function is preserved."

The preserved-function, biventricular pattern is the observation both readings have to explain, and it is compatible with either a developmental or a volume-loading origin, which is why the question stays open.

What functional evidence should be required before an HCN4 variant found in a bradycardic patient is called causal for SSS2?

CONTROVERSY OPEN q_sss2_variant_causality_threshold

Attached to

genetic#HCN4 loss-of-function variants pathophysiology#HCN4 Loss-of-Function Variant

SSS2 is defined by an HCN4 variant, so the entry's causal claim is only as good as the variant calls behind it. HCN4 variant discovery has outrun functional characterisation: most reported variants have never been patch-clamped, and at least one variant that had been treated as pathogenic, and linked in the literature to sudden infant death and malignant epilepsy, was found on characterisation to be indistinguishable from wild type in voltage dependence, kinetics, cAMP-gating and surface expression, and not to segregate with disease in the proband's own family. The alleles curated in this entry all carry electrophysiological or segregation evidence, which is the standard this discussion argues for, but the boundary is not settled and the field has no agreed threshold. Practically, this bears on cascade screening: a carrier identified on a panel without functional or segregation support has not been shown to have SSS2.

Show evidence (2 references)

PMID:33095298 SUPPORT In Vitro

"However, detailed electrophysiological and cell biological characterization of HCN4 V759I in Xenopus laevis oocytes and embryonic rat cardiomyocytes, respectively, did not reveal any obvious abnormality."

A variant treated as pathogenic behaves as wild type on functional testing, which is the concrete case the controversy rests on.

PMID:33095298 SUPPORT Human Clinical

"In good agreement, the clinically likewise affected mother of the patient does not exhibit the reported HCN4 variance."

Adds the segregation half of the argument: the affected relative does not carry the variant, so the family data contradict causality independently of the electrophysiology.

Should an HCN4 carrier with sinus node dysfunction but no documented atrial fibrillation receive anticoagulation?

KNOWLEDGE GAP OPEN q_sss2_anticoagulation_without_documented_af

Attached to

treatments#Stroke Prevention in Atrial Fibrillation phenotypes#Atrial Fibrillation

Two independent lines of evidence say sinus node dysfunction raises ischaemic stroke risk whether or not atrial fibrillation has been documented, which has been read as an atrial myopathy underlying both. If that is right, the risk-score logic that gates anticoagulation on a documented arrhythmia is the wrong gate. Nothing resolves this for SSS2 in particular: no cohort in either source was genotyped, no trial has tested anticoagulation in sinus node dysfunction without atrial fibrillation, and HCN4 carriers are a young population in whom the bleeding side of the trade-off runs for decades. The practical question is whether prolonged rhythm monitoring in carriers, which they often already have through an implanted device or loop recorder, converts the question into an ordinary documented-atrial-fibrillation decision often enough to make the untested group small.

Show evidence (2 references)

PMID:40315941 SUPPORT INDIRECT Human Clinical

"SND is an independent risk marker for the development of IS in individuals without AF."

States the finding the gap turns on, that the excess stroke risk does not require documented atrial fibrillation. The cohort is unselected sinus node dysfunction rather than HCN4 carriers.

PMID:37977871 SUPPORT Human Clinical

"Future studies are needed to investigate whether interventions targeting stroke prevention, such as anticoagulation therapy, can help to prevent stroke in patients with SND."

The authors name the same gap and state that it is untested, which is why this is recorded as an open question rather than as a treatment recommendation.

Does the mouse carrying the human cAMP-insensitive HCN4-573X allele reproduce human chronotropic incompetence, given that its relative rate adaptation to exercise is preserved?

HUMAN MODEL MISMATCH OPEN q_sss2_chronotropic_incompetence_model_mismatch

Attached to

pathophysiology#Loss of cAMP-Dependent Rate Modulation phenotypes#Chronotropic Incompetence

The hHCN4-573X mouse carries the human disease allele and loses cAMP sensitivity of I_f completely, yet the relative extent of its heart rate regulation during physical activity is preserved: basal and maximal rates fall, but the animal still scales its rate with demand. The human index patient was described with chronotropic incompetence. Both can be true if human chronotropic incompetence is a consequence of the depressed maximal rate rather than of a lost ability to modulate, and this entry's pathophysiology is written that way. The mismatch is nonetheless real and unresolved: it is not established that cAMP insensitivity is what produces the clinical exercise limitation, and the mouse is the only experiment that separates the two. Deciding it needs formal chronotropic-index testing in genotyped carriers of cyclic-nucleotide-binding-domain truncations, compared against carriers of pore and trafficking alleles that retain cAMP sensitivity.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"Despite the complete loss of cAMP sensitivity of I(f), the relative extent of SAN cell frequency and heart rate regulation are preserved."

States the mismatch directly: the model loses the molecular property proposed to underlie chronotropic incompetence without losing rate regulation.

⚙

Pathophysiology

6

HCN4 Loss-of-Function Variant

A heterozygous loss-of-function variant in HCN4 alters the pore-forming subunit of the cardiac pacemaker channel. Reported disease alleles cluster in three structural regions with three corresponding biophysical consequences: pore-domain missense changes (G480R, G482R) that impair channel synthesis, trafficking, and gating; C-linker and cyclic-nucleotide-binding-domain changes (S672R, K530N) that shift activation gating; and C-terminal truncations (573X, 695X) that delete the cyclic-nucleotide-binding domain. All are heterozygous, and most act dominant-negatively on wild-type subunits within the heterotetramer.

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

cardiac pacemaker cell of sinoatrial node CL:1000477

HCN4 hgnc:16882

intracellularly cAMP-activated cation channel activity GO:0005222 ↓ DECREASED

sinoatrial node UBERON:0002351

Experimental models

Patient-derived hiPSC lines carrying a heterozygous and a homozygous HCN4 variant (UKMi009-A, UKMi011-A) IPSC DERIVED MODEL The lines carry the family's own HCN4 variant at the endogenous locus in one and two copies, instantiating the genetic lesion of this node as a dose series rather than as an overexpressed construct.

Downstream

Reduced Funny Current and Slowed Diastolic Depolarization Reduced channel availability, a hyperpolarizing shift of the activation curve, or dominant-negative suppression of wild-type subunits lowers the inward diastolic current carried by I_f.

Loss of cAMP-Dependent Rate Modulation Truncations that remove the cyclic-nucleotide-binding domain, and C-linker changes that alter its coupling to the gate, uncouple the pacemaker current from cAMP.

Impaired Ventricular Trabecular Compaction In several pedigrees the same HCN4 allele co-segregates with left ventricular noncompaction, implicating the channel in myocardial development; the intermediate steps are not established.

Show evidence (3 references)

PMID:16407510 SUPPORT Human Clinical

"We found that sinus bradycardia in members of a large family was associated with a mutation in the gene coding for the pacemaker HCN4 ion channel."

The founding family study links a heterozygous HCN4 variant to inherited sinus bradycardia.

PMID:17646576 SUPPORT In Vitro

"Synthesis and expression of the wild-type and mutant HCN4 channel on the plasma membrane tested in human embryonic kidney 293 cells using biotinylation and Western blot analysis demonstrated a reduction in synthesis and a trafficking defect in mutant compared with wild-type channels."

Documents the synthesis/trafficking route to reduced channel availability for the pore-domain class of HCN4 alleles.

PMID:26835093 SUPPORT Other

"All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia."

Confirms that the HCN4 disease alleles reported to date are uniformly loss-of-function.

Reduced Funny Current and Slowed Diastolic Depolarization

The funny current I_f is the hyperpolarization-activated inward cation current that drives the early phase of spontaneous diastolic depolarization in sinoatrial node pacemaker cells. Mutant HCN4 channels activate at more negative voltages than wild-type channels, so at the diastolic potentials actually reached by a pacemaker cell less inward current flows. The diastolic depolarization slope falls, the interval to threshold lengthens, and the intrinsic firing rate of the node drops. The biophysical change has been described as mimicking mild vagal stimulation — a permanent, genetically imposed version of a physiological brake.

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

cardiac pacemaker cell of sinoatrial node CL:1000477

membrane depolarization during SA node cell action potential GO:0086046 ↓ DECREASED SA node cell action potential GO:0086015 ↓ DECREASED

sinoatrial node UBERON:0002351

Experimental models

hiPSC-derived pacemaker cardiomyocytes as a human I_f measurement platform IPSC DERIVED MODEL Provides direct patch-clamp measurement of I_f and of its autonomic modulation in human pacemaker-like cardiomyocytes, the quantity whose reduction defines this node.

Computational models

Fabbri-Severi human sinoatrial node cell model with HCN4 mutation-induced I_f changes PHYSIOLOGICAL The simulated beating rate of the human sinoatrial node cell model tracks the computed diastolic I_f charge very closely, and the same quantity correlates strongly with the resting and minimum heart rates observed in carriers of the corresponding HCN4 mutations.

Downstream

Sinoatrial Node Automaticity Failure A slower diastolic depolarization slope lengthens the pacemaker cycle and depresses automaticity of the node as a whole.

Show evidence (3 references)

PMID:12750403 SUPPORT Other

"The cardiac pacemaker current I(f) is a major determinant of diastolic depolarization in sinus nodal cells and has a key role in heartbeat generation."

Establishes the normal role of I_f in diastolic depolarization that is lost in SSS2.

PMID:16407510 SUPPORT In Vitro

"These changes, which mimic those of mild vagal stimulation, slow the heart rate by decreasing the inward diastolic current."

States the biophysical mechanism directly: less inward diastolic current slows the heart rate.

PMID:23178648 SUPPORT In Vitro

"In contrast, heteromeric channels composed of mutant and wild-type subunits displayed a significant hyperpolarizing shift in the half-maximal activation voltage."

Shows that the hyperpolarizing gating shift emerges specifically in heteromeric mutant/wild-type channels, the situation in a heterozygous carrier.

Loss of cAMP-Dependent Rate Modulation

Beta-adrenergic stimulation raises intracellular cAMP, which binds the cyclic-nucleotide-binding domain of HCN4 and shifts activation to more positive voltages, accelerating diastolic depolarization; vagal tone does the reverse. Truncating HCN4 alleles such as 573X delete this domain entirely, so the residual current is insensitive to cAMP. This is the proposed mechanistic basis of chronotropic incompetence in SSS2 — a failure of rate adaptation that is separable from the resting bradycardia. The corresponding mouse model shows that cAMP sensitivity of I_f sets basal and maximal heart rate while relative rate regulation during exercise is partially preserved by other mechanisms.

cardiac pacemaker cell of sinoatrial node CL:1000477

regulation of heart rate GO:0002027 ↓ DECREASED regulation of SA node cell action potential GO:0098907 ↓ DECREASED

Animal models

hHCN4-573X inducible cardiac transgenic mouse Mouse recapitulates Expression of the human disease allele eliminates cAMP sensitivity of I_f in sinoatrial node cells and lowers resting and maximal heart rate, the mechanism proposed for the human carrier.

Downstream

Chronotropic Incompetence Without cAMP-dependent acceleration of the pacemaker current, heart rate fails to rise appropriately with sympathetic drive.

Sinoatrial Node Automaticity Failure Loss of the cAMP-dependent positive shift lowers the operating range of pacemaker firing, compounding the resting depression of automaticity.

Show evidence (3 references)

PMID:12750403 SUPPORT In Vitro

"Patch-clamp experiments showed that HCN4-573X channels mediated I(f)-like currents that were insensitive to increased cellular cAMP levels."

Direct demonstration that a truncating HCN4 allele abolishes cAMP responsiveness of the pacemaker current.

PMID:12750403 SUPPORT Human Clinical

"Taken together, the clinical, genetic, and in vitro data provide a likely explanation for the patient's sinus bradycardia and the chronotropic incompetence."

Links the cAMP-insensitive channel phenotype to the patient's chronotropic incompetence.

PMID:19570998 SUPPORT INDIRECT Model Organism

"Our data demonstrate that cAMP-mediated regulation of I(f) determines basal and maximal heart rates but does not play an indispensable role in heart rate adaptation during physical activity."

A mouse model of the human 573X allele shows cAMP sensitivity of I_f sets basal and maximal rate. The same study finds that relative exercise rate adaptation is preserved, so the chronotropic claim rests on the loss of maximal rate rather than on a loss of rate adaptation itself.

Sinoatrial Node Automaticity Failure

Depressed pacemaker-cell firing translates into failure of the sinoatrial node to generate and deliver impulses at an appropriate rate: sinus bradycardia at rest, intermittent sinus pauses or arrest, and an inadequate rate response to demand. Because the node also anchors atrial activation, chronic bradycardia and the associated atrial electrical and structural remodeling raise susceptibility to atrial fibrillation, giving the tachycardia-bradycardia pattern that is unusually common in HCN4 carriers.

Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)

cardiac pacemaker cell of sinoatrial node CL:1000477

cardiac conduction GO:0061337 ↓ DECREASED regulation of heart rate by cardiac conduction GO:0086091 ↓ DECREASED

sinoatrial node UBERON:0002351

Animal models

Inducible cardiac-specific HCN4 knockout mouse (ciHCN4-KO) Mouse partially recapitulates Ablation reduces I_f and the spontaneous rate of isolated sinoatrial node myocytes and produces severe bradycardia in vivo, confirming that loss of HCN4 function is sufficient to depress nodal automaticity.

Downstream

Sinus Bradycardia Depressed nodal firing rate presents as resting sinus bradycardia.

Sinus Pauses and Sinus Arrest Intermittent failure of impulse formation produces sinus pauses and asystolic gaps.

Atrial Fibrillation Chronic bradycardia and atrial remodeling raise susceptibility to atrial fibrillation, producing tachycardia-bradycardia syndrome.

Syncope and Sudden Cardiac Death Severe bradycardia or a prolonged pause reduces cerebral perfusion, producing presyncope and syncope.

Show evidence (2 references)

PMID:17646576 SUPPORT Human Clinical

"Electrophysiological testing performed on 2 affected family members confirmed significant isolated sinus node dysfunction."

Invasive electrophysiology in HCN4-G480R carriers confirms isolated sinoatrial node dysfunction as the tissue-level lesion.

PMID:16407510 SUPPORT Human Clinical

"Thus, diminished function of pacemaker channels is linked to familial bradycardia."

States the causal chain from diminished pacemaker-channel function to the familial bradycardia phenotype.

Impaired Ventricular Trabecular Compaction

HCN4 is expressed during cardiac development, and in several independent pedigrees the same segregating HCN4 allele produces both bradycardia and left ventricular noncompaction — a myocardium with a persistently trabeculated, poorly compacted layer and deep intertrabecular recesses. This developmental arm is what distinguishes the HCN4 form of familial sick sinus syndrome from the sodium-channel forms, in which no structural abnormality is found. It is curated here as a parallel branch of the same genetic lesion rather than as maladaptive remodeling secondary to the arrhythmia: the noncompaction is present from childhood and does not follow a preceding phase of cardiomyocyte injury and neurohormonal activation. Some pedigrees additionally show dilation of the ascending aorta.

cardiac muscle cell CL:0000746

ventricular trabecula myocardium morphogenesis GO:0003222 ⚠ ABNORMAL

heart left ventricle UBERON:0002084

Downstream

Left Ventricular Noncompaction Failure of trabecular compaction gives the two-layered noncompacted myocardium seen on echocardiography and cardiac MRI.

Dilatation of the Ascending Aorta Ascending aortic dilation accompanies the noncompaction phenotype in some HCN4 families; the mechanism linking the channel to the aortic wall is unknown.

Show evidence (3 references)

PMID:25145517 SUPPORT Human Clinical

"One of these, p.Gly482Arg in HCN4, segregated with the combined bradycardia and LVNC phenotype in the entire family."

Establishes co-segregation of a single HCN4 allele with both the electrical and the structural phenotype.

PMID:25145517 SUPPORT Human Clinical

"Although mutations in HCN4 have been previously linked to bradycardia, our study provides the first evidence to our knowledge that mutations in this ion channel gene also may be associated with structural abnormalities of the myocardium."

States explicitly that HCN4 variants can produce a structural myocardial abnormality, not only an electrical one.

PMID:25145518 SUPPORT Human Clinical

"The symptom complex of SND and NCCM is associated with heritable HCN4 defects."

An independent German cohort reaches the same conclusion for the combined sinus-node/noncompaction phenotype.

Syncope and Sudden Cardiac Death

Severe bradycardia or a prolonged sinus pause transiently abolishes effective cardiac output, producing presyncope and syncope from cerebral hypoperfusion; an unterminated pause carries a risk of asystolic sudden death. This is the shared clinical endpoint with the other inherited arrhythmia syndromes, reached in SSS2 through bradyarrhythmia rather than ventricular tachyarrhythmia. Prognosis is variable and allele-dependent: the G480R pore-domain family remained asymptomatic with normal exercise capacity throughout long-term follow-up and required no pacemaker.

Show evidence (2 references)

PMID:34383451 SUPPORT Human Clinical

"About 50% of patients present with cerebral hypoperfusion (e.g., syncope, presyncope, lightheadedness, cerebrovascular accident)."

Supports cerebral hypoperfusion (syncope/presyncope) as the clinical endpoint of symptomatic sinus node dysfunction.

PMID:17646576 SUPPORT Human Clinical

"Despite its critical location, this mutation carries a favorable prognosis without the need for pacemaker implantation during long-term follow-up."

Qualifies the outcome node: at least one HCN4 pore-domain allele carries a benign long-term course, so the outcome is allele- and family-dependent.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

12

Sinus Bradycardia VERY_FREQUENT Cardiovascular HP:0001688

Show evidence (2 references)

PMID:16407510 SUPPORT Human Clinical

"We found that sinus bradycardia in members of a large family was associated with a mutation in the gene coding for the pacemaker HCN4 ion channel."

Sinus bradycardia is the defining familial phenotype in the founding HCN4 pedigree.

PMID:35328031 SUPPORT Human Clinical

"Sinus bradycardia and dilation of the ascending aorta occurred in five studied patients."

Supports the VERY_FREQUENT band: sinus bradycardia was present in five of the six prospectively enrolled patients in this HCN4/LVNC series.

Sick Sinus Syndrome Cardiovascular HP:0011704

Show evidence (1 reference)

PMID:28104484 SUPPORT Human Clinical

"SSS with HCN4 mutations may form a distinct SSS subgroup characterized by early clinical manifestation after adolescence and frequent association with AF and LVNC."

Defines HCN4-related disease as a distinct clinical subgroup of sick sinus syndrome.

Sinus Pauses and Sinus Arrest Cardiovascular HP:0011702

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Electrocardiography findings include sinus bradycardia, sinus pauses or arrest, sinoatrial exit block, chronotropic incompetence, or alternating bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome)."

Sinus pauses and arrest are core electrocardiographic manifestations of sinus node dysfunction, the syndrome SSS2 produces.

Chronotropic Incompetence Cardiovascular HP:0033992

Show evidence (4 references)

PMID:12750403 SUPPORT Human Clinical

"Taken together, the clinical, genetic, and in vitro data provide a likely explanation for the patient's sinus bradycardia and the chronotropic incompetence."

Documents chronotropic incompetence in the index HCN4-573X patient and attributes it to the cAMP-insensitive pacemaker channel.

PMID:17646576 REFUTE Human Clinical

"All affected family members were asymptomatic with normal exercise capacity during long-term follow-up."

Counter-evidence that chronotropic incompetence is not obligate in SSS2: the HCN4-G480R family retained normal exercise capacity.

PMID:28465117 SUPPORT Human Clinical

"Under maximum exercise test carriers achieved significantly lower heart rates than non-carrier family members, and percent heart rate reserve and percent corrected heart rate reserve were significantly lower in carriers."

A quantified heart-rate-reserve comparison between genotyped carriers and non-carrier relatives in the same family, which is the comparison the two case reports above cannot make.

+ 1 more reference

Prolonged QT Interval VERY_RARE Cardiovascular HP:0001657

Show evidence (2 references)

PMID:15123648 SUPPORT Human Clinical

"A missense mutation, D553N, was found in a patient with sinus node dysfunction who showed recurrent syncope, QT prolongation in electrocardiogram, and polymorphic ventricular tachycardia, torsade de pointes."

Records QT prolongation, with torsade de pointes, in a genotyped HCN4 carrier.

PMID:39698436 SUPPORT Human Clinical

"Electrocardiography (ECG) after birth revealed sinus bradycardia with a heart rate of 70–80 bpm, associated with a slightly prolonged QTc of 500."

An independent HCN4 carrier with QT prolongation. The value normalised on follow-up, which is part of why the phenotype is banded VERY_RARE and described as unsettled rather than asserted as a core feature.

Atrial Fibrillation FREQUENT Cardiovascular HP:0005110

Show evidence (3 references)

PMID:28104484 SUPPORT Human Clinical

"Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation"

Quantifies atrial fibrillation at 43.8% of HCN4 mutation carriers, supporting the FREQUENT band (30-79%).

PMID:23178648 SUPPORT Human Clinical

"The index patient developed tachycardia-bradycardia syndrome and persistent atrial fibrillation (AF) in an age-dependent fashion. Pedigree analysis identified eight affected family members with a similar course of disease."

An HCN4 pedigree in which tachycardia-bradycardia syndrome with persistent atrial fibrillation is the segregating phenotype.

PMID:24607718 SUPPORT INDIRECT In Vitro

"Our findings are consistent with HCN4 haploinsufficiency as the likely mechanism for early-onset AF in the p.Pro257Ser carrier."

Adds a second route to the atrial fibrillation arm. This carrier's allele fails to reach the membrane and does not co-localise with wild-type channel, so the atrial phenotype here follows from simple haploinsufficiency rather than from the dominant-negative suppression that predominates elsewhere in SSS2. The carrier was ascertained from an early-onset atrial fibrillation cohort rather than a sinus node dysfunction one, so reading the finding into SSS2 takes an inference step.

Left Ventricular Noncompaction FREQUENT Cardiovascular HP:0030682

Show evidence (2 references)

PMID:28104484 SUPPORT Human Clinical

"Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation"

Quantifies left ventricular noncompaction at 50% of HCN4 mutation carriers, supporting the FREQUENT band (30-79%).

PMID:25145517 SUPPORT Human Clinical

"Subsequent screening of HCN4 in 3 additional families with the same clinical combination of bradycardia and LVNC identified HCN4 mutations in each."

Replication across three additional families establishes noncompaction as part of the HCN4 phenotype rather than a chance co-occurrence.

Biventricular Noncompaction with Preserved Systolic Function OCCASIONAL Cardiovascular HP:0012818

Show evidence (2 references)

PMID:34088380 SUPPORT INDIRECT Human Clinical

"we found that those patients had higher median LV ejection fraction (60% vs 40%; P < .001) and more biventricular noncompaction (53.1% vs 18.5%; P < .001) than the 81 other patients with LVNC"

Quantifies the preserved ejection fraction and the biventricular distribution. The 53.1% is the share among ion-channel-mutation noncompaction patients, that is, conditioned on already having noncompaction, not the share among SSS2 carriers. Since noncompaction itself is banded FREQUENT at 50% of HCN4 carriers, the implied share of all carriers is roughly a quarter, which is why this phenotype is banded OCCASIONAL.

PMID:34088380 SUPPORT INDIRECT Human Clinical

"both the 19 patients with an HCN4 mutation and the 11 patients with an RYR2 mutation presented with a higher LV ejection fraction and more frequent biventricular noncompaction than the 81 patients with LVNC but with no mutation in the ion channel gene, but only patients with HCN4 mutation..."

Confirms the direction of the effect in the 19 HCN4 carriers taken on their own, and adds the bradycardia that separates HCN4 from RYR2 within the ion-channel group. It gives a direction rather than an HCN4-specific percentage, so the band above is not derived from it.

Mitral Valve Prolapse OCCASIONAL Cardiovascular HP:0001634

Show evidence (2 references)

PMID:35257104 SUPPORT Human Clinical

"more recently, a more complex phenotype has emerged, including primarily noncompaction cardiomyopathy (NCC), aortic dilatation but also mitral valve defects, early-onset atrial fibrillation, atrioventricular block, and ventricular tachycardia"

Places mitral valve disease in the extended HCN4 phenotype spectrum alongside the noncompaction and aortic findings already curated here.

PMID:35257104 SUPPORT Human Clinical

"a mildly dysplastic aortic valve with mild central regurgitation and no stenosis and mild mitral valve prolapse"

Documents mitral valve prolapse directly in a p.Gly482Arg carrier, giving an individual observation behind the spectrum statement above. The frequency is banded OCCASIONAL because it is reported in individual carriers rather than counted in any cohort.

Dilatation of the Ascending Aorta Cardiovascular HP:0004970

Show evidence (1 reference)

PMID:35328031 SUPPORT Human Clinical

"The HCN4 molecular variants influence the presence of a complex LVNC phenotype, sinus bradycardia and dilation of the ascending aorta."

Reports ascending aortic dilation in HCN4 families. The HPO binding is exact rather than approximate — "Dilatation of ascending aorta" is an EXACT synonym of HP:0004970, and the source measured the ascending aorta in the parasternal long-axis view indexed to body surface area, the same segment the term names. The series is small (six patients, four families) and the mechanism linking the pacemaker channel to the aortic wall is unknown, so the association is better established than its explanation.

Syncope Neurologic HP:0001279

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"About 50% of patients present with cerebral hypoperfusion (e.g., syncope, presyncope, lightheadedness, cerebrovascular accident)."

Syncope is a direct manifestation of the cerebral hypoperfusion caused by sinus node dysfunction.

Atrioventricular Block Cardiovascular HP:0001678

Show evidence (1 reference)

PMID:26835093 SUPPORT Other

"Funny channel-linked arrhythmias, however, also include atrioventricular (AV) block and atrial fibrillation, in agreement with an emerging new concept according to which defective funny channels have a still unexplored role in impairing AV conduction and triggering atrial fibrillation."

A review places AV block in the HCN4 arrhythmia spectrum. The review itself describes the AV-conduction role as an emerging and still unexplored concept, so this is the weakest arm of the phenotype.

🧬

Genetic Associations

1

HCN4 loss-of-function variants (Causative)

Gene: HCN4 hgnc:16882 gene page relationship_type: CAUSATIVE

Show evidence (3 references)

PMID:26835093 SUPPORT Other

"All mutations described so far are loss-of-function and in agreement with the role of funny channels, the predominant type of arrhythmia found is bradycardia."

Confirms the uniform loss-of-function direction of HCN4 disease alleles, which holds for every allele curated here except P883R.

PMID:31481236 REFUTE In Vitro

"Patch-clamp recordings of HCN4-P883R channels expressed in HEK293 cells showed remarkable alterations of channel properties shifting the half-maximal activation voltage to more depolarized potentials, while channel deactivation was faster compared to wild-type (WT)."

The counterexample to the uniform loss-of-function statement above. A depolarising shift of the activation curve increases channel availability at diastolic potentials, the opposite of the hyperpolarising shift the loss-of-function alleles produce.

PMID:16407510 SUPPORT Human Clinical

"Thus, diminished function of pacemaker channels is linked to familial bradycardia."

States the gene-disease relationship established by the founding pedigree.

Variants (9)

HCN4 p.Ser672Arg

Gene: HCN4 hgnc:16882

Missense change near the cyclic-nucleotide-binding site, identified in a large familial sinus bradycardia pedigree. Mutant channels retain a normal response to cAMP but activate at more negative voltages than wild-type, reducing the inward diastolic current.

Functional effects

hyperpolarizing shift of activation voltage loss-of-function

Activation is displaced to more negative potentials while cAMP responsiveness is retained, so less current flows during diastole at any given membrane potential.

Show evidence (1 reference)

PMID:16407510 SUPPORT In Vitro

"The mutation associated with bradycardia is located near the cAMP-binding site; functional analysis found that mutant channels respond normally to cAMP but are activated at more negative voltages than are wild-type channels."

Characterizes the gating-shift mechanism of this allele.

HCN4 573X (c.1631delC)

Gene: HCN4 hgnc:16882

Heterozygous single-base deletion in exon 5 producing a C-terminally truncated subunit that lacks the cyclic-nucleotide-binding domain. Trafficking is normal, but the resulting current is cAMP-insensitive and the subunit exerts a dominant-negative effect on wild-type channels.

Functional effects

loss of cAMP-dependent gating dominant-negative

Truncation removes the cyclic-nucleotide-binding domain, so the channel still reaches the membrane and conducts but no longer responds to cAMP. The subunit also suppresses wild-type current in co-expression.

loss of cAMP-dependent acceleration of the pacemaker current loss-of-function

The direction of effect, recorded alongside the dominant-negative mechanism above: the net result is less cAMP-responsive I_f than a wild-type heterotetramer would carry.

Show evidence (2 references)

PMID:12750403 SUPPORT Human Clinical

"In a candidate gene approach, a heterozygous 1-bp deletion (1631delC) in exon 5 of the human HCN4 gene was detected in a patient with idiopathic SND."

Identifies the truncating allele in the index patient with idiopathic sinus node dysfunction.

PMID:12750403 SUPPORT In Vitro

"The mutant HCN4 protein (HCN4-573X) had a truncated C-terminus and lacked the cyclic nucleotide-binding domain."

Establishes the structural basis for the loss of cAMP responsiveness.

HCN4 695X

Gene: HCN4 hgnc:16882

C-terminal truncating allele reported in a family with the combined sinus node dysfunction and noncompaction phenotype, in the same series that described G482R and P883R. It is grouped with 573X as a truncation, but unlike 573X it has not been characterised electrophysiologically in the cited work, so its consequence is inferred from the variant class and the family phenotype rather than measured.

Functional effects

reduced pacemaker current loss-of-function

Inferred from the C-terminal truncating class and from the segregating phenotype, not from a functional assay: no patch-clamp characterisation of this allele is presented in the cited report.

Show evidence (1 reference)

PMID:25145518 SUPPORT Human Clinical

"Moreover, different truncation (695X) and missense (P883R) HCN4 mutations segregated with a similar combined phenotype in an additional, unrelated family and a single unrelated proband respectively, which both lacked CSRP3-W4R."

Establishes the allele, its truncating class, and its co-segregation with the combined sinus node dysfunction and noncompaction phenotype in an unrelated family.

HCN4 p.Gly480Arg

Gene: HCN4 hgnc:16882

Pore-domain missense change segregating with autosomal dominant isolated sinus node dysfunction in a 16-member family. Reduces channel synthesis and membrane trafficking and shifts activation to more negative voltages, yet carries a benign long-term course.

Functional effects

reduced channel synthesis and membrane trafficking loss-of-function

Less channel protein is made and reaches the surface, and what does activate does so at more negative potentials.

Show evidence (1 reference)

PMID:17646576 SUPPORT Human Clinical

"Direct sequencing of the exons encoding HCN4 revealed a missense mutation, G480R, in the ion channel pore domain in all affected family members."

Establishes complete co-segregation of the pore-domain allele with the affected status.

HCN4 p.Gly482Arg

Gene: HCN4 hgnc:16882

Pore-domain missense change segregating with the combined sinus node dysfunction and biventricular noncompaction phenotype. Mutant subunits are nonfunctional and dominant-negative on wild-type current.

Functional effects

nonfunctional pore with suppression of wild-type current dominant-negative

Homomeric mutant channels carry no current, and the subunit suppresses wild-type current when the two are co-expressed.

reduced pacemaker current loss-of-function

The direction of effect, recorded alongside the dominant-negative mechanism above: nonfunctional subunits assembling into the heterotetramer leave less current than a wild-type channel carries.

Show evidence (1 reference)

PMID:25145518 SUPPORT In Vitro

"HCN4-G482R is located in the highly conserved channel pore domain. Mutant subunits were nonfunctional and exerted dominant-negative effects on wild-type current."

Characterizes the dominant-negative loss-of-function mechanism of this allele.

HCN4 p.Lys530Asn

Gene: HCN4 hgnc:16882

C-linker missense change identified by screening 422 patients with tachyarrhythmias. Homomeric mutant channels behave almost like wild-type; the loss of function appears only in heteromeric mutant/wild-type channels, which show a hyperpolarizing shift of half-maximal activation — the biophysical situation of a heterozygous carrier.

Functional effects

heteromer-restricted hyperpolarizing shift of activation loss-of-function

Homomeric mutant channels are close to wild-type; the shift in half-maximal activation appears only in mutant/wild-type heteromers, which is the configuration a heterozygous carrier actually has.

Show evidence (1 reference)

PMID:23178648 SUPPORT In Vitro

"In a candidate gene approach, we screened 422 patients with atrial and/or ventricular tachyarrhythmias and detected a novel HCN4 gene mutation that replaced the positively charged lysine 530 with an asparagine (HCN4-K530N) in a highly conserved region of the C-linker."

Identifies the C-linker allele and the screening context in which it was found.

HCN4 p.Asp553Asn

Gene: HCN4 hgnc:16882

Missense change in the C-linker region that reduces the amount of channel reaching the membrane. It is the worked example of the trafficking class of HCN4 allele, and it acts dominant-negatively on the wild-type subunit rather than by simple loss of one copy. The index carrier had recurrent syncope with a prolonged QT interval and torsade de pointes as well as sinus node dysfunction, so this allele's reported phenotype reaches repolarisation and ventricular arrhythmia as well as impulse generation.

Functional effects

trafficking defect reducing surface channel dominant-negative

Less channel reaches the membrane, lowering I_f, and the mutant subunit acts dominant-negatively rather than by simple loss of one copy.

reduced surface pacemaker current loss-of-function

The direction of effect, recorded alongside the dominant-negative mechanism above: less channel at the membrane means less I_f.

Show evidence (2 references)

PMID:15123648 SUPPORT In Vitro

"In vitro functional study of the D553N mutation showed a reduced membranous expression associated with decreased If currents because of a trafficking defect of the HCN4 channel in a dominant-negative manner."

Establishes both the mechanism class, defective trafficking, and the dominant-negative mode of action of this allele.

PMID:15123648 SUPPORT Human Clinical

"A missense mutation, D553N, was found in a patient with sinus node dysfunction who showed recurrent syncope, QT prolongation in electrocardiogram, and polymorphic ventricular tachycardia, torsade de pointes."

Gives the carrier phenotype, which extends beyond the sinus node to repolarization and ventricular arrhythmia.

HCN4 p.Pro883Arg Uncertain Significance

Gene: HCN4 hgnc:16882

C-terminal missense change that does not fit the loss-of-function pattern the rest of these alleles follow. It segregated with the combined sinus node dysfunction and noncompaction phenotype in one proband, but when characterised functionally it shifted activation to more depolarised potentials and, co-expressed with wild-type subunits as in a heterozygote, produced higher rather than lower current density. It is also common enough (minor allele frequency around 0.9%) that it cannot be a fully penetrant cause on its own. The authors of the functional study read it as a modifier acting with a common KCNE1 variant to favour atrial fibrillation and tachycardia-induced cardiomyopathy, rather than as an SSS2 allele. Both readings stand in the literature and neither has been withdrawn.

Functional effects

depolarizing shift of activation with increased current density gain-of-function

The opposite direction from every other allele in this entry. Activation moves to more depolarised potentials and deactivation is faster; in the heterozygous configuration, co-expressed with wild type, current density is higher than wild type rather than lower. This is why the statement that every reported HCN4 disease allele is loss-of-function does not hold for this one.

Show evidence (3 references)

PMID:25145518 SUPPORT Human Clinical

"Moreover, different truncation (695X) and missense (P883R) HCN4 mutations segregated with a similar combined phenotype in an additional, unrelated family and a single unrelated proband respectively, which both lacked CSRP3-W4R."

The observation that puts P883R in this entry at all: it segregated with the combined sinus node dysfunction and noncompaction phenotype in an unrelated proband.

PMID:31481236 REFUTE In Vitro

"Co-transfection of WT and mutant subunits, resembling the heterozygous cellular situation of our patients, revealed significantly higher current densities compared to WT."

Contradicts the loss-of-function reading for this particular allele. Reconstructed in the heterozygous configuration, P883R raises rather than lowers current density, which is the opposite of the mechanism every other allele in this entry works by.

PMID:31481236 SUPPORT In Vitro

"Together with the common KCNE1 variant S38G, previously proposed as a genetic modifier of AF, HCN4-P883R may provide a substrate for the development of AF and TIC."

States the modifier reading the functional study reaches, which is the alternative to treating this as an SSS2 allele.

HCN4 c.1737+1 G>T (splice site)

Gene: HCN4 hgnc:16882

Canonical splice-donor variant segregating in a large bradycardia family with a two-point LOD score of 4.87. Its interest is that the family was characterised by Holter and exercise testing rather than by patch clamp, so it supplies the quantitative human chronotropic phenotype: carriers reach lower peak heart rates, have a reduced heart rate reserve, and show increased short-term heart rate variability even after normalisation for rate.

Functional effects

reduced pacemaker current loss-of-function

Inferred from the canonical +1 splice-donor class and from the family's bradycardia phenotype rather than measured: this allele was characterised clinically, not by patch clamp.

Show evidence (1 reference)

PMID:28465117 SUPPORT Human Clinical

"A novel c.1737+1 G>T 'splice-site' HCN4 mutation was identified in a large family with familial bradycardia which co-segregated with the disease providing a two-point LOD score of 4.87."

Establishes the allele and the strength of its co-segregation with bradycardia in the family.

💊

Medical Actions

5

Permanent Pacemaker Implantation

Action: pacemaker implantation Ontology label: Pacemaker Placement NCIT:C80434

Platform: Device

Pacing is the definitive therapy for symptomatic bradycardia or symptomatic pauses; it does not correct the channel defect. In HCN4 carriers the age at implantation is later than in SCN5A-related familial sick sinus syndrome, and some HCN4 alleles never require a device. Chronotropic pharmacotherapy may defer but does not replace it.

Mechanism Target:

BYPASSES Sinoatrial Node Automaticity Failure — An implanted pacemaker substitutes an artificial impulse source for the failing sinoatrial node, bypassing rather than repairing the pacemaker current defect.

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"First-line treatment for patients with confirmed sinus node dysfunction is permanent pacemaker placement with atrial-based pacing and limited ventricular pacing when necessary."

Establishes pacing as the first-line intervention against the failing sinoatrial node.

Show evidence (2 references)

PMID:28104484 SUPPORT Human Clinical

"Moreover, HCN4 mutation carriers were more frequently associated with AF (43.8%) and LVNC (50%) and with older age at pacemaker implantation"

Reports age at pacemaker implantation specifically in HCN4 carriers, contrasted with the SCN5A form.

PMID:17646576 SUPPORT Human Clinical

"Despite its critical location, this mutation carries a favorable prognosis without the need for pacemaker implantation during long-term follow-up."

Supports the statement in this treatment's description that some HCN4 alleles never require a device: the G480R pore mutation carried a favorable prognosis without pacemaker implantation over long-term follow-up.

Chronotropic Pharmacotherapy (Cilostazol)

Action: Pharmacotherapy NCIT:C15986

Agent: cilostazol CHEBI:31401

Platform: Small molecule

Cilostazol, a phosphodiesterase-3 inhibitor, raises heart rate in sinus node dysfunction and has been used to defer or avoid permanent pacing in symptomatic sick sinus syndrome. It is a rate-raising palliative acting downstream of the pacemaker-current defect rather than a correction of it, and the supporting evidence comes from unselected sick sinus syndrome cohorts, not from genotyped HCN4 carriers.

Mechanism Target:

MODULATES Sinoatrial Node Automaticity Failure — Cilostazol raises the sinus rate, partially offsetting the depressed nodal automaticity without restoring the funny current.

Show evidence (1 reference)

PMID:30982679 SUPPORT INDIRECT Human Clinical

"Cilostazol was effective for symptomatic SSS to avoid PM implantation by increasing HR."

Shows a rate-raising effect on the failing sinoatrial node. The cohort is unselected sick sinus syndrome rather than genotyped HCN4 carriers, so the step to SSS2 is an inference from the shared nodal lesion.

Show evidence (2 references)

PMID:30982679 SUPPORT INDIRECT Human Clinical

"The 6-month PM implantation rate was lower in the cilostazol than the control group (20.4% vs. 55.8%, respectively; p<0.001)."

Quantifies the pacemaker-deferring effect. It is a single-centre retrospective case-control study in unselected sick sinus syndrome, not a randomized trial and not HCN4-genotyped, so the SSS2-specific effect size is unknown.

PMID:33017571 SUPPORT INDIRECT Other

"This review summarizes the current knowledge about SND mechanisms and discusses the possibility of introducing new pharmacologic therapies for treating SND."

Frames pharmacologic management of sinoatrial node dysfunction as an area of active development rather than established practice. It supports the existence of the therapeutic avenue, not the efficacy of any particular agent in SSS2.

Avoidance of Bradycardia-Inducing Medications

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Because SSS2 carriers already run a reduced pacemaker current, drugs that further depress sinoatrial automaticity or conduction (beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and the selective I_f blocker ivabradine, whose molecular target is HCN4 itself) can unmask or worsen symptomatic bradycardia. Extrinsic contributors to sinus node dysfunction are frequently reversible, so medication review is part of management as well as of diagnosis.

Show evidence (2 references)

PMID:34383451 SUPPORT INDIRECT Human Clinical

"The causes of sinus node dysfunction are intrinsic (e.g., degenerative idiopathic fibrosis, cardiac remodeling) or extrinsic (e.g., medications, metabolic abnormalities) to the sinoatrial node."

Establishes medications as an extrinsic cause of sinus node dysfunction, which is the rationale for avoiding rate-slowing drugs in a carrier. The source addresses sinus node dysfunction generally and names no specific agent to avoid in HCN4 carriers, so the carrier-specific application is an inference.

PMID:34383451 SUPPORT INDIRECT Human Clinical

"A diagnosis is made by directly correlating symptoms with a bradyarrhythmia and eliminating potentially reversible extrinsic causes."

Supports elimination of reversible extrinsic causes, of which drug therapy is the main modifiable one. The statement is framed as a diagnostic rather than a therapeutic step, so its use here as a management rationale is an inference.

Stroke Prevention in Atrial Fibrillation

Action: anticoagulation therapy Ontology label: Anticoagulation Therapy NCIT:C63341

Platform: Small molecule

Atrial fibrillation occurs in roughly 44% of HCN4 carriers, so thromboembolic prophylaxis is part of routine management once it is documented, prescribed on the same risk-score basis as in any other atrial fibrillation rather than on the genotype. What is genuinely unsettled is the carrier without documented atrial fibrillation: sinus node dysfunction carries an independently raised ischaemic stroke risk even in its absence, and the yearly stroke incidence in sinus node dysfunction with and without atrial fibrillation is indistinguishable, which has been read as evidence of an underlying atrial myopathy rather than of arrhythmia-driven stasis. No trial has tested anticoagulation in that group, and none of this evidence is HCN4-genotyped.

Show evidence (3 references)

PMID:37977871 SUPPORT INDIRECT Human Clinical

"The average yearly stroke incidence in patients with SND was 1.542% (95% CI: 1.334% to 1.749%). The stroke incidence was similar between the isolated SND (1.587%; 95% CI: 1.510% to 1.664%) and non-isolated (SND+AF) (1.660%; 95% CI: 0.705% to 2.615%) groups."

Quantifies the stroke burden that makes thromboembolic prophylaxis a management question here at all, and shows it does not depend on documented atrial fibrillation. The pooled population is unselected sinus node dysfunction, not HCN4 carriers.

PMID:37977871 NO_EVIDENCE Human Clinical

"Future studies are needed to investigate whether interventions targeting stroke prevention, such as anticoagulation therapy, can help to prevent stroke in patients with SND."

The authors state explicitly that whether anticoagulation prevents stroke in sinus node dysfunction has not been established, so this item is recorded as bearing on the burden rather than on the intervention. It is the reason this treatment is scoped to documented atrial fibrillation.

PMID:40315941 SUPPORT INDIRECT Human Clinical

"In multivariable competing-risk regression modeling accounting for death, isolated SND conferred a significantly increased risk of IS compared to controls (subdistribution hazard ratio 2.28; 95% confidence interval, 1.57-3.31; P < .001)."

A prospective population cohort finding the same excess risk in sinus node dysfunction without atrial fibrillation, which is what makes the untested group a real clinical question rather than a theoretical one. Again the cohort is not genotyped.

Genetic Counseling and Cascade Family Screening

Action: genetic counseling Ontology label: Genetic Counseling NCIT:C15240

Platform: Behavioral / lifestyle

SSS2 is autosomal dominant with variable penetrance, so first-degree relatives of a proband carry a 50% prior risk and may be affected while entirely asymptomatic. Counselling plus cascade ECG, Holter, echocardiographic and HCN4 sequencing of relatives identifies those carriers, which matters here because the HCN4 phenotype includes a structural (noncompaction) arm that is not detected by rhythm assessment alone.

Show evidence (2 references)

PMID:17646576 SUPPORT Human Clinical

"Sixteen members of a family with sinus bradycardia were evaluated. Evaluation included a clinical questionnaire, 12-lead ECGs, Holter monitoring, echocardiography, and treadmill exercise testing."

Documents the family-wide evaluation protocol by which HCN4 relatives are screened, including the echocardiography needed to catch the structural arm.

PMID:17646576 SUPPORT Human Clinical

"Eight family members (5 males) were classified as affected. All affected family members were asymptomatic with normal exercise capacity during long-term follow-up."

Demonstrates the yield of cascade screening in SSS2: half the evaluated family was affected and every affected member was asymptomatic, so relatives would not have been identified without screening.

🔬

Diagnosis

3

Electrocardiography and ambulatory rhythm monitoring

Resting ECG and 24-hour Holter monitoring document the sinus bradycardia, sinus pauses, and bradycardia-tachycardia alternation, and correlate them with symptoms. Exercise testing assesses chronotropic response.

electrocardiography NCIT:C38053

Show evidence (1 reference)

PMID:34383451 SUPPORT Human Clinical

"Heart rate monitoring using electrocardiography or ambulatory cardiac event monitoring is performed based on the frequency of symptoms."

Establishes ECG and ambulatory monitoring as the diagnostic modality for sinus node dysfunction.

Cardiac imaging for noncompaction and aortic dimensions

Because the HCN4 form uniquely carries a structural arm, echocardiography and cardiac magnetic resonance are needed to look for left ventricular noncompaction, late gadolinium enhancement, and dilation of the ascending aorta in a carrier who presents only with bradycardia.

echocardiography NCIT:C16525

Show evidence (1 reference)

PMID:35328031 SUPPORT Human Clinical

"All six patients were diagnosed with LVNC by echocardiography, and five participants additionally by CMR."

Documents echocardiography and cardiac MRI as the modalities that detect the structural arm in HCN4 families.

Genetic testing of HCN4

Targeted or panel sequencing of HCN4 confirms the diagnosis in a proband with familial or early-onset sinus node dysfunction, particularly when bradycardia is accompanied by noncompaction, and enables cascade screening of relatives, many of whom are asymptomatic.

genetic testing NCIT:C15709

Show evidence (1 reference)

PMID:25145518 SUPPORT Human Clinical

"Targeted next-generation and direct sequencing were used for candidate gene analysis and mutation scanning."

Describes the sequencing approach used to establish the HCN4 diagnosis in families with the combined phenotype.

📈

Progression

4

Prenatal and neonatal sinus bradycardia

Age: Second trimester through the neonatal period

The earliest detectable manifestation is a fetal heart rate below the gestational-age norm, which can be accompanied in utero by prominent left ventricular trabeculation. Neither the bradycardia nor the noncompaction is necessarily symptomatic at this stage, and de novo variants occur, so an unremarkable family history does not exclude SSS2 in a bradycardic fetus.

Show evidence (1 reference)

PMID:39698436 SUPPORT Human Clinical

"Fetal echocardiography revealed a normal fetal heart except for slightly prominent trabeculae in the left ventricle, normal cardiac function, and fetal sinus bradycardia with a heart rate of 100 bpm."

Documents both arms of the SSS2 phenotype, bradycardia and trabecular noncompaction, at the fetal stage in a carrier later shown to have a heterozygous HCN4 in-frame deletion.

Asymptomatic childhood and adolescent bradycardia

Age: Childhood through adolescence

Carriers ascertained through family screening or through an incidental finding are often asymptomatic in this window, with resting bradycardia and noncompaction already present on imaging and no indication for a device. Being asymptomatic is not the same as being low risk: in the same family the adolescent proband was asymptomatic yet had 66 sinus pauses of three seconds or longer, the longest 10.5 seconds, and received a primary-prevention device. This is the phase in which cascade screening is most useful, since the structural findings are established well before symptoms.

Show evidence (2 references)

PMID:35257104 SUPPORT Human Clinical

"Her cardiac investigations showed sinus bradycardia, borderline aortic dilatation on echocardiogram and mild biventricular dilatation, NNC, and normal systolic function on cardiac MRI"

A 13-year-old carrier identified by predictive family testing already has bradycardia, noncompaction and borderline aortic dilatation while remaining asymptomatic and device-free.

PMID:35257104 SUPPORT Human Clinical

"His ambulatory electrocardiographic (ECG) monitoring revealed 66 significant asymptomatic sinus pauses (≥3 seconds, the longest lasting 10.5 seconds), mainly nocturnal"

Her 15-year-old brother, in the same family and the same age window, was equally asymptomatic yet carried a heavy pause burden and was implanted, which is why this phase is described as often rather than uniformly device-free.

Symptomatic sinus node dysfunction and device therapy

Age: Late adolescence through mid-adulthood

Clinical manifestation follows adolescence, with a mean age at diagnosis near 40 years and pacemaker implantation on average in the fifth decade. Both are decades earlier than sporadic sick sinus syndrome and roughly two decades later than the SCN5A form, which is what makes age at presentation a usable discriminator between the familial subtypes.

Show evidence (2 references)

PMID:28104484 SUPPORT Human Clinical

"SSS with HCN4 mutations may form a distinct SSS subgroup characterized by early clinical manifestation after adolescence and frequent association with AF and LVNC."

States the post-adolescent onset window and the accompanying atrial fibrillation and noncompaction burden that define this phase.

PMID:28104484 SUPPORT Human Clinical

"Meta-analysis of HCN4 mutation carriers showed a significantly younger age at diagnosis (39.1 ± 21.7 years) than in sporadic SSS (74.3 ± 0.4 years; P <.001), but a significantly older age than in SCN5A mutation carriers (20.0 ± 17.6 years; P = .003)."

Quantifies the age at diagnosis for this phase against both sporadic sick sinus syndrome and the SCN5A form.

Aortic dilatation, onset not reliably age-ordered

Age: Adolescence through adulthood; onset not reliably age-ordered

Ascending aortic and aortic root dilatation has been described as age-dependent in penetrance across HCN4 families, but it has also been found in a 15-year-old and a 13-year-old carrier while absent in their 50-year-old mother, so it is not reliably ordered by age within a family. The practical consequence is that imaging surveillance cannot be deferred in a young carrier on the strength of the age-dependence claim.

Show evidence (2 references)

PMID:35257104 SUPPORT INDIRECT Human Clinical

"20 of 26 patients (77%) and 6/9 (66.6%) patients with the p.Gly482Arg variant had aortic dilatation"

Reports how often aortic dilatation accompanies the HCN4 phenotype. The counts are this paper's summary of an earlier eight-family series rather than its own measurements, so the figure reaches this record through the review step.

PMID:35257104 SUPPORT Human Clinical

"we could not demonstrate the age-dependent penetrance of the aortic dilatation as it was already present in the younger members of this family and absent in the mother"

The same report's own family contradicts a strict age dependence, which is the reason this phase is recorded with a caveat rather than as a staged expectation.

📊

Prevalence

1

First-degree relatives of individuals with pacemaker-treated sinus node dysfunction, Denmark

Lifetime Prevalence 790.0 per 100,000 >1 in 1,000

Cumulative incidence of pacemaker-treated sinus node dysfunction by age 68 was 0.79% in first-degree relatives against 0.27% in the general population, a rate ratio of 2.9 that rose to 5.5 when the index case was implanted at or before 60 years. Study design: nationwide register-based cohort, 6,027,090 individuals followed 1982 to 2022. This is heritable sinus node dysfunction at population scale and is not genotyped, so SSS2 is one of several contributing causes rather than the measured entity, and the recorded rate is the rate for that relative population, not a prevalence for SSS2. It is recorded because it is the only population-scale occurrence figure available for the familial form, and because the inverse relationship with onset age is the epidemiological shadow of exactly the early-onset Mendelian subgroup this entry describes. No general-population prevalence has been reported for SSS2 itself; the HCN4 shares of ascertained cohorts are recorded under genetic.case_fractions, which is the slot for a genetic-spectrum share.

Show evidence (1 reference)

PMID:39535890 SUPPORT INDIRECT Human Clinical

"The adjusted rate ratio (RR) of pacemaker-treated SND was 2.9 (2.4-3.6) for individuals having any father, mother, or sibling with a pacemaker implanted on this indication compared with the general population (derived cumulative incidence at the age of 68 years: 0.79 and 0.27%, respectively)."

Gives both the recorded cumulative incidence and its general-population comparator. The cohort is not genotyped, so the step from familial sinus node dysfunction to SSS2 specifically is an inference.

🔀

Differential Diagnoses

5

Conditions with similar clinical presentations that must be differentiated from Sick Sinus Syndrome 2, Autosomal Dominant:

Familial Sick Sinus Syndrome MONDO:0012061

Overlapping Features The dismech umbrella entry for inherited sinoatrial node dysfunction, which spans several causal genes (HCN4, SCN5A, ANK2, LMNA) and both dominant and recessive transmission. SSS2 is the HCN4-specific, autosomal dominant member of that set and is curated separately because MONDO models it as a distinct disease-series-by-gene entity with its own OMIM record.

Distinguishing Features

The umbrella entry is gene-heterogeneous and also spans the autosomal recessive SCN5A form, LMNA and ANK2.
SSS2 is defined by a heterozygous HCN4 loss-of-function variant acting on the funny current.
Left ventricular noncompaction is a characteristic co-segregating feature of the HCN4 form specifically.

Show evidence (1 reference)

PMID:28104484 SUPPORT Human Clinical

"Familial sick sinus syndrome (SSS) is often attributable to mutations in genes encoding the cardiac Na channel SCN5A and pacemaker channel HCN4."

States the gene heterogeneity of the umbrella entity, which is what makes the HCN4 form a member of it rather than a synonym for it.

Sick sinus syndrome 1 Not Yet Curated MONDO:0024562

Overlapping Features The SCN5A-related form of familial sick sinus syndrome, in which compound-heterozygous loss-of-function alleles of the cardiac sodium channel reduce myocardial excitability.

Distinguishing Features

Recessive rather than dominant transmission.
Markedly younger age at diagnosis and at pacemaker implantation than the HCN4 form.
Lacks the atrial fibrillation and left ventricular noncompaction burden characteristic of SSS2.

Show evidence (1 reference)

PMID:28104484 SUPPORT Human Clinical

"Meta-analysis of HCN4 mutation carriers showed a significantly younger age at diagnosis"

Establishes the age-at-diagnosis separation between HCN4 (SSS2), sporadic sick sinus syndrome, and SCN5A (SSS1) carriers.

Sinoatrial Block MONDO:0020806

Overlapping Features Failure of conduction of the sinoatrial impulse out of the node into atrial myocardium, producing pauses that on the surface ECG can look like sinus arrest.

Distinguishing Features

Sinoatrial block is a disorder of impulse exit (conduction); SSS2 is a disorder of impulse generation (automaticity).
Sinoatrial exit block may also occur within the SSS2 phenotype, so the distinction is mechanistic rather than mutually exclusive.

Show evidence (1 reference)

PMID:34383451 SUPPORT INDIRECT Human Clinical

"Electrocardiography findings include sinus bradycardia, sinus pauses or arrest, sinoatrial exit block, chronotropic incompetence, or alternating bradycardia and tachycardia"

Lists sinoatrial exit block among the electrocardiographic findings of sinus node dysfunction itself, which is why this differential is a mechanistic distinction rather than a mutually exclusive alternative diagnosis.

Sinoatrial Node Dysfunction and Deafness MONDO:0013960

Overlapping Features An autosomal recessive channelopathy caused by biallelic CACNA1D loss-of-function, in which loss of the Cav1.3 L-type calcium current produces both sinoatrial node dysfunction and congenital deafness.

Distinguishing Features

Recessive CACNA1D rather than dominant HCN4.
The calcium-current lesion is shared with the cochlear inner hair cell ribbon synapse, so congenital sensorineural deafness accompanies the bradycardia.
No left ventricular noncompaction.

Show evidence (2 references)

PMID:21131953 SUPPORT Human Clinical

"We describe a human channelopathy (termed SANDD syndrome, sinoatrial node dysfunction and deafness) with a cardiac and auditory phenotype that closely resembles that of Cacna1d(-/-) mice."

Names the entity and its combined cardiac and auditory phenotype, the feature that separates it from SSS2 at the bedside.

PMID:21131953 SUPPORT Human Clinical

"We used positional cloning to identify a mutation in CACNA1D, which encodes the pore-forming α1 subunit of Ca(v)1.3 LTCCs, in two consanguineous families with deafness."

Establishes the causal gene and the consanguineous, recessive transmission that contrasts with dominant HCN4.

Sick sinus syndrome 4 Not Yet Curated MONDO:0859173

Overlapping Features Familial sinus node and atrioventricular conduction dysfunction caused by variation in the G-protein subunit gene GNB2.

Distinguishing Features

The lesion is in G-protein signalling upstream of the pacemaker channels rather than in the channel itself.
Atrioventricular conduction disease is a defining rather than incidental component.

Show evidence (1 reference)

PMID:30645171 SUPPORT Human Clinical

"Recently, a gain-of-function mutation in the G-protein gene GNB2 led to enhanced activation of the GIRK (G-protein activated inwardly rectifying K+ channel)."

Places the SSS4 lesion in G-protein signalling acting on a potassium channel, upstream of and distinct from the HCN4 pacemaker channel defect of SSS2. The quoted sentence is this paper's background summarising the primary GNB2 report rather than its own result, which is a KCNJ5 variant in a separate family, so it is cited here for the mechanism class it states and not as the primary source for SSS4.

📊

Related Datasets

3

Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes [CITE-seq] geo:GSE279632

The two-sample CITE-seq component of a study that resolved the human sinoatrial node into Core Pacemaker, Sinus Venosus and Transitional pacemaker subtypes and identified CD34 as a surface marker enriching functional pacemaker cells. This accession holds only that component; the single-nuclei and single-cell RNA sequencing of fetal and stem cell-derived sinoatrial node cells that the quoted sentence describes sits in sibling accessions of the same series. This is a reference dataset for the cell type whose failure defines SSS2, not an SSS2 patient cohort, and it contains no HCN4 variant carriers. Its value here is that it makes the affected compartment addressable: a CD34 sort yields the pacemaker cells in which an HCN4 allele would have to be assayed.

human SINGLE CELL RNA SEQ

PMID:39604360

Relevance is at the level of cell type rather than genotype. Verified with just verify-datasets.

Show evidence (1 reference)

PMID:39604360 SUPPORT In Vitro

"Here we use single-nuclei/cell RNA sequencing of fetal and human pluripotent stem cell-derived sinoatrial node cells to reveal that they consist of three subtypes of pacemaker cells: Core Pacemaker, Sinus Venosus, and Transitional Cells."

Describes the study this accession belongs to and the material it profiles, human sinoatrial node pacemaker cells at single-cell resolution. The sentence covers the whole series rather than this CITE-seq component alone, which the description states.

A single cell transcriptional roadmap of human pacemaker cell differentiation geo:GSE189782

Single-cell RNA sequencing and trajectory inference over human induced pluripotent stem cells differentiating into sinoatrial-node-like cardiomyocytes, resolving the head, tail and transitional subtypes and the WNT and TGF-beta signalling decisions that separate them. It is the developmental counterpart of the atlas above and the transcriptional map of the platform used by the hiPSC pacemaker-cardiomyocyte model in this entry.

human SINGLE CELL RNA SEQ

PMID:36217819

Wild-type differentiation series, no disease genotypes. Verified with just verify-datasets.

Show evidence (1 reference)

PMID:36217819 SUPPORT In Vitro

"Here, we performed single cell RNA sequencing (scRNA-seq) and trajectory inference on human induced pluripotent stem cells (hiPSCs) differentiating to SAN-like cardiomyocytes (SANCMs) to construct a roadmap of transcriptional changes and lineage decisions."

Describes the assay and material behind this accession and ties it to the hiPSC pacemaker-cardiomyocyte platform recorded under experimental_models.

HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload geo:GSE329403

Cardiac RNA sequencing from HCN4(Y527F) knock-in mice, which carry a gain-of-function C-linker mutation that shifts channel activation to more positive potentials. The allele is the mirror image of the SSS2 lesion, and the mice have a higher intrinsic heart rate with no structural cardiomyopathy up to twelve months. It is included here as the opposite-direction control on the same gene: it is the closest available transcriptional readout of altered HCN4 channel availability in myocardium, and it bears on whether the structural arm of SSS2 can be a consequence of the rate change alone.

house mouse BULK RNA SEQ

PMID:42358349

Triage note: this is a gain-of-function allele in mouse, not the human loss-of-function lesion of SSS2, and it must not be read as an SSS2 expression dataset. Verified with just verify-datasets.

Show evidence (1 reference)

PMID:42358349 SUPPORT Model Organism

"We generated HCN4(Y527F) knock-in mice (HCN4F) carrying a GOF mutation in the C-linker of HCN4 channels, which shifts their activation curves to more positive potentials."

Describes the genotype behind this accession and makes explicit that the direction of effect is opposite to the SSS2 lesion.

🧫

Experimental Models

2

Patient-derived hiPSC lines carrying a heterozygous and a homozygous HCN4 variant (UKMi009-A, UKMi011-A) IPSC_DERIVED_MODEL

Two human induced pluripotent stem cell lines reprogrammed from members of a consanguineous family with sinus node dysfunction, one carrying the familial HCN4 variant heterozygously and the other homozygously. The pair is a gene-dose series in the patients' own genetic background and at the native locus, which is the closest available human substrate for the SSS2 lesion. As published, the lines are characterised only for pluripotency (karyotype, marker expression, three-germ-layer differentiation); no cardiomyocyte electrophysiology is reported, so nothing yet establishes that they reproduce the funny-current deficit.

Organism

human NCBITaxon:9606

Cell source

Reprogrammed somatic cells from two members of a consanguineous family with inherited sinus node dysfunction.

Publication

PMID:40414080

Pathograph links

HCN4 Loss-of-Function Variant perturbs fidelity: unknown The lines carry the family's own HCN4 variant at the endogenous locus in one and two copies, instantiating the genetic lesion of this node as a dose series rather than as an overexpressed construct.

Limitations: The family is consanguineous and the report does not say which members are affected, so it is not established that the heterozygous carrier has the disease; in a consanguineous pedigree segregating a homozygous allele the heterozygote may well be an unaffected carrier. Neither line is therefore known to instantiate the dominant heterozygous genotype of SSS2, and the homozygous state has no counterpart in it at all. The report also does not characterise the variant as loss-of-function: the link to this node rests on the gene, not on a demonstrated functional consequence. The publication reports pluripotency characterisation alone, with no cardiomyocyte differentiation, no I_f recording and no beating rate, so the functional fidelity of the model is untested rather than moderate or high.

Show evidence (2 references)

PMID:40414080 SUPPORT In Vitro

"Here, we generated two hiPSC lines from a consanguineous family with SND where the HCN4 variant was either present in heterozygous or homozygous state."

Establishes that the lines carry the patient HCN4 variant in a gene-dose series, which is the perturbation this link records.

+ 1 more reference

Show evidence (1 reference)

PMID:40414080 SUPPORT In Vitro

"Generated hiPSCs enable further cardiomyocyte cell differentiation to provide unique patient-derived SND in-vitro disease models in a gene-dose dependent manner."

The authors state the intended use of the lines as patient-derived sinus node dysfunction disease models, which is the basis for listing them here.

hiPSC-derived pacemaker cardiomyocytes as a human I_f measurement platform IPSC_DERIVED_MODEL

Human induced pluripotent stem cell-derived cardiomyocytes differentiated toward a pacemaker phenotype and characterised by patch clamp across differentiation time. The cells express HCN4 as the dominant HCN isoform together with the accessory subunits that shape I_f in situ, and their diastolic depolarisation responds to adrenergic and muscarinic agonists. This is a wild-type platform rather than an SSS2 model: it supplies the human measurement context against which a variant line's funny current would be interpreted.

Organism

human NCBITaxon:9606

Publication

PMID:33934225

Pathograph links

Reduced Funny Current and Slowed Diastolic Depolarization measures fidelity: moderate Provides direct patch-clamp measurement of I_f and of its autonomic modulation in human pacemaker-like cardiomyocytes, the quantity whose reduction defines this node.

Limitations: The cells are wild type, so they establish the measurement context rather than the disease state. Their I_f properties drift with differentiation time, activating at more negative potentials after day 30, and basal cAMP is low enough that the muscarinic response is small unless the cells are pre-stimulated, so absolute values are not directly comparable with adult human sinoatrial node myocytes.

Readouts

Funny current density and voltage dependence of activation

Direction: ALTERED

Interpretation: The measurement that a variant line would be compared against; in wild-type cells it shifts negative and slows with time in culture.

Show evidence (1 reference)

PMID:33934225 SUPPORT In Vitro

"Patch-clamp analysis showed that If density did not change during differentiation; however, after day 30, it activates at more negative potential and with slower time constants."

Reports the direct I_f measurement and its time dependence in the platform.

Beating rate response to adrenergic and muscarinic agonists

Direction: INCREASED

Interpretation: Confirms that the autonomic arm of pacemaking, the arm lost in cAMP-insensitive HCN4 alleles, is measurable in this platform.

Show evidence (1 reference)

PMID:33934225 SUPPORT In Vitro

"The adrenergic agonist isoproterenol induced rate acceleration and a positive shift of If voltage-dependence (EC50 73.4 nM)."

Demonstrates that adrenergic modulation of I_f voltage dependence and of rate can be resolved in these cells.

Show evidence (1 reference)

PMID:33934225 SUPPORT In Vitro

"pCMs express mainly HCN4 and HCN1 together with the accessory subunits CAV3, KCR1, MiRP1, and SAP97 that contribute to the context-dependence of If."

Establishes that the current being measured is carried predominantly by the gene this disease affects, which is what makes the platform informative for this node.

Show evidence (1 reference)

PMID:33934225 SUPPORT In Vitro

"we demonstrated that pCMs display an If with the physiological properties expected by pacemaker cells and may thus represent a suitable model for studying human If-related sinus arrhythmias."

The authors propose the platform for studying human I_f-related sinus arrhythmias, the class this disease belongs to.

🐁

Animal Models

2

hHCN4-573X inducible cardiac transgenic mouse

Mice engineered for heart-specific, inducible expression of the human truncating HCN4-573X allele found in the index SSS2 patient. The model isolates the cAMP-insensitivity arm of the human mechanism.

Species

Mouse

Genotype

heart-specific, inducible expression of the human HCN4-573X allele

Publication

PMID:19570998

Pathograph links

Loss of cAMP-Dependent Rate Modulation recapitulates fidelity: high Expression of the human disease allele eliminates cAMP sensitivity of I_f in sinoatrial node cells and lowers resting and maximal heart rate, the mechanism proposed for the human carrier.

Limitations: The transgene is expressed heart-wide and inducibly rather than as a germline heterozygous allele, and murine sinoatrial physiology operates at a resting rate roughly an order of magnitude faster than human. The model also shows that relative rate adaptation during exercise is preserved, so it does not reproduce chronotropic incompetence as completely as the human case report implies.

Readouts

cAMP sensitivity of I_f in sinoatrial node pacemaker cells

Direction: ABOLISHED

Interpretation: Direct molecular readout of the proposed human mechanism.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"We found that hHCN4-573X expression causes elimination of the cAMP sensitivity of I(f) and decreases the maximum firing rates of SAN pacemaker cells."

Reports elimination of cAMP sensitivity and reduced maximal pacemaker firing rate.

Heart rate in conscious mice at rest and during exercise

Direction: DECREASED

Interpretation: Whole-animal correlate of the human resting bradycardia and blunted maximal rate.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"In conscious mice, hHCN4-573X expression leads to a marked reduction in heart rate at rest and during exercise."

Direct in vivo measurement of the bradycardic phenotype.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"Our data also reveal the pathophysiologic mechanism of hHCN4-573X-linked SAN dysfunction in humans."

The authors state explicitly that the model is informative for the human HCN4-573X sinoatrial node dysfunction mechanism.

Show evidence (1 reference)

PMID:19570998 SUPPORT Model Organism

"we generated mice with heart-specific and inducible expression of a human HCN4 mutation (573X) that abolishes the cAMP-dependent regulation of HCN channels"

Establishes that the model carries the human SSS2 allele itself rather than a species-matched surrogate, which is what makes it informative for this entry.

Inducible cardiac-specific HCN4 knockout mouse (ciHCN4-KO)

Adult-onset, cardiac-specific ablation of Hcn4, which removes rather than alters the pacemaker channel. Establishes that HCN4 is required for normal impulse generation in the adult heart.

Species

Mouse

Genotype

inducible, cardiac-specific Hcn4 ablation in the adult

Publication

PMID:21220308

Pathograph links

Sinoatrial Node Automaticity Failure partially recapitulates fidelity: moderate Ablation reduces I_f and the spontaneous rate of isolated sinoatrial node myocytes and produces severe bradycardia in vivo, confirming that loss of HCN4 function is sufficient to depress nodal automaticity.

Limitations: Complete ablation of both alleles in the adult heart is a far more severe lesion than the heterozygous, partially functional channels of human SSS2: the mice progress to atrioventricular block, cardiac arrest and death within days, an outcome not seen in HCN4 carriers, so the model overstates severity and adds an AV-conduction phenotype not characteristic of the human disease.

Readouts

HCN4 protein expression in sinoatrial node tissue and cells

Direction: DECREASED

Interpretation: Confirms the molecular lesion underlying the depressed nodal automaticity measured in the same animals.

Show evidence (1 reference)

PMID:21220308 SUPPORT Model Organism

"In agreement with functional results, immunofluorescence and Western blot analysis showed reduced expression of HCN4 protein in SAN tissue and cells."

Confirms loss of HCN4 protein in sinoatrial node tissue accompanying the functional deficit.

Show evidence (1 reference)

PMID:21220308 SUPPORT Model Organism

"Our data show that cardiac HCN4 channels are essential for normal heart impulse generation and conduction in adult mice and support the notion that dysfunctional HCN4 channels can be a direct cause of rhythm disorders."

States that the model supports dysfunctional HCN4 channels as a direct cause of rhythm disorders, the claim this entry makes for SSS2.

Show evidence (1 reference)

PMID:21220308 SUPPORT Model Organism

"ablation of HCN4 consistently leads to progressive development of severe bradycardia"

Establishes the model's core phenotype, progressive severe bradycardia on loss of HCN4, which is the reason it is used here as the loss-of-function reference point.

🧮

Computational Models

1

Fabbri-Severi human sinoatrial node cell model with HCN4 mutation-induced I_f changes PHYSIOLOGICAL

A published in-silico risk-stratification study of SSS2. In-vitro biophysical data for HCN4 loss-of-function alleles were used to compute the charge carried by I_f during diastolic depolarization of a prerecorded human sinoatrial node action potential, and that quantity was used to drive the Fabbri-Severi model of a human sinoatrial node pacemaker cell. It is the computational counterpart of the funny-current node in this entry: it makes the qualitative claim (less diastolic I_f, slower firing) quantitative and allele-specific.

PMID:37760888

Pathograph links

Reduced Funny Current and Slowed Diastolic Depolarization measures fidelity: moderate The simulated beating rate of the human sinoatrial node cell model tracks the computed diastolic I_f charge very closely, and the same quantity correlates strongly with the resting and minimum heart rates observed in carriers of the corresponding HCN4 mutations.

Limitations: The correlation with clinical heart rate is strong but not deterministic, the analysis is restricted to the subset of HCN4 alleles with both quantitative clinical and in-vitro data, and the authors state that a translational perspective remains to be established.

Show evidence (1 reference)

PMID:37760888 SUPPORT Computational

"The clinically observed minimum or resting heart rates showed a strong correlation with Qf"

Links the simulated diastolic funny-current charge to the heart rate actually measured in HCN4 mutation carriers.

Findings

The diastolic funny-current charge computed by action-potential clamp predicts both the simulated pacemaker rate of a human sinoatrial node cell model and the resting or minimum heart rate of HCN4 mutation carriers, making it a candidate risk-stratification measure for HCN4 loss-of-function sinus bradycardia.

Show evidence (1 reference)

PMID:37760888 SUPPORT Computational

"The beating rate of the model cell showed a very strong correlation with Qf from the simulated action potential clamp experiments"

Reports the correlation between simulated pacemaker rate and diastolic funny-current charge that this finding states.

Show evidence (1 reference)

PMID:37760888 SUPPORT Computational

"HCN4 is the gene responsible for the hyperpolarization-activated 'funny' current If, which is an important modulator of the spontaneous diastolic depolarization underlying the sinus node pacemaker activity."

States the mechanistic premise the simulation encodes, matching this entry's funny-current pathophysiology node.

{ }

Source YAML

click to show

name: Sick Sinus Syndrome 2, Autosomal Dominant
creation_date: "2026-08-17T00:00:00Z"
category: Mendelian
description: >-
  Sick sinus syndrome 2 (SSS2) is the autosomal dominant, HCN4-related form of
  familial sinus node dysfunction. HCN4 encodes the pore-forming subunit of the
  hyperpolarization-activated, cyclic-nucleotide-gated pacemaker channel that
  carries the funny current (I_f), the inward current responsible for the early
  phase of diastolic depolarization in sinoatrial node pacemaker cells and for
  the cAMP-dependent autonomic modulation of heart rate. Heterozygous
  loss-of-function variants act either by shifting the voltage dependence of
  activation to more negative potentials, by dominant-negative suppression of
  wild-type subunits, by defective channel synthesis and trafficking, or by
  truncating the cyclic-nucleotide-binding domain so that the channel becomes
  cAMP-insensitive. The result is a smaller inward diastolic current, a slower
  rate of diastolic depolarization, and depressed sinoatrial automaticity —
  clinically, sinus bradycardia, sinus pauses, chronotropic incompetence,
  syncope, and a high burden of atrial fibrillation. A distinctive feature of
  the HCN4 form, not shared with the sodium-channel forms of familial sick
  sinus syndrome, is co-segregation of left ventricular noncompaction
  cardiomyopathy (and, in some pedigrees, dilation of the ascending aorta) with
  the bradycardia, indicating that the same channel lesion also perturbs
  myocardial development.
disease_term:
  preferred_term: sick sinus syndrome 2, autosomal dominant
  term:
    id: MONDO:0008102
    label: sick sinus syndrome 2, autosomal dominant
parents:
- Familial Sick Sinus Syndrome
- Channelopathy
synonyms:
- SSS2
- HCN4 sick sinus syndrome
- sick sinus syndrome caused by mutation in HCN4
- HCN4-related sinus node dysfunction
- familial sinus bradycardia, HCN4-related
prevalence:
- population: >-
    First-degree relatives of individuals with pacemaker-treated sinus node
    dysfunction, Denmark
  measure_type: LIFETIME_PREVALENCE
  prevalence_class: ABOVE_1_IN_1000
  rate_per_100000: 790.0
  notes: >-
    Cumulative incidence of pacemaker-treated sinus node dysfunction by age 68
    was 0.79% in first-degree relatives against 0.27% in the general
    population, a rate ratio of 2.9 that rose to 5.5 when the index case was
    implanted at or before 60 years. Study design: nationwide register-based
    cohort, 6,027,090 individuals followed 1982 to 2022. This is heritable
    sinus node dysfunction at population scale and is not genotyped, so SSS2 is
    one of several contributing causes rather than the measured entity, and the
    recorded rate is the rate for that relative population, not a prevalence
    for SSS2. It is recorded because it is the only population-scale occurrence
    figure available for the familial form, and because the inverse
    relationship with onset age is the epidemiological shadow of exactly the
    early-onset Mendelian subgroup this entry describes. No general-population
    prevalence has been reported for SSS2 itself; the HCN4 shares of
    ascertained cohorts are recorded under genetic.case_fractions, which is the
    slot for a genetic-spectrum share.
  evidence:
  - reference: PMID:39535890
    reference_title: "Familial risk of sinus node dysfunction indicating pacemaker implantation: a nationwide cohort study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      The adjusted rate ratio (RR) of pacemaker-treated SND was 2.9 (2.4-3.6)
      for individuals having any father, mother, or sibling with a pacemaker
      implanted on this indication compared with the general population (derived
      cumulative incidence at the age of 68 years: 0.79 and 0.27%,
      respectively).
    explanation: >-
      Gives both the recorded cumulative incidence and its general-population
      comparator. The cohort is not genotyped, so the step from familial sinus
      node dysfunction to SSS2 specifically is an inference.
progression:
- phase: Prenatal and neonatal sinus bradycardia
  age_range: Second trimester through the neonatal period
  notes: >-
    The earliest detectable manifestation is a fetal heart rate below the
    gestational-age norm, which can be accompanied in utero by prominent left
    ventricular trabeculation. Neither the bradycardia nor the noncompaction is
    necessarily symptomatic at this stage, and de novo variants occur, so an
    unremarkable family history does not exclude SSS2 in a bradycardic fetus.
  evidence:
  - reference: PMID:39698436
    reference_title: "Fetal bradycardia associated with left ventricle noncompaction diagnosed as HCN4 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Fetal echocardiography revealed a normal fetal heart except for slightly
      prominent trabeculae in the left ventricle, normal cardiac function, and
      fetal sinus bradycardia with a heart rate of 100 bpm.
    explanation: >-
      Documents both arms of the SSS2 phenotype, bradycardia and trabecular
      noncompaction, at the fetal stage in a carrier later shown to have a
      heterozygous HCN4 in-frame deletion.
- phase: Asymptomatic childhood and adolescent bradycardia
  age_range: Childhood through adolescence
  notes: >-
    Carriers ascertained through family screening or through an incidental
    finding are often asymptomatic in this window, with resting bradycardia and
    noncompaction already present on imaging and no indication for a device.
    Being asymptomatic is not the same as being low risk: in the same family
    the adolescent proband was asymptomatic yet had 66 sinus pauses of three
    seconds or longer, the longest 10.5 seconds, and received a
    primary-prevention device. This is the phase in which cascade screening is
    most useful, since the structural findings are established well before
    symptoms.
  evidence:
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Her cardiac investigations showed sinus bradycardia, borderline aortic
      dilatation on echocardiogram and mild biventricular dilatation, NNC, and
      normal systolic function on cardiac MRI
    explanation: >-
      A 13-year-old carrier identified by predictive family testing already has
      bradycardia, noncompaction and borderline aortic dilatation while
      remaining asymptomatic and device-free.
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      His ambulatory electrocardiographic (ECG) monitoring revealed 66
      significant asymptomatic sinus pauses (≥3 seconds, the longest lasting
      10.5 seconds), mainly nocturnal
    explanation: >-
      Her 15-year-old brother, in the same family and the same age window, was
      equally asymptomatic yet carried a heavy pause burden and was implanted,
      which is why this phase is described as often rather than uniformly
      device-free.
- phase: Symptomatic sinus node dysfunction and device therapy
  age_range: Late adolescence through mid-adulthood
  notes: >-
    Clinical manifestation follows adolescence, with a mean age at diagnosis
    near 40 years and pacemaker implantation on average in the fifth decade.
    Both are decades earlier than sporadic sick sinus syndrome and roughly two
    decades later than the SCN5A form, which is what makes age at presentation
    a usable discriminator between the familial subtypes.
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      SSS with HCN4 mutations may form a distinct SSS subgroup characterized by
      early clinical manifestation after adolescence and frequent association
      with AF and LVNC.
    explanation: >-
      States the post-adolescent onset window and the accompanying atrial
      fibrillation and noncompaction burden that define this phase.
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Meta-analysis of HCN4 mutation carriers showed a significantly younger age
      at diagnosis (39.1 ± 21.7 years) than in sporadic SSS (74.3 ± 0.4 years; P
      <.001), but a significantly older age than in SCN5A mutation carriers
      (20.0 ± 17.6 years; P = .003).
    explanation: >-
      Quantifies the age at diagnosis for this phase against both sporadic sick
      sinus syndrome and the SCN5A form.
- phase: Aortic dilatation, onset not reliably age-ordered
  age_range: Adolescence through adulthood; onset not reliably age-ordered
  notes: >-
    Ascending aortic and aortic root dilatation has been described as
    age-dependent in penetrance across HCN4 families, but it has also been
    found in a 15-year-old and a 13-year-old carrier while absent in their
    50-year-old mother, so it is not reliably ordered by age within a family.
    The practical consequence is that imaging surveillance cannot be deferred
    in a young carrier on the strength of the age-dependence claim.
  evidence:
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      20 of 26 patients (77%) and 6/9 (66.6%) patients with the p.Gly482Arg
      variant had aortic dilatation
    explanation: >-
      Reports how often aortic dilatation accompanies the HCN4 phenotype. The
      counts are this paper's summary of an earlier eight-family series rather
      than its own measurements, so the figure reaches this record through the
      review step.
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we could not demonstrate the age-dependent penetrance of the aortic
      dilatation as it was already present in the younger members of this family
      and absent in the mother
    explanation: >-
      The same report's own family contradicts a strict age dependence, which is
      the reason this phase is recorded with a caveat rather than as a staged
      expectation.

classifications:
  harrisons_chapter:
  - classification_value: CARDIOVASCULAR
    evidence:
    - reference: PMID:17646576
      reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We describe an inherited, autosomal-dominant form of sinus node
        dysfunction caused by a missense mutation in the HCN4 ion channel pore.
      explanation: >-
        SSS2 is a disorder of cardiac impulse generation and belongs with the
        cardiovascular disorders.
  - classification_value: GENETICS_ENVIRONMENT_DISEASE
    evidence:
    - reference: PMID:17646576
      reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Direct sequencing of the exons encoding HCN4 revealed a missense
        mutation, G480R, in the ion channel pore domain in all affected family
        members.
      explanation: >-
        SSS2 is a Mendelian single-gene disorder defined by a segregating HCN4
        variant, so it also belongs to the genetics Part.
  channelopathy_category:
    classification_value: cardiac channelopathy
    notes: >-
      SSS2 is a cardiac channelopathy of the pacemaker (funny) current rather
      than of a repolarizing current: the lesion depresses impulse generation in
      the sinoatrial node instead of destabilizing ventricular repolarization.
    evidence:
    - reference: PMID:26835093
      reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        All mutations described so far are loss-of-function and in agreement
        with the role of funny channels, the predominant type of arrhythmia
        found is bradycardia.
      explanation: >-
        A dedicated review of HCN4 channel mutations frames the disorder as a
        loss-of-function funny-channel channelopathy producing bradycardia.
inheritance:
- name: Autosomal dominant
  description: >-
    SSS2 segregates as an autosomal dominant trait. All reported disease
    variants are heterozygous, and the dominant mechanism is usually
    dominant-negative suppression of wild-type HCN4 subunits within the
    heterotetrameric channel rather than simple haploinsufficiency. Penetrance
    and expressivity vary widely, from asymptomatic sinus bradycardia detected
    only on screening to syncope requiring pacemaker implantation.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  evidence:
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrophysiological testing performed on 2 affected family members
      confirmed significant isolated sinus node dysfunction. Segregation
      analysis suggested autosomal-dominant inheritance.
    explanation: >-
      Formal segregation analysis in a 16-member HCN4-G480R family established
      autosomal dominant transmission of isolated sinus node dysfunction.
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Coexpression experiments showed a dominant-negative effect of HCN4-573X
      subunits on wild-type subunits.
    explanation: >-
      Co-expression of mutant with wild-type subunits demonstrates the
      dominant-negative mechanism underlying dominant transmission.
mechanistic_hypotheses:
- hypothesis_group_id: sinoatrial_automaticity_failure_model
  hypothesis_label: Sinoatrial Pacemaker Automaticity Failure Model (HCN4 specialization)
  status: CANONICAL
  description: >-
    The disease-specific specialization of the module-level
    cardiac_ion_channel_repolarization group of the same name. In SSS2 the
    depressed current is specifically the hyperpolarization-activated funny
    current I_f carried by HCN4, so the bradyarrhythmia arises from a slowed
    diastolic depolarization slope in sinoatrial pacemaker cells rather than
    from depressed sodium-dependent conduction, and syncope follows from
    hypoperfusion during pauses rather than from ventricular tachyarrhythmia.
  evidence:
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These changes, which mimic those of mild vagal stimulation, slow the heart
      rate by decreasing the inward diastolic current.
    explanation: >-
      Names the funny-current-specific route to bradycardia that distinguishes
      this specialization from the sodium-channel arm of the module group.
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All mutations described so far are loss-of-function and in agreement with
      the role of funny channels, the predominant type of arrhythmia found is
      bradycardia.
    explanation: >-
      Confirms that the HCN4 arm of the model consistently yields bradyarrhythmia
      rather than tachyarrhythmia.
pathophysiology:
- name: HCN4 Loss-of-Function Variant
  conforms_to: "cardiac_ion_channel_repolarization#Cardiac Ion-Channel or Calcium-Handling Variant"
  role: trigger
  biological_scale: MOLECULAR
  description: >-
    A heterozygous loss-of-function variant in HCN4 alters the pore-forming
    subunit of the cardiac pacemaker channel. Reported disease alleles cluster
    in three structural regions with three corresponding biophysical
    consequences: pore-domain missense changes (G480R, G482R) that impair
    channel synthesis, trafficking, and gating; C-linker and
    cyclic-nucleotide-binding-domain changes (S672R, K530N) that shift
    activation gating; and C-terminal truncations (573X, 695X) that delete the
    cyclic-nucleotide-binding domain. All are heterozygous, and most act
    dominant-negatively on wild-type subunits within the heterotetramer.
  genes:
  - preferred_term: HCN4
    term:
      id: hgnc:16882
      label: HCN4
  molecular_functions:
  - preferred_term: intracellularly cAMP-activated cation channel activity
    term:
      id: GO:0005222
      label: intracellularly cAMP-activated cation channel activity
    modifier: DECREASED
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found that sinus bradycardia in members of a large family was
      associated with a mutation in the gene coding for the pacemaker HCN4 ion
      channel.
    explanation: >-
      The founding family study links a heterozygous HCN4 variant to inherited
      sinus bradycardia.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Synthesis and expression of the wild-type and mutant HCN4 channel on the
      plasma membrane tested in human embryonic kidney 293 cells using
      biotinylation and Western blot analysis demonstrated a reduction in
      synthesis and a trafficking defect in mutant compared with wild-type
      channels.
    explanation: >-
      Documents the synthesis/trafficking route to reduced channel availability
      for the pore-domain class of HCN4 alleles.
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All mutations described so far are loss-of-function and in agreement with
      the role of funny channels, the predominant type of arrhythmia found is
      bradycardia.
    explanation: >-
      Confirms that the HCN4 disease alleles reported to date are uniformly
      loss-of-function.
  downstream:
  - target: Reduced Funny Current and Slowed Diastolic Depolarization
    causal_link_type: DIRECT
    description: >-
      Reduced channel availability, a hyperpolarizing shift of the activation
      curve, or dominant-negative suppression of wild-type subunits lowers the
      inward diastolic current carried by I_f.
    evidence:
    - reference: PMID:16407510
      reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The mutation associated with bradycardia is located near the cAMP-binding
        site; functional analysis found that mutant channels respond normally to
        cAMP but are activated at more negative voltages than are wild-type
        channels.
      explanation: >-
        Traces the step itself: the disease allele is shown by patch clamp to
        shift activation to more negative voltages, which is what reduces the
        current available during diastole.
    hypothesis_groups:
    - sinoatrial_automaticity_failure_model
  - target: Loss of cAMP-Dependent Rate Modulation
    causal_link_type: DIRECT
    description: >-
      Truncations that remove the cyclic-nucleotide-binding domain, and
      C-linker changes that alter its coupling to the gate, uncouple the
      pacemaker current from cAMP.
    evidence:
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The mutant HCN4 protein (HCN4-573X) had a truncated C-terminus and lacked
        the cyclic nucleotide-binding domain.
      explanation: >-
        Establishes the structural half of the step, that the disease allele
        removes the domain through which cAMP acts.
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Patch-clamp experiments showed that HCN4-573X channels mediated
        I(f)-like currents that were insensitive to increased cellular cAMP
        levels.
      explanation: >-
        Establishes the functional half: the truncated channel still carries
        current but no longer responds to cAMP, which is the loss this edge
        asserts.
  - target: Impaired Ventricular Trabecular Compaction
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      In several pedigrees the same HCN4 allele co-segregates with left
      ventricular noncompaction, implicating the channel in myocardial
      development; the intermediate steps are not established.
    evidence:
    - reference: PMID:25145517
      reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        our study provides the first evidence to our knowledge that mutations in
        this ion channel gene also may be associated with structural
        abnormalities of the myocardium
      explanation: >-
        The authors draw the link from the HCN4 allele to structural myocardial
        abnormality. The claim is co-segregation across pedigrees rather than a
        demonstrated developmental mechanism, which is why the edge is typed
        with unknown intermediates.
    - reference: PMID:25145518
      reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        The symptom complex of SND and NCCM is associated with heritable HCN4
        defects.
      explanation: >-
        Independent replication of the same link in a separate German family
        series published alongside the first, which is what raises this from a
        single-pedigree observation to a reproducible association.
- name: Reduced Funny Current and Slowed Diastolic Depolarization
  role: central_effector
  biological_scale: CELLULAR
  description: >-
    The funny current I_f is the hyperpolarization-activated inward cation
    current that drives the early phase of spontaneous diastolic depolarization
    in sinoatrial node pacemaker cells. Mutant HCN4 channels activate at more
    negative voltages than wild-type channels, so at the diastolic potentials
    actually reached by a pacemaker cell less inward current flows. The
    diastolic depolarization slope falls, the interval to threshold lengthens,
    and the intrinsic firing rate of the node drops. The biophysical change has
    been described as mimicking mild vagal stimulation — a permanent,
    genetically imposed version of a physiological brake.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: membrane depolarization during SA node cell action potential
    term:
      id: GO:0086046
      label: membrane depolarization during SA node cell action potential
    modifier: DECREASED
  - preferred_term: SA node cell action potential
    term:
      id: GO:0086015
      label: SA node cell action potential
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The cardiac pacemaker current I(f) is a major determinant of diastolic
      depolarization in sinus nodal cells and has a key role in heartbeat
      generation.
    explanation: >-
      Establishes the normal role of I_f in diastolic depolarization that is
      lost in SSS2.
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These changes, which mimic those of mild vagal stimulation, slow the heart
      rate by decreasing the inward diastolic current.
    explanation: >-
      States the biophysical mechanism directly: less inward diastolic current
      slows the heart rate.
  - reference: PMID:23178648
    reference_title: "Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In contrast, heteromeric channels composed of mutant and wild-type
      subunits displayed a significant hyperpolarizing shift in the half-maximal
      activation voltage.
    explanation: >-
      Shows that the hyperpolarizing gating shift emerges specifically in
      heteromeric mutant/wild-type channels, the situation in a heterozygous
      carrier.
  downstream:
  - target: Sinoatrial Node Automaticity Failure
    causal_link_type: DIRECT
    description: >-
      A slower diastolic depolarization slope lengthens the pacemaker cycle and
      depresses automaticity of the node as a whole.
    evidence:
    - reference: PMID:21220308
      reference_title: "Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: INDIRECT
      snippet: >-
        In vitro analysis of sinoatrial node (SAN) myocytes isolated from
        ciHCN4-KO mice at the mean time of death revealed a strong reduction of
        both the I(f) current (by ∼70%) and of the spontaneous rate (by
        ∼60%).
      explanation: >-
        Measures the reduction of I_f and the fall in spontaneous firing rate in
        the same isolated nodal myocytes, which is the step this edge asserts.
        The measurement is in mouse and under complete ablation rather than
        heterozygous loss, so it reaches the human edge by inference.
    hypothesis_groups:
    - sinoatrial_automaticity_failure_model
- name: Loss of cAMP-Dependent Rate Modulation
  role: effector
  biological_scale: MOLECULAR
  description: >-
    Beta-adrenergic stimulation raises intracellular cAMP, which binds the
    cyclic-nucleotide-binding domain of HCN4 and shifts activation to more
    positive voltages, accelerating diastolic depolarization; vagal tone does
    the reverse. Truncating HCN4 alleles such as 573X delete this domain
    entirely, so the residual current is insensitive to cAMP. This is the
    proposed mechanistic basis of chronotropic incompetence in SSS2 — a failure
    of rate adaptation that is separable from the resting bradycardia. The
    corresponding mouse model shows that cAMP sensitivity of I_f sets basal and
    maximal heart rate while relative rate regulation during exercise is
    partially preserved by other mechanisms.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: regulation of heart rate
    term:
      id: GO:0002027
      label: regulation of heart rate
    modifier: DECREASED
  - preferred_term: regulation of SA node cell action potential
    term:
      id: GO:0098907
      label: regulation of SA node cell action potential
    modifier: DECREASED
  evidence:
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Patch-clamp experiments showed that HCN4-573X channels mediated I(f)-like
      currents that were insensitive to increased cellular cAMP levels.
    explanation: >-
      Direct demonstration that a truncating HCN4 allele abolishes cAMP
      responsiveness of the pacemaker current.
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Taken together, the clinical, genetic, and in vitro data provide a likely
      explanation for the patient's sinus bradycardia and the chronotropic
      incompetence.
    explanation: >-
      Links the cAMP-insensitive channel phenotype to the patient's chronotropic
      incompetence.
  - reference: PMID:19570998
    reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: INDIRECT
    snippet: >-
      Our data demonstrate that cAMP-mediated regulation of I(f) determines
      basal and maximal heart rates but does not play an indispensable role in
      heart rate adaptation during physical activity.
    explanation: >-
      A mouse model of the human 573X allele shows cAMP sensitivity of I_f sets
      basal and maximal rate. The same study finds that relative exercise rate
      adaptation is preserved, so the chronotropic claim rests on the loss of
      maximal rate rather than on a loss of rate adaptation itself.
  downstream:
  - target: Chronotropic Incompetence
    causal_link_type: DIRECT
    description: >-
      Without cAMP-dependent acceleration of the pacemaker current, heart rate
      fails to rise appropriately with sympathetic drive.
    evidence:
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Taken together, the clinical, genetic, and in vitro data provide a likely
        explanation for the patient's sinus bradycardia and the chronotropic
        incompetence.
      explanation: >-
        The authors connect the cAMP-insensitive channel directly to the
        chronotropic incompetence observed in the carrier, which is this edge.
  - target: Sinoatrial Node Automaticity Failure
    causal_link_type: DIRECT
    description: >-
      Loss of the cAMP-dependent positive shift lowers the operating range of
      pacemaker firing, compounding the resting depression of automaticity.
    evidence:
    - reference: PMID:19570998
      reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      directness: INDIRECT
      snippet: >-
        We found that hHCN4-573X expression causes elimination of the cAMP
        sensitivity of I(f) and decreases the maximum firing rates of SAN
        pacemaker cells.
      explanation: >-
        Shows that removing cAMP sensitivity alone lowers the firing rate of
        sinoatrial pacemaker cells, which is the step from lost modulation to
        depressed automaticity. Measured in mouse cells expressing the human
        allele, so the human edge follows by inference.
- name: Sinoatrial Node Automaticity Failure
  conforms_to: "cardiac_ion_channel_repolarization#Sinoatrial Node Pacemaker Dysfunction"
  role: effector
  biological_scale: TISSUE
  description: >-
    Depressed pacemaker-cell firing translates into failure of the sinoatrial
    node to generate and deliver impulses at an appropriate rate: sinus
    bradycardia at rest, intermittent sinus pauses or arrest, and an inadequate
    rate response to demand. Because the node also anchors atrial activation,
    chronic bradycardia and the associated atrial electrical and structural
    remodeling raise susceptibility to atrial fibrillation, giving the
    tachycardia-bradycardia pattern that is unusually common in HCN4 carriers.
  cell_types:
  - preferred_term: cardiac pacemaker cell of sinoatrial node
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  biological_processes:
  - preferred_term: cardiac conduction
    term:
      id: GO:0061337
      label: cardiac conduction
    modifier: DECREASED
  - preferred_term: regulation of heart rate by cardiac conduction
    term:
      id: GO:0086091
      label: regulation of heart rate by cardiac conduction
    modifier: DECREASED
  locations:
  - preferred_term: sinoatrial node
    term:
      id: UBERON:0002351
      label: sinoatrial node
  evidence:
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrophysiological testing performed on 2 affected family members
      confirmed significant isolated sinus node dysfunction.
    explanation: >-
      Invasive electrophysiology in HCN4-G480R carriers confirms isolated
      sinoatrial node dysfunction as the tissue-level lesion.
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus, diminished function of pacemaker channels is linked to familial
      bradycardia.
    explanation: >-
      States the causal chain from diminished pacemaker-channel function to the
      familial bradycardia phenotype.
  downstream:
  - target: Sinus Bradycardia
    causal_link_type: DIRECT
    description: Depressed nodal firing rate presents as resting sinus bradycardia.
    evidence:
    - reference: PMID:34383451
      reference_title: "Sinus Node Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Electrocardiography findings include sinus bradycardia, sinus pauses or
        arrest, sinoatrial exit block, chronotropic incompetence, or alternating
        bradycardia and tachycardia
      explanation: >-
        Places resting sinus bradycardia first among the direct
        electrocardiographic expressions of the failing sinoatrial node, which
        is the step this edge asserts. The source describes sinus node
        dysfunction generally rather than HCN4 carriers, so the SSS2-specific
        edge follows by inference.
  - target: Sinus Pauses and Sinus Arrest
    causal_link_type: DIRECT
    description: >-
      Intermittent failure of impulse formation produces sinus pauses and
      asystolic gaps.
    evidence:
    - reference: PMID:34383451
      reference_title: "Sinus Node Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Electrocardiography findings include sinus bradycardia, sinus pauses or
        arrest, sinoatrial exit block, chronotropic incompetence, or alternating
        bradycardia and tachycardia
      explanation: >-
        Names sinus pauses and arrest among the electrocardiographic
        expressions of the failing node, which is the step this edge asserts.
        The source describes sinus node dysfunction generally rather than HCN4
        carriers, so the SSS2-specific edge follows by inference.
  - target: Atrial Fibrillation
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - bradycardia-associated atrial electrical and structural remodeling
    description: >-
      Chronic bradycardia and atrial remodeling raise susceptibility to atrial
      fibrillation, producing tachycardia-bradycardia syndrome.
    evidence:
    - reference: PMID:26835093
      reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
      supports: SUPPORT
      evidence_source: OTHER
      directness: INDIRECT
      snippet: >-
        Funny channel-linked arrhythmias, however, also include atrioventricular
        (AV) block and atrial fibrillation, in agreement with an emerging new
        concept according to which defective funny channels have a still
        unexplored role in impairing AV conduction and triggering atrial
        fibrillation.
      explanation: >-
        Supports the existence of the step from funny-channel failure to atrial
        fibrillation. The review calls the route unexplored, which is why the
        edge is typed with known intermediates rather than as direct causation.
  - target: Syncope and Sudden Cardiac Death
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    intermediate_mechanisms:
    - prolonged sinus pauses and asystole
    - cerebral hypoperfusion
    description: >-
      Severe bradycardia or a prolonged pause reduces cerebral perfusion,
      producing presyncope and syncope.
    evidence:
    - reference: PMID:34383451
      reference_title: "Sinus Node Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        About 50% of patients present with cerebral hypoperfusion (e.g.,
        syncope, presyncope, lightheadedness, cerebrovascular accident).
      explanation: >-
        Names the intermediate this edge runs through, cerebral hypoperfusion,
        and quantifies how often it is the presenting problem, which is why the
        link is typed with known intermediates rather than as a direct one. The
        cohort is unselected sinus node dysfunction rather than HCN4 carriers.
    hypothesis_groups:
    - sinoatrial_automaticity_failure_model
- name: Impaired Ventricular Trabecular Compaction
  role: effector
  biological_scale: TISSUE
  description: >-
    HCN4 is expressed during cardiac development, and in several independent
    pedigrees the same segregating HCN4 allele produces both bradycardia and
    left ventricular noncompaction — a myocardium with a persistently
    trabeculated, poorly compacted layer and deep intertrabecular recesses.
    This developmental arm is what distinguishes the HCN4 form of familial sick
    sinus syndrome from the sodium-channel forms, in which no structural
    abnormality is found. It is curated here as a parallel branch of the same
    genetic lesion rather than as maladaptive remodeling secondary to the
    arrhythmia: the noncompaction is present from childhood and does not follow
    a preceding phase of cardiomyocyte injury and neurohormonal activation.
    Some pedigrees additionally show dilation of the ascending aorta.
  cell_types:
  - preferred_term: cardiac muscle cell
    term:
      id: CL:0000746
      label: cardiac muscle cell
  biological_processes:
  - preferred_term: ventricular trabecula myocardium morphogenesis
    term:
      id: GO:0003222
      label: ventricular trabecula myocardium morphogenesis
    modifier: ABNORMAL
  locations:
  - preferred_term: heart left ventricle
    term:
      id: UBERON:0002084
      label: heart left ventricle
  evidence:
  - reference: PMID:25145517
    reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One of these, p.Gly482Arg in HCN4, segregated with the combined
      bradycardia and LVNC phenotype in the entire family.
    explanation: >-
      Establishes co-segregation of a single HCN4 allele with both the
      electrical and the structural phenotype.
  - reference: PMID:25145517
    reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although mutations in HCN4 have been previously linked to bradycardia, our
      study provides the first evidence to our knowledge that mutations in this
      ion channel gene also may be associated with structural abnormalities of
      the myocardium.
    explanation: >-
      States explicitly that HCN4 variants can produce a structural myocardial
      abnormality, not only an electrical one.
  - reference: PMID:25145518
    reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The symptom complex of SND and NCCM is associated with heritable HCN4
      defects.
    explanation: >-
      An independent German cohort reaches the same conclusion for the combined
      sinus-node/noncompaction phenotype.
  downstream:
  - target: Left Ventricular Noncompaction
    causal_link_type: DIRECT
    description: >-
      Failure of trabecular compaction gives the two-layered noncompacted
      myocardium seen on echocardiography and cardiac MRI.

    evidence:
    - reference: PMID:25145518
      reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        SND and biventricular NCCM were diagnosed in multiple members of a
        German family.
      explanation: >-
        Records the noncompaction at the end of this edge as a diagnosis made in
        carriers, and shows it involving both ventricles rather than the left
        alone.
  - target: Dilatation of the Ascending Aorta
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    description: >-
      Ascending aortic dilation accompanies the noncompaction phenotype in some
      HCN4 families; the mechanism linking the channel to the aortic wall is
      unknown.
- name: Syncope and Sudden Cardiac Death
  conforms_to: "cardiac_ion_channel_repolarization#Syncope and Sudden Cardiac Death"
  role: outcome
  biological_scale: ORGANISM
  description: >-
    Severe bradycardia or a prolonged sinus pause transiently abolishes
    effective cardiac output, producing presyncope and syncope from cerebral
    hypoperfusion; an unterminated pause carries a risk of asystolic sudden
    death. This is the shared clinical endpoint with the other inherited
    arrhythmia syndromes, reached in SSS2 through bradyarrhythmia rather than
    ventricular tachyarrhythmia. Prognosis is variable and allele-dependent:
    the G480R pore-domain family remained asymptomatic with normal exercise
    capacity throughout long-term follow-up and required no pacemaker.
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50% of patients present with cerebral hypoperfusion (e.g., syncope,
      presyncope, lightheadedness, cerebrovascular accident).
    explanation: >-
      Supports cerebral hypoperfusion (syncope/presyncope) as the clinical
      endpoint of symptomatic sinus node dysfunction.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite its critical location, this mutation carries a favorable prognosis
      without the need for pacemaker implantation during long-term follow-up.
    explanation: >-
      Qualifies the outcome node: at least one HCN4 pore-domain allele carries a
      benign long-term course, so the outcome is allele- and family-dependent.
phenotypes:
- name: Sinus Bradycardia
  category: Cardiovascular
  description: >-
    Persistently slow sinus rate arising from the reduced diastolic
    depolarization slope of HCN4-mutant pacemaker cells. It is the cardinal and
    most penetrant manifestation of SSS2 and is often the finding that brings a
    family to genetic attention, sometimes in an entirely asymptomatic carrier.
  phenotype_term:
    preferred_term: Sinus bradycardia
    term:
      id: HP:0001688
      label: Sinus bradycardia
  frequency: VERY_FREQUENT
  evidence:
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We found that sinus bradycardia in members of a large family was
      associated with a mutation in the gene coding for the pacemaker HCN4 ion
      channel.
    explanation: >-
      Sinus bradycardia is the defining familial phenotype in the founding HCN4
      pedigree.
  - reference: PMID:35328031
    reference_title: "Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sinus bradycardia and dilation of the ascending aorta occurred in five
      studied patients.
    explanation: >-
      Supports the VERY_FREQUENT band: sinus bradycardia was present in five of
      the six prospectively enrolled patients in this HCN4/LVNC series.
- name: Sick Sinus Syndrome
  category: Cardiovascular
  description: >-
    The composite clinical syndrome of sinoatrial node dysfunction —
    inappropriate bradycardia, pauses, chronotropic incompetence and
    bradycardia-tachycardia alternation — which in SSS2 is the direct
    consequence of the pacemaker-current defect rather than of age-related
    nodal fibrosis.
  phenotype_term:
    preferred_term: Sick sinus syndrome
    term:
      id: HP:0011704
      label: Sick sinus syndrome
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      SSS with HCN4 mutations may form a distinct SSS subgroup characterized by
      early clinical manifestation after adolescence and frequent association
      with AF and LVNC.
    explanation: >-
      Defines HCN4-related disease as a distinct clinical subgroup of sick sinus
      syndrome.
- name: Sinus Pauses and Sinus Arrest
  category: Cardiovascular
  description: >-
    Intermittent failure of sinoatrial impulse formation producing asystolic
    gaps on the electrocardiogram or Holter recording. Pauses are the proximate
    cause of presyncope and syncope in symptomatic carriers and the usual
    trigger for pacemaker implantation.
  phenotype_term:
    preferred_term: Abnormal electrophysiology of sinoatrial node origin
    term:
      id: HP:0011702
      label: Abnormal electrophysiology of sinoatrial node origin
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrocardiography findings include sinus bradycardia, sinus pauses or
      arrest, sinoatrial exit block, chronotropic incompetence, or alternating
      bradycardia and tachycardia (i.e., bradycardia-tachycardia syndrome).
    explanation: >-
      Sinus pauses and arrest are core electrocardiographic manifestations of
      sinus node dysfunction, the syndrome SSS2 produces.
- name: Chronotropic Incompetence
  category: Cardiovascular
  description: >-
    Failure of the heart rate to rise appropriately with metabolic demand. In
    SSS2 this is mechanistically distinct from the resting bradycardia: it
    follows from loss of cAMP-dependent modulation of the pacemaker current, so
    it is most pronounced for alleles that delete or uncouple the
    cyclic-nucleotide-binding domain. It is not universal — the G480R pore
    family had normal exercise capacity.
  phenotype_term:
    preferred_term: Chronotropic incompetence
    term:
      id: HP:0033992
      label: Chronotropic incompetence
  evidence:
  - reference: PMID:12750403
    reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Taken together, the clinical, genetic, and in vitro data provide a likely
      explanation for the patient's sinus bradycardia and the chronotropic
      incompetence.
    explanation: >-
      Documents chronotropic incompetence in the index HCN4-573X patient and
      attributes it to the cAMP-insensitive pacemaker channel.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All affected family members were asymptomatic with normal exercise
      capacity during long-term follow-up.
    explanation: >-
      Counter-evidence that chronotropic incompetence is not obligate in SSS2:
      the HCN4-G480R family retained normal exercise capacity.
  - reference: PMID:28465117
    reference_title: "A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Under maximum exercise test carriers achieved significantly lower heart
      rates than non-carrier family members, and percent heart rate reserve and
      percent corrected heart rate reserve were significantly lower in carriers.
    explanation: >-
      A quantified heart-rate-reserve comparison between genotyped carriers and
      non-carrier relatives in the same family, which is the comparison the two
      case reports above cannot make.
  - reference: PMID:28465117
    reference_title: "A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Applying rigorous criteria for chronotropic incompetence a higher number
      of carriers exhibited chronotropic incompetence.
    explanation: >-
      Applies a formal definition rather than a clinical impression, and finds
      chronotropic incompetence enriched but not universal among carriers,
      which is consistent with the refuting item above.
- name: Prolonged QT Interval
  category: Cardiovascular
  description: >-
    Lengthening of ventricular repolarisation on the surface electrocardiogram,
    reported in individual HCN4 carriers in two independent settings: a
    trafficking-defective D553N carrier who also had torsade de pointes, and a
    neonate with an in-frame HCN4 deletion whose QTc of 500 ms normalised over
    the first months of life. HCN4 is not a repolarising channel, so this is
    not an expected consequence of the funny-current lesion, and whether it is
    a real part of the SSS2 phenotype or a rate-related artefact of severe
    bradycardia is unsettled. Both reports are in genotyped carriers, and the
    distinction matters for drug avoidance. No pathophysiology node in this
    entry produces it, so it stands outside the causal graph rather than being
    given a parent the evidence does not support.
  phenotype_term:
    preferred_term: Prolonged QT interval
    term:
      id: HP:0001657
      label: Prolonged QT interval
  frequency: VERY_RARE
  evidence:
  - reference: PMID:15123648
    reference_title: "Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A missense mutation, D553N, was found in a patient with sinus node
      dysfunction who showed recurrent syncope, QT prolongation in
      electrocardiogram, and polymorphic ventricular tachycardia, torsade de
      pointes.
    explanation: >-
      Records QT prolongation, with torsade de pointes, in a genotyped HCN4
      carrier.
  - reference: PMID:39698436
    reference_title: "Fetal bradycardia associated with left ventricle noncompaction diagnosed as HCN4 mutations."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Electrocardiography (ECG) after birth revealed sinus bradycardia with a
      heart rate of 70–80 bpm, associated with a slightly prolonged QTc of 500.
    explanation: >-
      An independent HCN4 carrier with QT prolongation. The value normalised on
      follow-up, which is part of why the phenotype is banded VERY_RARE and
      described as unsettled rather than asserted as a core feature.
- name: Atrial Fibrillation
  category: Cardiovascular
  description: >-
    Disorganized atrial electrical activity with an irregularly irregular
    ventricular response. Atrial fibrillation is strikingly common in HCN4
    carriers — reported in 43.8% in a meta-analysis of HCN4 probands — and
    frequently alternates with the bradycardia as tachycardia-bradycardia
    syndrome.
  phenotype_term:
    preferred_term: Atrial fibrillation
    term:
      id: HP:0005110
      label: Atrial fibrillation
  frequency: FREQUENT
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moreover, HCN4 mutation carriers were more frequently associated with AF
      (43.8%) and LVNC (50%) and with older age at pacemaker implantation
    explanation: >-
      Quantifies atrial fibrillation at 43.8% of HCN4 mutation carriers,
      supporting the FREQUENT band (30-79%).
  - reference: PMID:23178648
    reference_title: "Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The index patient developed tachycardia-bradycardia syndrome and
      persistent atrial fibrillation (AF) in an age-dependent fashion. Pedigree
      analysis identified eight affected family members with a similar course of
      disease.
    explanation: >-
      An HCN4 pedigree in which tachycardia-bradycardia syndrome with persistent
      atrial fibrillation is the segregating phenotype.
  - reference: PMID:24607718
    reference_title: "A novel trafficking-defective HCN4 mutation is associated with early-onset atrial fibrillation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    directness: INDIRECT
    snippet: >-
      Our findings are consistent with HCN4 haploinsufficiency as the likely
      mechanism for early-onset AF in the p.Pro257Ser carrier.
    explanation: >-
      Adds a second route to the atrial fibrillation arm. This carrier's allele
      fails to reach the membrane and does not co-localise with wild-type
      channel, so the atrial phenotype here follows from simple
      haploinsufficiency rather than from the dominant-negative suppression
      that predominates elsewhere in SSS2. The carrier was ascertained from an
      early-onset atrial fibrillation cohort rather than a sinus node
      dysfunction one, so reading the finding into SSS2 takes an inference
      step.
- name: Left Ventricular Noncompaction
  category: Cardiovascular
  description: >-
    A two-layered left ventricular myocardium with prominent trabeculations and
    deep intertrabecular recesses over a thin compacted layer. It co-segregates
    with the bradycardia in multiple independent HCN4 families and was reported
    in 50% of HCN4 mutation carriers in a meta-analysis, making it the
    distinguishing extra-electrical feature of SSS2.
  phenotype_term:
    preferred_term: Left ventricular noncompaction
    term:
      id: HP:0030682
      label: Left ventricular noncompaction
  frequency: FREQUENT
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moreover, HCN4 mutation carriers were more frequently associated with AF
      (43.8%) and LVNC (50%) and with older age at pacemaker implantation
    explanation: >-
      Quantifies left ventricular noncompaction at 50% of HCN4 mutation
      carriers, supporting the FREQUENT band (30-79%).
  - reference: PMID:25145517
    reference_title: "HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subsequent screening of HCN4 in 3 additional families with the same
      clinical combination of bradycardia and LVNC identified HCN4 mutations in
      each.
    explanation: >-
      Replication across three additional families establishes noncompaction as
      part of the HCN4 phenotype rather than a chance co-occurrence.
- name: Biventricular Noncompaction with Preserved Systolic Function
  category: Cardiovascular
  description: >-
    In noncompaction cohorts stratified by genotype, carriers of ion-channel
    gene mutations, HCN4 among them, have noncompaction of both ventricles and
    a preserved left ventricular ejection fraction, whereas noncompaction
    driven by sarcomeric and cytoskeletal genes is more often left-sided with
    depressed systolic function. The HCN4 arm is additionally distinguished
    within the ion-channel group by the accompanying low heart rate. This makes
    the combination of biventricular involvement, preserved ejection fraction
    and bradycardia a genotype-suggestive pattern rather than an incidental
    imaging description.
  phenotype_term:
    preferred_term: Biventricular noncompaction cardiomyopathy
    term:
      id: HP:0012818
      label: Biventricular noncompaction cardiomyopathy
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:34088380
    reference_title: "Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      we found that those patients had higher median LV ejection fraction (60%
      vs 40%; P < .001) and more biventricular noncompaction (53.1% vs 18.5%; P
      < .001) than the 81 other patients with LVNC
    explanation: >-
      Quantifies the preserved ejection fraction and the biventricular
      distribution. The 53.1% is the share among ion-channel-mutation
      noncompaction patients, that is, conditioned on already having
      noncompaction, not the share among SSS2 carriers. Since noncompaction
      itself is banded FREQUENT at 50% of HCN4 carriers, the implied share of
      all carriers is roughly a quarter, which is why this phenotype is banded
      OCCASIONAL.
  - reference: PMID:34088380
    reference_title: "Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      both the 19 patients with an HCN4 mutation and the 11 patients with an
      RYR2 mutation presented with a higher LV ejection fraction and more
      frequent biventricular noncompaction than the 81 patients with LVNC but
      with no mutation in the ion channel gene, but only patients with HCN4
      mutation presented with a lower heart rate
    explanation: >-
      Confirms the direction of the effect in the 19 HCN4 carriers taken on
      their own, and adds the bradycardia that separates HCN4 from RYR2 within
      the ion-channel group. It gives a direction rather than an
      HCN4-specific percentage, so the band above is not derived from it.
- name: Mitral Valve Prolapse
  category: Cardiovascular
  description: >-
    Billowing of one or both mitral leaflets into the left atrium, reported
    within the extended HCN4 phenotype alongside the aortic and valvular
    findings. Like the aortic dilatation, it sits in the structural rather than
    the electrical arm of the disease and has no established mechanistic link
    to the pacemaker current. Like the prolonged QT interval, it is left
    unconnected in the causal graph rather than attached to the trabecular
    compaction node, since valve and trabecular development are separate
    programmes and nothing reported here links them.
  phenotype_term:
    preferred_term: Mitral valve prolapse
    term:
      id: HP:0001634
      label: Mitral valve prolapse
  frequency: OCCASIONAL
  evidence:
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      more recently, a more complex phenotype has emerged, including primarily
      noncompaction cardiomyopathy (NCC), aortic dilatation but also mitral
      valve defects, early-onset atrial fibrillation, atrioventricular block,
      and ventricular tachycardia
    explanation: >-
      Places mitral valve disease in the extended HCN4 phenotype spectrum
      alongside the noncompaction and aortic findings already curated here.
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a mildly dysplastic aortic valve with mild central regurgitation and no
      stenosis and mild mitral valve prolapse
    explanation: >-
      Documents mitral valve prolapse directly in a p.Gly482Arg carrier, giving
      an individual observation behind the spectrum statement above. The
      frequency is banded OCCASIONAL because it is reported in individual
      carriers rather than counted in any cohort.
- name: Dilatation of the Ascending Aorta
  category: Cardiovascular
  description: >-
    Enlargement of the ascending aorta beyond a body-surface-area-indexed
    z-score of 2, reported alongside noncompaction and bradycardia in HCN4
    families. The mechanism connecting the pacemaker channel to the aortic wall
    is unknown, and this feature is not part of the classical SSS2 description.
  phenotype_term:
    preferred_term: Dilatation of the ascending aorta
    term:
      id: HP:0004970
      label: Ascending tubular aorta aneurysm
  evidence:
  - reference: PMID:35328031
    reference_title: "Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The HCN4 molecular variants influence the presence of a complex LVNC
      phenotype, sinus bradycardia and dilation of the ascending aorta.
    explanation: >-
      Reports ascending aortic dilation in HCN4 families. The HPO binding is
      exact rather than approximate — "Dilatation of ascending aorta" is an
      EXACT synonym of HP:0004970, and the source measured the ascending aorta
      in the parasternal long-axis view indexed to body surface area, the same
      segment the term names. The series is small (six patients, four
      families) and the mechanism linking the pacemaker channel to the aortic
      wall is unknown, so the association is better established than its
      explanation.
- name: Syncope
  category: Neurologic
  description: >-
    Transient loss of consciousness from abrupt cerebral hypoperfusion during a
    prolonged sinus pause or severe bradycardia. Syncope is the usual
    symptomatic presentation that leads to device therapy in SSS2, but many
    carriers ascertained through family screening never have an episode.
  phenotype_term:
    preferred_term: Syncope
    term:
      id: HP:0001279
      label: Syncope
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      About 50% of patients present with cerebral hypoperfusion (e.g., syncope,
      presyncope, lightheadedness, cerebrovascular accident).
    explanation: >-
      Syncope is a direct manifestation of the cerebral hypoperfusion caused by
      sinus node dysfunction.
- name: Atrioventricular Block
  category: Cardiovascular
  description: >-
    Impaired conduction from atria to ventricles. HCN4 is expressed throughout
    the cardiac conduction system, not only in the sinoatrial node, and AV block
    is part of the reported funny-channel arrhythmia spectrum, though it is much
    less consistent than the sinus-node phenotype.
  phenotype_term:
    preferred_term: Atrioventricular block
    term:
      id: HP:0001678
      label: Atrioventricular block
  evidence:
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Funny channel-linked arrhythmias, however, also include atrioventricular
      (AV) block and atrial fibrillation, in agreement with an emerging new
      concept according to which defective funny channels have a still
      unexplored role in impairing AV conduction and triggering atrial
      fibrillation.
    explanation: >-
      A review places AV block in the HCN4 arrhythmia spectrum. The review
      itself describes the AV-conduction role as an emerging and still
      unexplored concept, so this is the weakest arm of the phenotype.
genetic:
- name: HCN4 loss-of-function variants
  association: Causative
  relationship_type: CAUSATIVE
  gene_term:
    preferred_term: HCN4
    term:
      id: hgnc:16882
      label: HCN4
  features: >-
    Heterozygous loss-of-function variants in HCN4 are the sole established
    cause of SSS2. Reported alleles include pore-domain missense changes (G480R,
    G482R), C-linker and cyclic-nucleotide-binding-domain changes (K530N, S672R,
    D553N), C-terminal truncations (573X, 695X), and canonical splice-donor
    changes (c.1737+1 G>T). Loss of function is achieved by a hyperpolarizing
    shift in the voltage dependence of activation, by reduced channel synthesis
    and defective trafficking, or by loss of cAMP responsiveness; most alleles
    additionally suppress wild-type subunits within the heterotetramer. P883R is
    the one curated allele that does not follow this pattern: it shifts
    activation in the opposite direction and raises current density, and whether
    it causes SSS2 at all is disputed, so it is not counted among the
    established causes above.
  case_fractions:
  - population: 38 unrelated familial sick sinus syndrome families, genetic screening cohort
    case_fraction_percent: 5.3
    cohort_size: 38
    notes: >-
      Two of 38 unrelated familial SSS families carried an HCN4
      loss-of-function variant (three carried SCN5A), so HCN4 accounts for a
      minority of familial sick sinus syndrome overall even though it defines
      SSS2.
    evidence:
    - reference: PMID:28104484
      reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We genetically screened 38 unrelated SSS families and functionally
        analyzed the mutant SCN5A and HCN4 channels by patch clamping.
      explanation: >-
        Gives the denominator (38 unrelated familial SSS families) for the HCN4
        case fraction.
    - reference: PMID:28104484
      reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We identified two HCN4 and three SCN5A loss-of-function mutations in our
        familial SSS cohort.
      explanation: >-
        Gives the numerator (two HCN4 families) for the HCN4 case fraction.
  - population: Mutation-positive familial sick sinus syndrome probands
    case_fraction_percent: 33.3
    cohort_size: 48
    notes: >-
      HCN4 accounted for 16 of the 48 gene-positive familial sick sinus
      syndrome probands pooled in this meta-analysis, with SCN5A accounting for
      the other 32. Study design: meta-analysis pooling the authors' own cohort
      with previously reported probands. The denominator differs from the 5.3%
      record above and the two are not alternative estimates of the same
      quantity: that record counts HCN4 among all screened familial SSS
      families, whether or not a causal variant was found, while this one
      counts HCN4 only among families in which one was.
    evidence:
    - reference: PMID:28104484
      reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        We also evaluated the clinical features of familial SSS by a
        meta-analysis of 48 SSS probands with mutations in HCN4 (n = 16) and
        SCN5A (n = 32), including previously reported cases, and 538 sporadic
        SSS cases.
      explanation: >-
        Gives both the numerator (16 HCN4 probands) and the denominator (48
        mutation-positive familial probands) behind the recorded share.
  - population: Children with isolated left ventricular noncompaction
    case_fraction_percent: 12.9
    cohort_size: 31
    notes: >-
      HCN4 was the single most frequent causal gene in this paediatric
      noncompaction cohort, 4 of 31 patients. Study design: prospective
      recruitment at a single paediatric reference centre with panel or exome
      sequencing. The cohort is ascertained through the structural phenotype
      rather than through bradycardia, and the report does not state whether
      the four HCN4-positive children had sinus node dysfunction, so this
      measures how often an HCN4 variant underlies childhood noncompaction
      rather than how often SSS2 does.
    evidence:
    - reference: PMID:35893073
      reference_title: "Genetic Profile of Left Ventricular Noncompaction Cardiomyopathy in Children-A Single Reference Center Experience."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Thirty-one paediatric patients prospectively diagnosed with LVNC by
        echocardiography and cardiovascular magnetic resonance examination were
        recruited into the study group.
      explanation: >-
        Establishes the denominator of 31 prospectively recruited paediatric
        noncompaction patients. The step to SSS2 is an inference because the
        cohort is defined by noncompaction rather than by sinus node
        dysfunction.
    - reference: PMID:35893073
      reference_title: "Genetic Profile of Left Ventricular Noncompaction Cardiomyopathy in Children-A Single Reference Center Experience."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        The most frequent defects in our cohort were found in the genes HCN4 (n
        = 4), MYH7 (n = 2) and PRDM16 (n = 2).
      explanation: >-
        Gives the numerator of 4 HCN4-positive children and establishes HCN4 as
        the leading gene in this cohort, again through the noncompaction
        ascertainment rather than a bradycardia one.
  - population: Adults with isolated left ventricular noncompaction
    cohort_size: 95
    notes: >-
      No percentage is recorded because the source ranks genes without giving a
      per-patient count for HCN4: it reports 52 pathogenic or probably
      pathogenic variants in 40 of 95 patients and then ranks the genes, without
      stating which denominator the ranking uses. Study design: prospective
      cohort of 95 unrelated adults screened across 107 cardiomyopathy and
      arrhythmia genes. The ordinal result is still informative, and it is
      recorded because it replicates the paediatric finding in adults: HCN4
      ranked second only to TTN among the causal genes of adult isolated
      noncompaction.
    evidence:
    - reference: PMID:30471092
      reference_title: "Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        The most prevalent genes were TTN, then HCN4, MYH7, and RYR2.
      explanation: >-
        Ranks HCN4 second among causal genes in a 95-patient adult noncompaction
        cohort. As with the paediatric record, the ascertainment is structural
        rather than electrical, so the step to SSS2 is an inference.
  variants:
  - name: HCN4 p.Ser672Arg
    description: >-
      Missense change near the cyclic-nucleotide-binding site, identified in a
      large familial sinus bradycardia pedigree. Mutant channels retain a normal
      response to cAMP but activate at more negative voltages than wild-type,
      reducing the inward diastolic current.
    functional_effects:
    - function: hyperpolarizing shift of activation voltage
      description: >-
        Activation is displaced to more negative potentials while cAMP
        responsiveness is retained, so less current flows during diastole at any
        given membrane potential.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:16407510
      reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The mutation associated with bradycardia is located near the
        cAMP-binding site; functional analysis found that mutant channels
        respond normally to cAMP but are activated at more negative voltages
        than are wild-type channels.
      explanation: >-
        Characterizes the gating-shift mechanism of this allele.
  - name: HCN4 573X (c.1631delC)
    description: >-
      Heterozygous single-base deletion in exon 5 producing a C-terminally
      truncated subunit that lacks the cyclic-nucleotide-binding domain.
      Trafficking is normal, but the resulting current is cAMP-insensitive and
      the subunit exerts a dominant-negative effect on wild-type channels.
    functional_effects:
    - function: loss of cAMP-dependent gating
      description: >-
        Truncation removes the cyclic-nucleotide-binding domain, so the channel
        still reaches the membrane and conducts but no longer responds to cAMP. The
        subunit also suppresses wild-type current in co-expression.
      type: dominant-negative
    - function: loss of cAMP-dependent acceleration of the pacemaker current
      description: >-
        The direction of effect, recorded alongside the dominant-negative
        mechanism above: the net result is less cAMP-responsive I_f than a
        wild-type heterotetramer would carry.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In a candidate gene approach, a heterozygous 1-bp deletion (1631delC) in
        exon 5 of the human HCN4 gene was detected in a patient with idiopathic
        SND.
      explanation: >-
        Identifies the truncating allele in the index patient with idiopathic
        sinus node dysfunction.
    - reference: PMID:12750403
      reference_title: "Pacemaker channel dysfunction in a patient with sinus node disease."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        The mutant HCN4 protein (HCN4-573X) had a truncated C-terminus and
        lacked the cyclic nucleotide-binding domain.
      explanation: >-
        Establishes the structural basis for the loss of cAMP responsiveness.
  - name: HCN4 695X
    description: >-
      C-terminal truncating allele reported in a family with the combined sinus
      node dysfunction and noncompaction phenotype, in the same series that
      described G482R and P883R. It is grouped with 573X as a truncation, but
      unlike 573X it has not been characterised electrophysiologically in the
      cited work, so its consequence is inferred from the variant class and the
      family phenotype rather than measured.
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    functional_effects:
    - function: reduced pacemaker current
      description: >-
        Inferred from the C-terminal truncating class and from the segregating
        phenotype, not from a functional assay: no patch-clamp characterisation
        of this allele is presented in the cited report.
      type: loss-of-function
    evidence:
    - reference: PMID:25145518
      reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Moreover, different truncation (695X) and missense (P883R) HCN4
        mutations segregated with a similar combined phenotype in an
        additional, unrelated family and a single unrelated proband
        respectively, which both lacked CSRP3-W4R.
      explanation: >-
        Establishes the allele, its truncating class, and its co-segregation
        with the combined sinus node dysfunction and noncompaction phenotype in
        an unrelated family.
  - name: HCN4 p.Gly480Arg
    description: >-
      Pore-domain missense change segregating with autosomal dominant isolated
      sinus node dysfunction in a 16-member family. Reduces channel synthesis
      and membrane trafficking and shifts activation to more negative voltages,
      yet carries a benign long-term course.
    functional_effects:
    - function: reduced channel synthesis and membrane trafficking
      description: >-
        Less channel protein is made and reaches the surface, and what does
        activate does so at more negative potentials.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:17646576
      reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Direct sequencing of the exons encoding HCN4 revealed a missense
        mutation, G480R, in the ion channel pore domain in all affected family
        members.
      explanation: >-
        Establishes complete co-segregation of the pore-domain allele with the
        affected status.
  - name: HCN4 p.Gly482Arg
    description: >-
      Pore-domain missense change segregating with the combined sinus node
      dysfunction and biventricular noncompaction phenotype. Mutant subunits are
      nonfunctional and dominant-negative on wild-type current.
    functional_effects:
    - function: nonfunctional pore with suppression of wild-type current
      description: >-
        Homomeric mutant channels carry no current, and the subunit suppresses
        wild-type current when the two are co-expressed.
      type: dominant-negative
    - function: reduced pacemaker current
      description: >-
        The direction of effect, recorded alongside the dominant-negative
        mechanism above: nonfunctional subunits assembling into the
        heterotetramer leave less current than a wild-type channel carries.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:25145518
      reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        HCN4-G482R is located in the highly conserved channel pore domain.
        Mutant subunits were nonfunctional and exerted dominant-negative effects
        on wild-type current.
      explanation: >-
        Characterizes the dominant-negative loss-of-function mechanism of this
        allele.
  - name: HCN4 p.Lys530Asn
    description: >-
      C-linker missense change identified by screening 422 patients with
      tachyarrhythmias. Homomeric mutant channels behave almost like wild-type;
      the loss of function appears only in heteromeric mutant/wild-type
      channels, which show a hyperpolarizing shift of half-maximal activation —
      the biophysical situation of a heterozygous carrier.
    functional_effects:
    - function: heteromer-restricted hyperpolarizing shift of activation
      description: >-
        Homomeric mutant channels are close to wild-type; the shift in half-maximal
        activation appears only in mutant/wild-type heteromers, which is the
        configuration a heterozygous carrier actually has.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:23178648
      reference_title: "Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        In a candidate gene approach, we screened 422 patients with atrial
        and/or ventricular tachyarrhythmias and detected a novel HCN4 gene
        mutation that replaced the positively charged lysine 530 with an
        asparagine (HCN4-K530N) in a highly conserved region of the C-linker.
      explanation: >-
        Identifies the C-linker allele and the screening context in which it was
        found.
  - name: HCN4 p.Asp553Asn
    description: >-
      Missense change in the C-linker region that reduces the amount of channel
      reaching the membrane. It is the worked example of the trafficking class
      of HCN4 allele, and it acts dominant-negatively on the wild-type subunit
      rather than by simple loss of one copy. The index carrier had recurrent
      syncope with a prolonged QT interval and torsade de pointes as well as
      sinus node dysfunction, so this allele's reported phenotype reaches
      repolarisation and ventricular arrhythmia as well as impulse generation.
    functional_effects:
    - function: trafficking defect reducing surface channel
      description: >-
        Less channel reaches the membrane, lowering I_f, and the mutant subunit acts
        dominant-negatively rather than by simple loss of one copy.
      type: dominant-negative
    - function: reduced surface pacemaker current
      description: >-
        The direction of effect, recorded alongside the dominant-negative
        mechanism above: less channel at the membrane means less I_f.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:15123648
      reference_title: "Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        In vitro functional study of the D553N mutation showed a reduced
        membranous expression associated with decreased If currents because of a
        trafficking defect of the HCN4 channel in a dominant-negative manner.
      explanation: >-
        Establishes both the mechanism class, defective trafficking, and the
        dominant-negative mode of action of this allele.
    - reference: PMID:15123648
      reference_title: "Functional characterization of a trafficking-defective HCN4 mutation, D553N, associated with cardiac arrhythmia."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A missense mutation, D553N, was found in a patient with sinus node
        dysfunction who showed recurrent syncope, QT prolongation in
        electrocardiogram, and polymorphic ventricular tachycardia, torsade de
        pointes.
      explanation: >-
        Gives the carrier phenotype, which extends beyond the sinus node to
        repolarization and ventricular arrhythmia.
  - name: HCN4 p.Pro883Arg
    description: >-
      C-terminal missense change that does not fit the loss-of-function pattern
      the rest of these alleles follow. It segregated with the combined sinus
      node dysfunction and noncompaction phenotype in one proband, but when
      characterised functionally it shifted activation to more depolarised
      potentials and, co-expressed with wild-type subunits as in a
      heterozygote, produced higher rather than lower current density. It is
      also common enough (minor allele frequency around 0.9%) that it cannot
      be a fully penetrant cause on its own. The authors of the functional
      study read it as a modifier acting with a common KCNE1 variant to favour
      atrial fibrillation and tachycardia-induced cardiomyopathy, rather than
      as an SSS2 allele. Both readings stand in the literature and neither has
      been withdrawn.
    clinical_significance: UNCERTAIN_SIGNIFICANCE
    functional_effects:
    - function: depolarizing shift of activation with increased current density
      description: >-
        The opposite direction from every other allele in this entry. Activation
        moves to more depolarised potentials and deactivation is faster; in the
        heterozygous configuration, co-expressed with wild type, current density is
        higher than wild type rather than lower. This is why the statement that
        every reported HCN4 disease allele is loss-of-function does not hold for
        this one.
      type: gain-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:25145518
      reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Moreover, different truncation (695X) and missense (P883R) HCN4
        mutations segregated with a similar combined phenotype in an
        additional, unrelated family and a single unrelated proband
        respectively, which both lacked CSRP3-W4R.
      explanation: >-
        The observation that puts P883R in this entry at all: it segregated
        with the combined sinus node dysfunction and noncompaction phenotype in
        an unrelated proband.
    - reference: PMID:31481236
      reference_title: "The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease."
      supports: REFUTE
      evidence_source: IN_VITRO
      snippet: >-
        Co-transfection of WT and mutant subunits, resembling the heterozygous
        cellular situation of our patients, revealed significantly higher
        current densities compared to WT.
      explanation: >-
        Contradicts the loss-of-function reading for this particular allele.
        Reconstructed in the heterozygous configuration, P883R raises rather
        than lowers current density, which is the opposite of the mechanism
        every other allele in this entry works by.
    - reference: PMID:31481236
      reference_title: "The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Together with the common KCNE1 variant S38G, previously proposed as a
        genetic modifier of AF, HCN4-P883R may provide a substrate for the
        development of AF and TIC.
      explanation: >-
        States the modifier reading the functional study reaches, which is the
        alternative to treating this as an SSS2 allele.
  - name: HCN4 c.1737+1 G>T (splice site)
    description: >-
      Canonical splice-donor variant segregating in a large bradycardia family
      with a two-point LOD score of 4.87. Its interest is that the family was
      characterised by Holter and exercise testing rather than by patch clamp,
      so it supplies the quantitative human chronotropic phenotype: carriers
      reach lower peak heart rates, have a reduced heart rate reserve, and show
      increased short-term heart rate variability even after normalisation for
      rate.
    functional_effects:
    - function: reduced pacemaker current
      description: >-
        Inferred from the canonical +1 splice-donor class and from the family's
        bradycardia phenotype rather than measured: this allele was
        characterised clinically, not by patch clamp.
      type: loss-of-function
    gene:
      preferred_term: HCN4
      term:
        id: hgnc:16882
        label: HCN4
    evidence:
    - reference: PMID:28465117
      reference_title: "A novel 'splice site' HCN4 Gene mutation, c.1737+1 G>T, causes familial bradycardia, reduced heart rate response, impaired chronotropic competence and increased short-term heart rate variability."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        A novel c.1737+1 G>T 'splice-site' HCN4 mutation was identified in a
        large family with familial bradycardia which co-segregated with the
        disease providing a two-point LOD score of 4.87.
      explanation: >-
        Establishes the allele and the strength of its co-segregation with
        bradycardia in the family.
  evidence:
  - reference: PMID:26835093
    reference_title: "HCN4, Sinus Bradycardia and Atrial Fibrillation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      All mutations described so far are loss-of-function and in agreement with
      the role of funny channels, the predominant type of arrhythmia found is
      bradycardia.
    explanation: >-
      Confirms the uniform loss-of-function direction of HCN4 disease alleles,
      which holds for every allele curated here except P883R.
  - reference: PMID:31481236
    reference_title: "The C-terminal HCN4 variant P883R alters channel properties and acts as genetic modifier of atrial fibrillation and structural heart disease."
    supports: REFUTE
    evidence_source: IN_VITRO
    snippet: >-
      Patch-clamp recordings of HCN4-P883R channels expressed in HEK293 cells
      showed remarkable alterations of channel properties shifting the
      half-maximal activation voltage to more depolarized potentials, while
      channel deactivation was faster compared to wild-type (WT).
    explanation: >-
      The counterexample to the uniform loss-of-function statement above. A
      depolarising shift of the activation curve increases channel availability
      at diastolic potentials, the opposite of the hyperpolarising shift the
      loss-of-function alleles produce.
  - reference: PMID:16407510
    reference_title: "Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Thus, diminished function of pacemaker channels is linked to familial
      bradycardia.
    explanation: >-
      States the gene-disease relationship established by the founding pedigree.
animal_models:
- name: hHCN4-573X inducible cardiac transgenic mouse
  species: Mouse
  genotype: heart-specific, inducible expression of the human HCN4-573X allele
  description: >-
    Mice engineered for heart-specific, inducible expression of the human
    truncating HCN4-573X allele found in the index SSS2 patient. The model
    isolates the cAMP-insensitivity arm of the human mechanism.
  publication: PMID:19570998
  modeled_mechanisms:
  - target: Loss of cAMP-Dependent Rate Modulation
    relationship: RECAPITULATES
    fidelity: HIGH
    description: >-
      Expression of the human disease allele eliminates cAMP sensitivity of I_f
      in sinoatrial node cells and lowers resting and maximal heart rate, the
      mechanism proposed for the human carrier.
    limitations: >-
      The transgene is expressed heart-wide and inducibly rather than as a
      germline heterozygous allele, and murine sinoatrial physiology operates at
      a resting rate roughly an order of magnitude faster than human. The model
      also shows that relative rate adaptation during exercise is preserved, so
      it does not reproduce chronotropic incompetence as completely as the human
      case report implies.
    readouts:
    - name: cAMP sensitivity of I_f in sinoatrial node pacemaker cells
      target: Loss of cAMP-Dependent Rate Modulation
      direction: ABOLISHED
      interpretation: >-
        Direct molecular readout of the proposed human mechanism.
      evidence:
      - reference: PMID:19570998
        reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          We found that hHCN4-573X expression causes elimination of the cAMP
          sensitivity of I(f) and decreases the maximum firing rates of SAN
          pacemaker cells.
        explanation: >-
          Reports elimination of cAMP sensitivity and reduced maximal pacemaker
          firing rate.
    - name: Heart rate in conscious mice at rest and during exercise
      target: Loss of cAMP-Dependent Rate Modulation
      direction: DECREASED
      interpretation: >-
        Whole-animal correlate of the human resting bradycardia and blunted
        maximal rate.
      evidence:
      - reference: PMID:19570998
        reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          In conscious mice, hHCN4-573X expression leads to a marked reduction
          in heart rate at rest and during exercise.
        explanation: >-
          Direct in vivo measurement of the bradycardic phenotype.
    evidence:
    - reference: PMID:19570998
      reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our data also reveal the pathophysiologic mechanism of hHCN4-573X-linked
        SAN dysfunction in humans.
      explanation: >-
        The authors state explicitly that the model is informative for the human
        HCN4-573X sinoatrial node dysfunction mechanism.
  evidence:
  - reference: PMID:19570998
    reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      we generated mice with heart-specific and inducible expression of a human
      HCN4 mutation (573X) that abolishes the cAMP-dependent regulation of HCN
      channels
    explanation: >-
      Establishes that the model carries the human SSS2 allele itself rather
      than a species-matched surrogate, which is what makes it informative for
      this entry.
- name: Inducible cardiac-specific HCN4 knockout mouse (ciHCN4-KO)
  species: Mouse
  genotype: inducible, cardiac-specific Hcn4 ablation in the adult
  description: >-
    Adult-onset, cardiac-specific ablation of Hcn4, which removes rather than
    alters the pacemaker channel. Establishes that HCN4 is required for normal
    impulse generation in the adult heart.
  publication: PMID:21220308
  modeled_mechanisms:
  - target: Sinoatrial Node Automaticity Failure
    relationship: PARTIALLY_RECAPITULATES
    fidelity: MODERATE
    description: >-
      Ablation reduces I_f and the spontaneous rate of isolated sinoatrial node
      myocytes and produces severe bradycardia in vivo, confirming that loss of
      HCN4 function is sufficient to depress nodal automaticity.
    limitations: >-
      Complete ablation of both alleles in the adult heart is a far more severe
      lesion than the heterozygous, partially functional channels of human SSS2:
      the mice progress to atrioventricular block, cardiac arrest and death
      within days, an outcome not seen in HCN4 carriers, so the model overstates
      severity and adds an AV-conduction phenotype not characteristic of the
      human disease.
    readouts:
    - name: HCN4 protein expression in sinoatrial node tissue and cells
      target: Sinoatrial Node Automaticity Failure
      direction: DECREASED
      interpretation: >-
        Confirms the molecular lesion underlying the depressed nodal
        automaticity measured in the same animals.
      evidence:
      - reference: PMID:21220308
        reference_title: "Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4."
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          In agreement with functional results, immunofluorescence and Western
          blot analysis showed reduced expression of HCN4 protein in SAN tissue
          and cells.
        explanation: >-
          Confirms loss of HCN4 protein in sinoatrial node tissue accompanying
          the functional deficit.
    evidence:
    - reference: PMID:21220308
      reference_title: "Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Our data show that cardiac HCN4 channels are essential for normal heart
        impulse generation and conduction in adult mice and support the notion
        that dysfunctional HCN4 channels can be a direct cause of rhythm
        disorders.
      explanation: >-
        States that the model supports dysfunctional HCN4 channels as a direct
        cause of rhythm disorders, the claim this entry makes for SSS2.
  evidence:
  - reference: PMID:21220308
    reference_title: "Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      ablation of HCN4 consistently leads to progressive development of severe
      bradycardia
    explanation: >-
      Establishes the model's core phenotype, progressive severe bradycardia on
      loss of HCN4, which is the reason it is used here as the loss-of-function
      reference point.
experimental_models:
- name: Patient-derived hiPSC lines carrying a heterozygous and a homozygous HCN4 variant (UKMi009-A, UKMi011-A)
  description: >-
    Two human induced pluripotent stem cell lines reprogrammed from members of
    a consanguineous family with sinus node dysfunction, one carrying the
    familial HCN4 variant heterozygously and the other homozygously. The pair
    is a gene-dose series in the patients' own genetic background and at the
    native locus, which is the closest available human substrate for the SSS2
    lesion. As published, the lines are characterised only for pluripotency
    (karyotype, marker expression, three-germ-layer differentiation); no
    cardiomyocyte electrophysiology is reported, so nothing yet establishes
    that they reproduce the funny-current deficit.
  experimental_model_type: IPSC_DERIVED_MODEL
  cell_source: >-
    Reprogrammed somatic cells from two members of a consanguineous family with
    inherited sinus node dysfunction.
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:40414080
  modeled_mechanisms:
  - target: HCN4 Loss-of-Function Variant
    relationship: PERTURBS
    fidelity: UNKNOWN
    description: >-
      The lines carry the family's own HCN4 variant at the endogenous locus in
      one and two copies, instantiating the genetic lesion of this node as a
      dose series rather than as an overexpressed construct.
    limitations: >-
      The family is consanguineous and the report does not say which members
      are affected, so it is not established that the heterozygous carrier has
      the disease; in a consanguineous pedigree segregating a homozygous allele
      the heterozygote may well be an unaffected carrier. Neither line is
      therefore known to instantiate the dominant heterozygous genotype of
      SSS2, and the homozygous state has no counterpart in it at all. The
      report also does not characterise the variant as loss-of-function: the
      link to this node rests on the gene, not on a demonstrated functional
      consequence. The publication reports pluripotency characterisation alone,
      with no cardiomyocyte differentiation, no I_f recording and no beating
      rate, so the functional fidelity of the model is untested rather than
      moderate or high.
    evidence:
    - reference: PMID:40414080
      reference_title: "Generation of human induced pluripotent stem cell (hiPSC) lines (UKMi009-A and UKMi011-A) harboring a homozygous and heterozygous HCN4 variant from a family with inherited sinus node dysfunction (SND)."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Here, we generated two hiPSC lines from a consanguineous family with SND
        where the HCN4 variant was either present in heterozygous or homozygous
        state.
      explanation: >-
        Establishes that the lines carry the patient HCN4 variant in a
        gene-dose series, which is the perturbation this link records.
    - reference: PMID:40414080
      reference_title: "Generation of human induced pluripotent stem cell (hiPSC) lines (UKMi009-A and UKMi011-A) harboring a homozygous and heterozygous HCN4 variant from a family with inherited sinus node dysfunction (SND)."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Both cell lines exhibited normal karyotype, cell morphology, hiPSC
        marker expression, and differentiation into all three germ layers,
        confirmed by immunofluorescence staining.
      explanation: >-
        The reported characterisation stops at pluripotency, which is why the
        fidelity of this link is recorded as UNKNOWN rather than asserted.
  evidence:
  - reference: PMID:40414080
    reference_title: "Generation of human induced pluripotent stem cell (hiPSC) lines (UKMi009-A and UKMi011-A) harboring a homozygous and heterozygous HCN4 variant from a family with inherited sinus node dysfunction (SND)."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Generated hiPSCs enable further cardiomyocyte cell differentiation to
      provide unique patient-derived SND in-vitro disease models in a gene-dose
      dependent manner.
    explanation: >-
      The authors state the intended use of the lines as patient-derived sinus
      node dysfunction disease models, which is the basis for listing them here.
- name: hiPSC-derived pacemaker cardiomyocytes as a human I_f measurement platform
  description: >-
    Human induced pluripotent stem cell-derived cardiomyocytes differentiated
    toward a pacemaker phenotype and characterised by patch clamp across
    differentiation time. The cells express HCN4 as the dominant HCN isoform
    together with the accessory subunits that shape I_f in situ, and their
    diastolic depolarisation responds to adrenergic and muscarinic agonists.
    This is a wild-type platform rather than an SSS2 model: it supplies the
    human measurement context against which a variant line's funny current
    would be interpreted.
  experimental_model_type: IPSC_DERIVED_MODEL
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: hiPSC-derived sinoatrial-node-like pacemaker cardiomyocyte
    term:
      id: CL:1000477
      label: cardiac pacemaker cell of sinoatrial node
  publication: PMID:33934225
  modeled_mechanisms:
  - target: Reduced Funny Current and Slowed Diastolic Depolarization
    relationship: MEASURES
    fidelity: MODERATE
    description: >-
      Provides direct patch-clamp measurement of I_f and of its autonomic
      modulation in human pacemaker-like cardiomyocytes, the quantity whose
      reduction defines this node.
    limitations: >-
      The cells are wild type, so they establish the measurement context rather
      than the disease state. Their I_f properties drift with differentiation
      time, activating at more negative potentials after day 30, and basal cAMP
      is low enough that the muscarinic response is small unless the cells are
      pre-stimulated, so absolute values are not directly comparable with adult
      human sinoatrial node myocytes.
    readouts:
    - name: Funny current density and voltage dependence of activation
      target: Reduced Funny Current and Slowed Diastolic Depolarization
      direction: ALTERED
      interpretation: >-
        The measurement that a variant line would be compared against; in
        wild-type cells it shifts negative and slows with time in culture.
      evidence:
      - reference: PMID:33934225
        reference_title: "A detailed characterization of the hyperpolarization-activated \"funny\" current (I(f)) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          Patch-clamp analysis showed that If density did not change during
          differentiation; however, after day 30, it activates at more negative
          potential and with slower time constants.
        explanation: >-
          Reports the direct I_f measurement and its time dependence in the
          platform.
    - name: Beating rate response to adrenergic and muscarinic agonists
      target: Reduced Funny Current and Slowed Diastolic Depolarization
      direction: INCREASED
      interpretation: >-
        Confirms that the autonomic arm of pacemaking, the arm lost in
        cAMP-insensitive HCN4 alleles, is measurable in this platform.
      evidence:
      - reference: PMID:33934225
        reference_title: "A detailed characterization of the hyperpolarization-activated \"funny\" current (I(f)) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity."
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          The adrenergic agonist isoproterenol induced rate acceleration and a
          positive shift of If voltage-dependence (EC50 73.4 nM).
        explanation: >-
          Demonstrates that adrenergic modulation of I_f voltage dependence and
          of rate can be resolved in these cells.
    evidence:
    - reference: PMID:33934225
      reference_title: "A detailed characterization of the hyperpolarization-activated \"funny\" current (I(f)) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity."
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        pCMs express mainly HCN4 and HCN1 together with the accessory subunits
        CAV3, KCR1, MiRP1, and SAP97 that contribute to the context-dependence
        of If.
      explanation: >-
        Establishes that the current being measured is carried predominantly by
        the gene this disease affects, which is what makes the platform
        informative for this node.
  evidence:
  - reference: PMID:33934225
    reference_title: "A detailed characterization of the hyperpolarization-activated \"funny\" current (I(f)) in human-induced pluripotent stem cell (iPSC)-derived cardiomyocytes with pacemaker activity."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      we demonstrated that pCMs display an If with the physiological properties
      expected by pacemaker cells and may thus represent a suitable model for
      studying human If-related sinus arrhythmias.
    explanation: >-
      The authors propose the platform for studying human I_f-related sinus
      arrhythmias, the class this disease belongs to.

computational_models:
- name: Fabbri-Severi human sinoatrial node cell model with HCN4 mutation-induced I_f changes
  model_type: PHYSIOLOGICAL
  description: >-
    A published in-silico risk-stratification study of SSS2. In-vitro biophysical
    data for HCN4 loss-of-function alleles were used to compute the charge
    carried by I_f during diastolic depolarization of a prerecorded human
    sinoatrial node action potential, and that quantity was used to drive the
    Fabbri-Severi model of a human sinoatrial node pacemaker cell. It is the
    computational counterpart of the funny-current node in this entry: it makes
    the qualitative claim (less diastolic I_f, slower firing) quantitative and
    allele-specific.
  publication: PMID:37760888
  modeled_mechanisms:
  - target: Reduced Funny Current and Slowed Diastolic Depolarization
    relationship: MEASURES
    fidelity: MODERATE
    description: >-
      The simulated beating rate of the human sinoatrial node cell model tracks
      the computed diastolic I_f charge very closely, and the same quantity
      correlates strongly with the resting and minimum heart rates observed in
      carriers of the corresponding HCN4 mutations.
    limitations: >-
      The correlation with clinical heart rate is strong but not deterministic,
      the analysis is restricted to the subset of HCN4 alleles with both
      quantitative clinical and in-vitro data, and the authors state that a
      translational perspective remains to be established.
    evidence:
    - reference: PMID:37760888
      reference_title: "The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: >-
        The clinically observed minimum or resting heart rates showed a strong
        correlation with Qf
      explanation: >-
        Links the simulated diastolic funny-current charge to the heart rate
        actually measured in HCN4 mutation carriers.
  findings:
  - statement: >-
      The diastolic funny-current charge computed by action-potential clamp
      predicts both the simulated pacemaker rate of a human sinoatrial node cell
      model and the resting or minimum heart rate of HCN4 mutation carriers,
      making it a candidate risk-stratification measure for HCN4
      loss-of-function sinus bradycardia.
    evidence:
    - reference: PMID:37760888
      reference_title: "The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data."
      supports: SUPPORT
      evidence_source: COMPUTATIONAL
      snippet: >-
        The beating rate of the model cell showed a very strong correlation with
        Qf from the simulated action potential clamp experiments
      explanation: >-
        Reports the correlation between simulated pacemaker rate and diastolic
        funny-current charge that this finding states.
  evidence:
  - reference: PMID:37760888
    reference_title: "The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data."
    supports: SUPPORT
    evidence_source: COMPUTATIONAL
    snippet: >-
      HCN4 is the gene responsible for the hyperpolarization-activated 'funny'
      current If, which is an important modulator of the spontaneous diastolic
      depolarization underlying the sinus node pacemaker activity.
    explanation: >-
      States the mechanistic premise the simulation encodes, matching this
      entry's funny-current pathophysiology node.
datasets:
- accession: geo:GSE279632
  title: Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes [CITE-seq]
  description: >-
    The two-sample CITE-seq component of a study that resolved the human
    sinoatrial node into Core Pacemaker, Sinus Venosus and Transitional
    pacemaker subtypes and identified CD34 as a surface marker enriching
    functional pacemaker cells. This accession holds only that component; the
    single-nuclei and single-cell RNA sequencing of fetal and stem
    cell-derived sinoatrial node cells that the quoted sentence describes sits
    in sibling accessions of the same series. This is a reference dataset for
    the cell type whose failure defines SSS2, not an SSS2 patient cohort, and
    it contains no HCN4 variant carriers. Its value here is that it makes the
    affected compartment addressable: a CD34 sort yields the pacemaker cells in
    which an HCN4 allele would have to be assayed.
  data_type: SINGLE_CELL_RNA_SEQ
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:39604360
  notes: >-
    Relevance is at the level of cell type rather than genotype. Verified with
    just verify-datasets.
  evidence:
  - reference: PMID:39604360
    reference_title: "Single-cell transcriptome analysis reveals CD34 as a marker of human sinoatrial node pacemaker cardiomyocytes."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here we use single-nuclei/cell RNA sequencing of fetal and human
      pluripotent stem cell-derived sinoatrial node cells to reveal that they
      consist of three subtypes of pacemaker cells: Core Pacemaker, Sinus
      Venosus, and Transitional Cells.
    explanation: >-
      Describes the study this accession belongs to and the material it
      profiles, human sinoatrial node pacemaker cells at single-cell
      resolution. The sentence covers the whole series rather than this
      CITE-seq component alone, which the description states.
- accession: geo:GSE189782
  title: A single cell transcriptional roadmap of human pacemaker cell differentiation
  description: >-
    Single-cell RNA sequencing and trajectory inference over human induced
    pluripotent stem cells differentiating into sinoatrial-node-like
    cardiomyocytes, resolving the head, tail and transitional subtypes and the
    WNT and TGF-beta signalling decisions that separate them. It is the
    developmental counterpart of the atlas above and the transcriptional map of
    the platform used by the hiPSC pacemaker-cardiomyocyte model in this entry.
  data_type: SINGLE_CELL_RNA_SEQ
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  publication: PMID:36217819
  notes: >-
    Wild-type differentiation series, no disease genotypes. Verified with just
    verify-datasets.
  evidence:
  - reference: PMID:36217819
    reference_title: "A single cell transcriptional roadmap of human pacemaker cell differentiation."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Here, we performed single cell RNA sequencing (scRNA-seq) and trajectory
      inference on human induced pluripotent stem cells (hiPSCs)
      differentiating to SAN-like cardiomyocytes (SANCMs) to construct a roadmap
      of transcriptional changes and lineage decisions.
    explanation: >-
      Describes the assay and material behind this accession and ties it to the
      hiPSC pacemaker-cardiomyocyte platform recorded under experimental_models.
- accession: geo:GSE329403
  title: HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload
  description: >-
    Cardiac RNA sequencing from HCN4(Y527F) knock-in mice, which carry a
    gain-of-function C-linker mutation that shifts channel activation to more
    positive potentials. The allele is the mirror image of the SSS2 lesion, and
    the mice have a higher intrinsic heart rate with no structural cardiomyopathy
    up to twelve months. It is included here as the opposite-direction control
    on the same gene: it is the closest available transcriptional readout of
    altered HCN4 channel availability in myocardium, and it bears on whether the
    structural arm of SSS2 can be a consequence of the rate change alone.
  data_type: BULK_RNA_SEQ
  organism:
    preferred_term: house mouse
    term:
      id: NCBITaxon:10090
      label: Mus musculus
  publication: PMID:42358349
  notes: >-
    Triage note: this is a gain-of-function allele in mouse, not the human
    loss-of-function lesion of SSS2, and it must not be read as an SSS2
    expression dataset. Verified with just verify-datasets.
  evidence:
  - reference: PMID:42358349
    reference_title: "HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We generated HCN4(Y527F) knock-in mice (HCN4F) carrying a GOF mutation in
      the C-linker of HCN4 channels, which shifts their activation curves to
      more positive potentials.
    explanation: >-
      Describes the genotype behind this accession and makes explicit that the
      direction of effect is opposite to the SSS2 lesion.

diagnosis:
- name: Electrocardiography and ambulatory rhythm monitoring
  description: >-
    Resting ECG and 24-hour Holter monitoring document the sinus bradycardia,
    sinus pauses, and bradycardia-tachycardia alternation, and correlate them
    with symptoms. Exercise testing assesses chronotropic response.
  diagnosis_term:
    preferred_term: electrocardiography
    term:
      id: NCIT:C38053
      label: Electrocardiography
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Heart rate monitoring using electrocardiography or ambulatory cardiac
      event monitoring is performed based on the frequency of symptoms.
    explanation: >-
      Establishes ECG and ambulatory monitoring as the diagnostic modality for
      sinus node dysfunction.
- name: Cardiac imaging for noncompaction and aortic dimensions
  description: >-
    Because the HCN4 form uniquely carries a structural arm, echocardiography
    and cardiac magnetic resonance are needed to look for left ventricular
    noncompaction, late gadolinium enhancement, and dilation of the ascending
    aorta in a carrier who presents only with bradycardia.
  diagnosis_term:
    preferred_term: echocardiography
    term:
      id: NCIT:C16525
      label: Echocardiography Test
  evidence:
  - reference: PMID:35328031
    reference_title: "Clinical Presentation of Left Ventricular Noncompaction Cardiomyopathy and Bradycardia in Three Families Carrying HCN4 Pathogenic Variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All six patients were diagnosed with LVNC by echocardiography, and five
      participants additionally by CMR.
    explanation: >-
      Documents echocardiography and cardiac MRI as the modalities that detect
      the structural arm in HCN4 families.
- name: Genetic testing of HCN4
  description: >-
    Targeted or panel sequencing of HCN4 confirms the diagnosis in a proband
    with familial or early-onset sinus node dysfunction, particularly when
    bradycardia is accompanied by noncompaction, and enables cascade screening
    of relatives, many of whom are asymptomatic.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:25145518
    reference_title: "The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Targeted next-generation and direct sequencing were used for candidate
      gene analysis and mutation scanning.
    explanation: >-
      Describes the sequencing approach used to establish the HCN4 diagnosis in
      families with the combined phenotype.
treatments:
- name: Permanent Pacemaker Implantation
  description: >-
    Pacing is the definitive therapy for symptomatic bradycardia or symptomatic
    pauses; it does not correct the channel defect. In HCN4 carriers the age at
    implantation is later than in SCN5A-related familial sick sinus syndrome,
    and some HCN4 alleles never require a device. Chronotropic pharmacotherapy
    may defer but does not replace it.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: pacemaker implantation
    term:
      id: NCIT:C80434
      label: Pacemaker Placement
  target_mechanisms:
  - target: Sinoatrial Node Automaticity Failure
    treatment_effect: BYPASSES
    description: >-
      An implanted pacemaker substitutes an artificial impulse source for the
      failing sinoatrial node, bypassing rather than repairing the pacemaker
      current defect.
    evidence:
    - reference: PMID:34383451
      reference_title: "Sinus Node Dysfunction."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        First-line treatment for patients with confirmed sinus node dysfunction
        is permanent pacemaker placement with atrial-based pacing and limited
        ventricular pacing when necessary.
      explanation: >-
        Establishes pacing as the first-line intervention against the failing
        sinoatrial node.
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Moreover, HCN4 mutation carriers were more frequently associated with AF
      (43.8%) and LVNC (50%) and with older age at pacemaker implantation
    explanation: >-
      Reports age at pacemaker implantation specifically in HCN4 carriers,
      contrasted with the SCN5A form.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Despite its critical location, this mutation carries a favorable prognosis
      without the need for pacemaker implantation during long-term follow-up.
    explanation: >-
      Supports the statement in this treatment's description that some HCN4
      alleles never require a device: the G480R pore mutation carried a
      favorable prognosis without pacemaker implantation over long-term
      follow-up.
- name: Chronotropic Pharmacotherapy (Cilostazol)
  description: >-
    Cilostazol, a phosphodiesterase-3 inhibitor, raises heart rate in sinus node
    dysfunction and has been used to defer or avoid permanent pacing in
    symptomatic sick sinus syndrome. It is a rate-raising palliative acting
    downstream of the pacemaker-current defect rather than a correction of it,
    and the supporting evidence comes from unselected sick sinus syndrome
    cohorts, not from genotyped HCN4 carriers.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: cilostazol
      term:
        id: CHEBI:31401
        label: cilostazol
  target_mechanisms:
  - target: Sinoatrial Node Automaticity Failure
    treatment_effect: MODULATES
    description: >-
      Cilostazol raises the sinus rate, partially offsetting the depressed
      nodal automaticity without restoring the funny current.
    evidence:
    - reference: PMID:30982679
      reference_title: "Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      directness: INDIRECT
      snippet: >-
        Cilostazol was effective for symptomatic SSS to avoid PM implantation by
        increasing HR.
      explanation: >-
        Shows a rate-raising effect on the failing sinoatrial node. The cohort
        is unselected sick sinus syndrome rather than genotyped HCN4 carriers,
        so the step to SSS2 is an inference from the shared nodal lesion.
  evidence:
  - reference: PMID:30982679
    reference_title: "Efficacy of cilostazol for sick sinus syndrome to avoid permanent pacemaker implantation: A retrospective case-control study."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      The 6-month PM implantation rate was lower in the cilostazol than the
      control group (20.4% vs. 55.8%, respectively; p<0.001).
    explanation: >-
      Quantifies the pacemaker-deferring effect. It is a single-centre
      retrospective case-control study in unselected sick sinus syndrome, not a
      randomized trial and not HCN4-genotyped, so the SSS2-specific effect size
      is unknown.
  - reference: PMID:33017571
    reference_title: "Pharmacologic Approach to Sinoatrial Node Dysfunction."
    supports: SUPPORT
    evidence_source: OTHER
    directness: INDIRECT
    snippet: >-
      This review summarizes the current knowledge about SND mechanisms and
      discusses the possibility of introducing new pharmacologic therapies for
      treating SND.
    explanation: >-
      Frames pharmacologic management of sinoatrial node dysfunction as an area
      of active development rather than established practice. It supports the
      existence of the therapeutic avenue, not the efficacy of any particular
      agent in SSS2.
- name: Avoidance of Bradycardia-Inducing Medications
  description: >-
    Because SSS2 carriers already run a reduced pacemaker current, drugs that
    further depress sinoatrial automaticity or conduction (beta-blockers,
    non-dihydropyridine calcium channel blockers, digoxin, and the selective
    I_f blocker ivabradine, whose molecular target is HCN4 itself) can unmask
    or worsen symptomatic bradycardia. Extrinsic contributors to sinus node
    dysfunction are frequently reversible, so medication review is part of
    management as well as of diagnosis.
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      The causes of sinus node dysfunction are intrinsic (e.g., degenerative
      idiopathic fibrosis, cardiac remodeling) or extrinsic (e.g., medications,
      metabolic abnormalities) to the sinoatrial node.
    explanation: >-
      Establishes medications as an extrinsic cause of sinus node dysfunction,
      which is the rationale for avoiding rate-slowing drugs in a carrier. The
      source addresses sinus node dysfunction generally and names no specific
      agent to avoid in HCN4 carriers, so the carrier-specific application is
      an inference.
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      A diagnosis is made by directly correlating symptoms with a bradyarrhythmia
      and eliminating potentially reversible extrinsic causes.
    explanation: >-
      Supports elimination of reversible extrinsic causes, of which drug therapy
      is the main modifiable one. The statement is framed as a diagnostic rather
      than a therapeutic step, so its use here as a management rationale is an
      inference.
- name: Stroke Prevention in Atrial Fibrillation
  description: >-
    Atrial fibrillation occurs in roughly 44% of HCN4 carriers, so thromboembolic
    prophylaxis is part of routine management once it is documented, prescribed
    on the same risk-score basis as in any other atrial fibrillation rather than
    on the genotype. What is genuinely unsettled is the carrier without
    documented atrial fibrillation: sinus node dysfunction carries an
    independently raised ischaemic stroke risk even in its absence, and the
    yearly stroke incidence in sinus node dysfunction with and without atrial
    fibrillation is indistinguishable, which has been read as evidence of an
    underlying atrial myopathy rather than of arrhythmia-driven stasis. No trial
    has tested anticoagulation in that group, and none of this evidence is
    HCN4-genotyped.
  therapeutic_modality: SMALL_MOLECULE
  treatment_term:
    preferred_term: anticoagulation therapy
    term:
      id: NCIT:C63341
      label: Anticoagulation Therapy
  evidence:
  - reference: PMID:37977871
    reference_title: "Sinus node dysfunction and stroke risk: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      The average yearly stroke incidence in patients with SND was 1.542% (95%
      CI: 1.334% to 1.749%). The stroke incidence was similar between the
      isolated SND (1.587%; 95% CI: 1.510% to 1.664%) and non-isolated (SND+AF)
      (1.660%; 95% CI: 0.705% to 2.615%) groups.
    explanation: >-
      Quantifies the stroke burden that makes thromboembolic prophylaxis a
      management question here at all, and shows it does not depend on
      documented atrial fibrillation. The pooled population is unselected sinus
      node dysfunction, not HCN4 carriers.
  - reference: PMID:37977871
    reference_title: "Sinus node dysfunction and stroke risk: a systematic review and meta-analysis."
    supports: NO_EVIDENCE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Future studies are needed to investigate whether interventions targeting
      stroke prevention, such as anticoagulation therapy, can help to prevent
      stroke in patients with SND.
    explanation: >-
      The authors state explicitly that whether anticoagulation prevents stroke
      in sinus node dysfunction has not been established, so this item is
      recorded as bearing on the burden rather than on the intervention. It is
      the reason this treatment is scoped to documented atrial fibrillation.
  - reference: PMID:40315941
    reference_title: "Risk of ischemic stroke in sinus node dysfunction with and without atrial fibrillation: Evidence for the presence of a left atrial myopathy in patients with isolated sinus node dysfunction-an analysis of the UK Biobank."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      In multivariable competing-risk regression modeling accounting for death,
      isolated SND conferred a significantly increased risk of IS compared to
      controls (subdistribution hazard ratio 2.28; 95% confidence interval,
      1.57-3.31; P < .001).
    explanation: >-
      A prospective population cohort finding the same excess risk in sinus node
      dysfunction without atrial fibrillation, which is what makes the untested
      group a real clinical question rather than a theoretical one. Again the
      cohort is not genotyped.
- name: Genetic Counseling and Cascade Family Screening
  description: >-
    SSS2 is autosomal dominant with variable penetrance, so first-degree
    relatives of a proband carry a 50% prior risk and may be affected while
    entirely asymptomatic. Counselling plus cascade ECG, Holter, echocardiographic
    and HCN4 sequencing of relatives identifies those carriers, which matters
    here because the HCN4 phenotype includes a structural (noncompaction) arm
    that is not detected by rhythm assessment alone.
  therapeutic_modality: BEHAVIORAL
  treatment_term:
    preferred_term: genetic counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Sixteen members of a family with sinus bradycardia were evaluated.
      Evaluation included a clinical questionnaire, 12-lead ECGs, Holter
      monitoring, echocardiography, and treadmill exercise testing.
    explanation: >-
      Documents the family-wide evaluation protocol by which HCN4 relatives are
      screened, including the echocardiography needed to catch the structural
      arm.
  - reference: PMID:17646576
    reference_title: "Point mutation in the HCN4 cardiac ion channel pore affecting synthesis, trafficking, and functional expression is associated with familial asymptomatic sinus bradycardia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Eight family members (5 males) were classified as affected. All affected
      family members were asymptomatic with normal exercise capacity during
      long-term follow-up.
    explanation: >-
      Demonstrates the yield of cascade screening in SSS2: half the evaluated
      family was affected and every affected member was asymptomatic, so
      relatives would not have been identified without screening.
differential_diagnoses:
- name: Familial Sick Sinus Syndrome
  description: >-
    The dismech umbrella entry for inherited sinoatrial node dysfunction, which
    spans several causal genes (HCN4, SCN5A, ANK2, LMNA) and both dominant and
    recessive transmission. SSS2 is the HCN4-specific, autosomal dominant member
    of that set and is curated separately because MONDO models it as a distinct
    disease-series-by-gene entity with its own OMIM record.
  disease_term:
    preferred_term: familial sick sinus syndrome
    term:
      id: MONDO:0012061
      label: familial sick sinus syndrome
  distinguishing_features:
  - The umbrella entry is gene-heterogeneous and also spans the autosomal recessive SCN5A form, LMNA and ANK2.
  - SSS2 is defined by a heterozygous HCN4 loss-of-function variant acting on the funny current.
  - Left ventricular noncompaction is a characteristic co-segregating feature of the HCN4 form specifically.
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Familial sick sinus syndrome (SSS) is often attributable to mutations in
      genes encoding the cardiac Na channel SCN5A and pacemaker channel HCN4.
    explanation: >-
      States the gene heterogeneity of the umbrella entity, which is what makes
      the HCN4 form a member of it rather than a synonym for it.
- name: Sick sinus syndrome 1
  description: >-
    The SCN5A-related form of familial sick sinus syndrome, in which
    compound-heterozygous loss-of-function alleles of the cardiac sodium channel
    reduce myocardial excitability.
  disease_term:
    preferred_term: sick sinus syndrome 1
    term:
      id: MONDO:0024562
      label: sick sinus syndrome 1
  distinguishing_features:
  - Recessive rather than dominant transmission.
  - Markedly younger age at diagnosis and at pacemaker implantation than the HCN4 form.
  - Lacks the atrial fibrillation and left ventricular noncompaction burden characteristic of SSS2.
  evidence:
  - reference: PMID:28104484
    reference_title: "Sick sinus syndrome with HCN4 mutations shows early onset and frequent association with atrial fibrillation and left ventricular noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Meta-analysis of HCN4 mutation carriers showed a significantly younger age
      at diagnosis
    explanation: >-
      Establishes the age-at-diagnosis separation between HCN4 (SSS2), sporadic
      sick sinus syndrome, and SCN5A (SSS1) carriers.
- name: Sinoatrial Block
  description: >-
    Failure of conduction of the sinoatrial impulse out of the node into atrial
    myocardium, producing pauses that on the surface ECG can look like sinus
    arrest.
  disease_term:
    preferred_term: sinoatrial block
    term:
      id: MONDO:0020806
      label: sinoatrial block
  distinguishing_features:
  - Sinoatrial block is a disorder of impulse exit (conduction); SSS2 is a disorder of impulse generation (automaticity).
  - Sinoatrial exit block may also occur within the SSS2 phenotype, so the distinction is mechanistic rather than mutually exclusive.
  evidence:
  - reference: PMID:34383451
    reference_title: "Sinus Node Dysfunction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Electrocardiography findings include sinus bradycardia, sinus pauses or
      arrest, sinoatrial exit block, chronotropic incompetence, or alternating
      bradycardia and tachycardia
    explanation: >-
      Lists sinoatrial exit block among the electrocardiographic findings of
      sinus node dysfunction itself, which is why this differential is a
      mechanistic distinction rather than a mutually exclusive alternative
      diagnosis.
- name: Sinoatrial Node Dysfunction and Deafness
  description: >-
    An autosomal recessive channelopathy caused by biallelic CACNA1D
    loss-of-function, in which loss of the Cav1.3 L-type calcium current
    produces both sinoatrial node dysfunction and congenital deafness.
  disease_term:
    preferred_term: sinoatrial node dysfunction and deafness
    term:
      id: MONDO:0013960
      label: sinoatrial node dysfunction and deafness
  distinguishing_features:
  - Recessive CACNA1D rather than dominant HCN4.
  - The calcium-current lesion is shared with the cochlear inner hair cell ribbon synapse, so congenital sensorineural deafness accompanies the bradycardia.
  - No left ventricular noncompaction.
  evidence:
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We describe a human channelopathy (termed SANDD syndrome, sinoatrial node
      dysfunction and deafness) with a cardiac and auditory phenotype that
      closely resembles that of Cacna1d(-/-) mice.
    explanation: >-
      Names the entity and its combined cardiac and auditory phenotype, the
      feature that separates it from SSS2 at the bedside.
  - reference: PMID:21131953
    reference_title: "Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We used positional cloning to identify a mutation in CACNA1D, which
      encodes the pore-forming α1 subunit of Ca(v)1.3 LTCCs, in two
      consanguineous families with deafness.
    explanation: >-
      Establishes the causal gene and the consanguineous, recessive
      transmission that contrasts with dominant HCN4.
- name: Sick sinus syndrome 4
  description: >-
    Familial sinus node and atrioventricular conduction dysfunction caused by
    variation in the G-protein subunit gene GNB2.
  disease_term:
    preferred_term: sick sinus syndrome 4
    term:
      id: MONDO:0859173
      label: sick sinus syndrome 4
  distinguishing_features:
  - The lesion is in G-protein signalling upstream of the pacemaker channels rather than in the channel itself.
  - Atrioventricular conduction disease is a defining rather than incidental component.
  evidence:
  - reference: PMID:30645171
    reference_title: "Familial Sinus Node Disease Caused by a Gain of GIRK (G-Protein Activated Inwardly Rectifying K(+) Channel) Channel Function."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Recently, a gain-of-function mutation in the G-protein gene GNB2 led to
      enhanced activation of the GIRK (G-protein activated inwardly rectifying
      K+ channel).
    explanation: >-
      Places the SSS4 lesion in G-protein signalling acting on a potassium
      channel, upstream of and distinct from the HCN4 pacemaker channel defect
      of SSS2. The quoted sentence is this paper's background summarising the
      primary GNB2 report rather than its own result, which is a KCNJ5 variant
      in a separate family, so it is cited here for the mechanism class it
      states and not as the primary source for SSS4.
discussions:
- discussion_id: q_sss2_aortic_wall_mechanism
  prompt: >-
    By what route does a loss-of-function variant in the sinoatrial pacemaker
    channel produce dilatation of the ascending aorta?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - phenotypes#Dilatation of the Ascending Aorta
  - pathophysiology#Impaired Ventricular Trabecular Compaction
  rationale: >-
    Aortic root and ascending aortic dilatation has now been reported in
    several independent HCN4 families and in a majority of carriers in the
    largest series, so the association is replicated. What is missing is any
    mechanism. HCN4 has no described role in the aortic wall, no HCN4 animal
    model has been reported with an aortic phenotype, and neither of the two
    candidate routes has been tested: a direct requirement for HCN4 in
    neural-crest-derived or second-heart-field-derived outflow tract
    mesenchyme, or a haemodynamic consequence of lifelong bradycardia acting on
    the wall through increased stroke volume. The distinction is not academic,
    because it decides whether pacing a carrier would be expected to slow the
    aortic course. Until it is resolved, imaging surveillance in carriers rests
    on the observed association alone.
  evidence:
  - reference: PMID:35257104
    reference_title: "Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis?"
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Earliest expression of HCN4 has been reported to be a potential marker for
      the first heart field.
    explanation: >-
      The one developmental fact that makes a direct route plausible: HCN4 marks
      an early cardiac progenitor population, so a developmental role in outflow
      structures is not excluded. It is a marker claim rather than a functional
      one, which is exactly the gap.
- discussion_id: q_sss2_noncompaction_developmental_or_rate_driven
  prompt: >-
    Is the ventricular noncompaction of SSS2 a developmental consequence of
    HCN4 loss in the early myocardium, or a secondary remodelling response to
    lifelong bradycardia?
  kind: OPEN_QUESTION
  status: OPEN
  attaches_to:
  - pathophysiology#Impaired Ventricular Trabecular Compaction
  - phenotypes#Left Ventricular Noncompaction
  rationale: >-
    Both readings fit the human data. The developmental reading is supported by
    HCN4 expression in early cardiac progenitors, by noncompaction being
    present already in fetal and adolescent carriers, and by Hcn4 sitting
    downstream of a transcriptional cascade rather than being an isolated
    channel gene: in mouse, loss of Shox2 abolishes Tbx3 and Hcn4 expression
    and leaves a hypoplastic sinoatrial node. That cascade is characterised for
    the sinoatrial node and not for ventricular trabeculation, so it shows that
    HCN4 has a developmental context without showing that it has one in the
    compacting ventricle. The haemodynamic reading
    is supported by the observation that HCN4 carriers with noncompaction have
    preserved ejection fraction and mild ventricular dilatation, a picture that
    could equally reflect volume loading at a low heart rate. One experiment on
    the same gene bears on the haemodynamic reading, though only on part of it:
    a knock-in mouse with a gain-of-function HCN4 allele runs chronically
    faster and develops no structural cardiomyopathy over twelve months. That
    speaks to adult remodelling under a sustained rate change, in the opposite
    direction from the bradycardia at issue and in a species whose baseline
    rate is an order of magnitude higher; it says nothing about whether
    lifelong bradycardia perturbs trabecular compaction during development,
    which is the reading actually in dispute. Settling that needs a
    loss-of-function HCN4 model examined for trabecular architecture, and a
    comparison of noncompaction burden between paced and unpaced carriers.
  evidence:
  - reference: PMID:42358349
    reference_title: "HCN4 gain-of-function mutation increases intrinsic heart rate and limits maladaptive remodeling under pressure overload."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: INDIRECT
    snippet: >-
      Histological analysis did not reveal structural changes consistent with
      tachycardia-induced cardiomyopathy. Cardiac morphology, fibrosis, and
      contractility were indistinguishable between genotypes up to 12 months of
      age.
    explanation: >-
      A sustained HCN4-driven change in heart rate produced no structural
      cardiomyopathy in the adult mouse heart. It bears on the adult-remodelling
      reading only, and in the opposite direction from the bradycardia at issue,
      so it constrains the question rather than answering it.
  - reference: PMID:19166829
    reference_title: "Shox2 is essential for the differentiation of cardiac pacemaker cells by repressing Nkx2-5."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    directness: INDIRECT
    snippet: >-
      Genetically, the lack of Tbx3 and Hcn4 expression, along with ectopic
      activation of Nppa, Cx40, and Nkx2-5 in the Shox2(-/-) SAN region,
      indicates a failure in SAN differentiation.
    explanation: >-
      Places Hcn4 inside a developmental transcriptional programme rather than
      treating it as a channel gene expressed only in the mature node, which is
      what makes a developmental reading of the structural phenotype coherent
      at all. Two inference steps separate it from the question: it is mouse,
      and the programme it describes builds the sinoatrial node, not the
      compacted ventricular wall.
  - reference: PMID:34088380
    reference_title: "Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      Ion channel gene mutations should be searched systematically in patients
      with LVNC associated with either bradycardia or biventricular
      noncompaction, particularly when LV systolic function is preserved.
    explanation: >-
      The preserved-function, biventricular pattern is the observation both
      readings have to explain, and it is compatible with either a developmental
      or a volume-loading origin, which is why the question stays open.
- discussion_id: q_sss2_variant_causality_threshold
  prompt: >-
    What functional evidence should be required before an HCN4 variant found in
    a bradycardic patient is called causal for SSS2?
  kind: CONTROVERSY
  status: OPEN
  attaches_to:
  - genetic#HCN4 loss-of-function variants
  - pathophysiology#HCN4 Loss-of-Function Variant
  rationale: >-
    SSS2 is defined by an HCN4 variant, so the entry's causal claim is only as
    good as the variant calls behind it. HCN4 variant discovery has outrun
    functional characterisation: most reported variants have never been
    patch-clamped, and at least one variant that had been treated as
    pathogenic, and linked in the literature to sudden infant death and
    malignant epilepsy, was found on characterisation to be
    indistinguishable from wild type in voltage dependence, kinetics,
    cAMP-gating and surface expression, and not to segregate with disease in
    the proband's own family. The alleles curated in this entry all carry
    electrophysiological or segregation evidence, which is the standard this
    discussion argues for, but the boundary is not settled and the field has no
    agreed threshold. Practically, this bears on cascade screening: a carrier
    identified on a panel without functional or segregation support has not
    been shown to have SSS2.
  evidence:
  - reference: PMID:33095298
    reference_title: "Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      However, detailed electrophysiological and cell biological
      characterization of HCN4 V759I in Xenopus laevis oocytes and embryonic rat
      cardiomyocytes, respectively, did not reveal any obvious abnormality.
    explanation: >-
      A variant treated as pathogenic behaves as wild type on functional
      testing, which is the concrete case the controversy rests on.
  - reference: PMID:33095298
    reference_title: "Disease-associated HCN4 V759I variant is not sufficient to impair cardiac pacemaking."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In good agreement, the clinically likewise affected mother of the patient
      does not exhibit the reported HCN4 variance.
    explanation: >-
      Adds the segregation half of the argument: the affected relative does not
      carry the variant, so the family data contradict causality independently
      of the electrophysiology.
- discussion_id: q_sss2_anticoagulation_without_documented_af
  prompt: >-
    Should an HCN4 carrier with sinus node dysfunction but no documented atrial
    fibrillation receive anticoagulation?
  kind: KNOWLEDGE_GAP
  status: OPEN
  attaches_to:
  - treatments#Stroke Prevention in Atrial Fibrillation
  - phenotypes#Atrial Fibrillation
  rationale: >-
    Two independent lines of evidence say sinus node dysfunction raises
    ischaemic stroke risk whether or not atrial fibrillation has been
    documented, which has been read as an atrial myopathy underlying both. If
    that is right, the risk-score logic that gates anticoagulation on a
    documented arrhythmia is the wrong gate. Nothing resolves this for SSS2 in
    particular: no cohort in either source was genotyped, no trial has tested
    anticoagulation in sinus node dysfunction without atrial fibrillation, and
    HCN4 carriers are a young population in whom the bleeding side of the
    trade-off runs for decades. The practical question is whether prolonged
    rhythm monitoring in carriers, which they often already have through an
    implanted device or loop recorder, converts the question into an ordinary
    documented-atrial-fibrillation decision often enough to make the untested
    group small.
  evidence:
  - reference: PMID:40315941
    reference_title: "Risk of ischemic stroke in sinus node dysfunction with and without atrial fibrillation: Evidence for the presence of a left atrial myopathy in patients with isolated sinus node dysfunction-an analysis of the UK Biobank."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    directness: INDIRECT
    snippet: >-
      SND is an independent risk marker for the development of IS in individuals
      without AF.
    explanation: >-
      States the finding the gap turns on, that the excess stroke risk does not
      require documented atrial fibrillation. The cohort is unselected sinus
      node dysfunction rather than HCN4 carriers.
  - reference: PMID:37977871
    reference_title: "Sinus node dysfunction and stroke risk: a systematic review and meta-analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Future studies are needed to investigate whether interventions targeting
      stroke prevention, such as anticoagulation therapy, can help to prevent
      stroke in patients with SND.
    explanation: >-
      The authors name the same gap and state that it is untested, which is why
      this is recorded as an open question rather than as a treatment
      recommendation.
- discussion_id: q_sss2_chronotropic_incompetence_model_mismatch
  prompt: >-
    Does the mouse carrying the human cAMP-insensitive HCN4-573X allele
    reproduce human chronotropic incompetence, given that its relative rate
    adaptation to exercise is preserved?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Loss of cAMP-Dependent Rate Modulation
  - phenotypes#Chronotropic Incompetence
  rationale: >-
    The hHCN4-573X mouse carries the human disease allele and loses cAMP
    sensitivity of I_f completely, yet the relative extent of its heart rate
    regulation during physical activity is preserved: basal and maximal rates
    fall, but the animal still scales its rate with demand. The human index
    patient was described with chronotropic incompetence. Both can be true if
    human chronotropic incompetence is a consequence of the depressed maximal
    rate rather than of a lost ability to modulate, and this entry's
    pathophysiology is written that way. The mismatch is nonetheless real and
    unresolved: it is not established that cAMP insensitivity is what produces
    the clinical exercise limitation, and the mouse is the only experiment that
    separates the two. Deciding it needs formal chronotropic-index testing in
    genotyped carriers of cyclic-nucleotide-binding-domain truncations,
    compared against carriers of pore and trafficking alleles that retain cAMP
    sensitivity.
  evidence:
  - reference: PMID:19570998
    reference_title: "Control of heart rate by cAMP sensitivity of HCN channels."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Despite the complete loss of cAMP sensitivity of I(f), the relative extent
      of SAN cell frequency and heart rate regulation are preserved.
    explanation: >-
      States the mismatch directly: the model loses the molecular property
      proposed to underlie chronotropic incompetence without losing rate
      regulation.

notes: >-
  LUMP-VS-SPLIT DECISION. kb/disorders/Familial_Sick_Sinus_Syndrome.yaml
  (MONDO:0012061) already carried an HCN4 pathophysiology node, an HCN4 genetic
  entry, and left ventricular noncompaction as a phenotype. This entry was
  nevertheless curated separately because MONDO:0008102 is a distinct
  disease-series-by-gene entity (is_a MONDO:0012061, RO:0004003 to HGNC:16882,
  xref OMIM:163800) and because the umbrella is deliberately gene-heterogeneous:
  it also spans the autosomal recessive SCN5A form, LMNA, ANK2, and GWAS-level
  susceptibility loci, so its HCN4 content is necessarily a summary. This entry
  adds what the umbrella cannot: the funny-current mechanism at pacemaker-cell
  resolution, the three structural classes of HCN4 allele and their distinct
  biophysical consequences, the separable cAMP-modulation arm that produces
  chronotropic incompetence, two HCN4 mouse models, an in-silico human
  sinoatrial node model, and the quantitative HCN4-specific phenotype
  frequencies (atrial fibrillation 43.8%, noncompaction 50%). The umbrella
  should retain its HCN4 content as the summary view; a follow-up may add
  MONDO:0008102 to it as a has_subtypes term.

  NEC PREFLIGHT. "Sick sinus syndrome 2" sits in a numbered series whose members
  have different causal genes (SSS1 SCN5A, SSS2 HCN4, SSS3 MYH6, SSS4 GNB2),
  a high named-entity-confusion risk class. The MONDO record for MONDO:0008102
  was read directly (runoak -i sqlite:obo:mondo info MONDO:0008102 -O obo) and
  asserts RO:0004003 HGNC:16882 (HCN4) with xref OMIM:163800. `just preflight-dr`
  on the falcon report returned PASS (HCN4 mentioned 91 times, SCN5A 3), and
  every citation used here was independently confirmed to concern HCN4 rather
  than SCN5A, MYH6 or GNB2.

  DEEP RESEARCH. A falcon (Edison) deep-research run was performed
  (research/Sick_Sinus_Syndrome_2_Autosomal_Dominant-deep-research-falcon.md;
  reference_validation reports 8/8 references verified, confabulation_rate 0.0).
  Its narrative was used as a lead only. It cited reviews rather than the
  primary SSS2 literature and its suggested ontology identifiers were largely
  wrong when checked with OAK (for example HP:0005209 and HP:0030247 offered for
  chronotropic incompetence and sinus pause, HP:0012810 for left ventricular
  noncompaction, and NCIT:C15632 offered as "Pacemaker Implantation" when that
  identifier is Chemotherapy). Every ontology term in this entry was therefore
  looked up independently with OAK, and the evidence base was rebuilt from the
  primary pedigree, electrophysiology, and cohort papers.

  GENEREVIEWS. PubMed was searched for a GeneReviews chapter covering sick sinus
  syndrome, sinus node dysfunction, or HCN4 (queries "sick sinus syndrome[TI]
  GeneReviews[TI]", "sinus node dysfunction GeneReviews[All Fields]", "HCN4
  GeneReviews[All Fields]"). No GeneReviews chapter exists for this disorder;
  the hits returned were unrelated chapters (Brugada Syndrome, Heritable
  Thoracic Aortic Disease, Hereditary Transthyretin Amyloidosis), so no
  GeneReviews baseline could be applied.

  TREATMENTS SCOPE. Four treatment entries are curated: pacing (definitive),
  chronotropic pharmacotherapy with cilostazol (pacemaker-deferring), avoidance
  of bradycardia-inducing medications, and genetic counselling with cascade
  family screening. Two management topics raised by the deep-research artifact
  are deliberately NOT curated. (1) Theophylline: the DR describes it as the
  most widely used outpatient drug for sinus node dysfunction, but the claim
  traces to a review rather than to a citable primary study with a quotable
  abstract, and no theophylline trial in sick sinus syndrome could be sourced
  with an exact-quote snippet — per the evidence SOP the claim is dropped rather
  than supported by a manufactured quote. (2) Anticoagulation for the atrial
  fibrillation curated here at FREQUENT: stroke-prevention anticoagulation is
  driven by CHA2DS2-VASc risk and is not specific to, or modified by, the HCN4
  lesion, so it belongs to atrial fibrillation management rather than to the
  SSS2 mechanism graph. Acute in-hospital chronotropes (atropine,
  isoproterenol) are likewise generic bradycardia rescue rather than
  SSS2-specific and are omitted for the same reason.

  IVABRADINE. Ivabradine is a selective I_f (HCN4) blocker used to slow heart
  rate in angina and heart failure. On mechanistic grounds it would be expected
  to aggravate the pacemaker-current deficit in an SSS2 carrier, but no cited
  publication states this for HCN4 carriers specifically, so it is named in the
  "Avoidance of Bradycardia-Inducing Medications" treatment description as a
  mechanistic inference and is not asserted there as an evidenced claim: the
  evidence attached to that entry supports drug-induced sinus node dysfunction
  in general, not ivabradine harm in HCN4 carriers.

  SINOATRIAL EXIT BLOCK. HP:0012723 (Sinoatrial block) exists and is a
  descendant of the HP:0011702 term used for the pause/arrest phenotype, and
  exit block appears in the general sick-sinus-syndrome ECG criteria quoted
  here. It is not curated as a separate phenotype because no HCN4-specific
  source in the cached references reports it in genotyped carriers; adding it
  would assert a genotype-phenotype link the evidence does not carry.

  UNCITED REFERENCE CACHES. Two cached references are deliberately not cited.
  PMID:27173043 (Vermeer et al 2016) is the primary report of ascending aortic
  dilatation in HCN4 families and would be the better citation for that
  phenotype, but it is a JACC letter with no abstract retrievable through the
  reference cache, so the frequency is cited through the case report
  PMID:35257104 with directness INDIRECT instead. PMID:33185997 has the same
  problem. Neither is a defective source; there is simply no quotable text to
  attach a snippet to. The remaining uncited caches back the openscientist
  deep-research report rather than this entry.

  PREVALENCE. There is still no general-population prevalence estimate
  specific to SSS2, and none is asserted. What the prevalence records hold
  instead are four conditioned occurrence figures, each labelled with the
  ascertainment that produced it: the HCN4 share of mutation-positive familial
  sick sinus syndrome probands, the HCN4 share of paediatric and of adult
  isolated left ventricular noncompaction cohorts, and the Danish nationwide
  cumulative incidence of pacemaker-treated sinus node dysfunction in
  first-degree relatives, which is heritable sinus node dysfunction at
  population scale rather than genotyped SSS2. The per-gene case fraction
  (2 of 38 familial SSS families) remains under genetic.case_fractions, which
  is the correct slot for a genetic-spectrum share rather than a population
  rate.

📚

References & Deep Research

Deep Research

2

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (3)

Record notes

LUMP-VS-SPLIT DECISION. kb/disorders/Familial_Sick_Sinus_Syndrome.yaml (MONDO:0012061) already carried an HCN4 pathophysiology node, an HCN4 genetic entry, and left ventricular noncompaction as a phenotype. This entry was nevertheless curated separately because MONDO:0008102 is a distinct disease-series-by-gene entity (is_a MONDO:0012061, RO:0004003 to HGNC:16882, xref OMIM:163800) and because the umbrella is deliberately gene-heterogeneous: it also spans the autosomal recessive SCN5A form, LMNA, ANK2, and GWAS-level susceptibility loci, so its HCN4 content is necessarily a summary. This entry adds what the umbrella cannot: the funny-current mechanism at pacemaker-cell resolution, the three structural classes of HCN4 allele and their distinct biophysical consequences, the separable cAMP-modulation arm that produces chronotropic incompetence, two HCN4 mouse models, an in-silico human sinoatrial node model, and the quantitative HCN4-specific phenotype frequencies (atrial fibrillation 43.8%, noncompaction 50%). The umbrella should retain its HCN4 content as the summary view; a follow-up may add MONDO:0008102 to it as a has_subtypes term. NEC PREFLIGHT. "Sick sinus syndrome 2" sits in a numbered series whose members have different causal genes (SSS1 SCN5A, SSS2 HCN4, SSS3 MYH6, SSS4 GNB2), a high named-entity-confusion risk class. The MONDO record for MONDO:0008102 was read directly (runoak -i sqlite:obo:mondo info MONDO:0008102 -O obo) and asserts RO:0004003 HGNC:16882 (HCN4) with xref OMIM:163800. `just preflight-dr` on the falcon report returned PASS (HCN4 mentioned 91 times, SCN5A 3), and every citation used here was independently confirmed to concern HCN4 rather than SCN5A, MYH6 or GNB2. DEEP RESEARCH. A falcon (Edison) deep-research run was performed (research/Sick_Sinus_Syndrome_2_Autosomal_Dominant-deep-research-falcon.md; reference_validation reports 8/8 references verified, confabulation_rate 0.0). Its narrative was used as a lead only. It cited reviews rather than the primary SSS2 literature and its suggested ontology identifiers were largely wrong when checked with OAK (for example HP:0005209 and HP:0030247 offered for chronotropic incompetence and sinus pause, HP:0012810 for left ventricular noncompaction, and NCIT:C15632 offered as "Pacemaker Implantation" when that identifier is Chemotherapy). Every ontology term in this entry was therefore looked up independently with OAK, and the evidence base was rebuilt from the primary pedigree, electrophysiology, and cohort papers. GENEREVIEWS. PubMed was searched for a GeneReviews chapter covering sick sinus syndrome, sinus node dysfunction, or HCN4 (queries "sick sinus syndrome[TI] GeneReviews[TI]", "sinus node dysfunction GeneReviews[All Fields]", "HCN4 GeneReviews[All Fields]"). No GeneReviews chapter exists for this disorder; the hits returned were unrelated chapters (Brugada Syndrome, Heritable Thoracic Aortic Disease, Hereditary Transthyretin Amyloidosis), so no GeneReviews baseline could be applied. TREATMENTS SCOPE. Four treatment entries are curated: pacing (definitive), chronotropic pharmacotherapy with cilostazol (pacemaker-deferring), avoidance of bradycardia-inducing medications, and genetic counselling with cascade family screening. Two management topics raised by the deep-research artifact are deliberately NOT curated. (1) Theophylline: the DR describes it as the most widely used outpatient drug for sinus node dysfunction, but the claim traces to a review rather than to a citable primary study with a quotable abstract, and no theophylline trial in sick sinus syndrome could be sourced with an exact-quote snippet — per the evidence SOP the claim is dropped rather than supported by a manufactured quote. (2) Anticoagulation for the atrial fibrillation curated here at FREQUENT: stroke-prevention anticoagulation is driven by CHA2DS2-VASc risk and is not specific to, or modified by, the HCN4 lesion, so it belongs to atrial fibrillation management rather than to the SSS2 mechanism graph. Acute in-hospital chronotropes (atropine, isoproterenol) are likewise generic bradycardia rescue rather than SSS2-specific and are omitted for the same reason. IVABRADINE. Ivabradine is a selective I_f (HCN4) blocker used to slow heart rate in angina and heart failure. On mechanistic grounds it would be expected to aggravate the pacemaker-current deficit in an SSS2 carrier, but no cited publication states this for HCN4 carriers specifically, so it is named in the "Avoidance of Bradycardia-Inducing Medications" treatment description as a mechanistic inference and is not asserted there as an evidenced claim: the evidence attached to that entry supports drug-induced sinus node dysfunction in general, not ivabradine harm in HCN4 carriers. SINOATRIAL EXIT BLOCK. HP:0012723 (Sinoatrial block) exists and is a descendant of the HP:0011702 term used for the pause/arrest phenotype, and exit block appears in the general sick-sinus-syndrome ECG criteria quoted here. It is not curated as a separate phenotype because no HCN4-specific source in the cached references reports it in genotyped carriers; adding it would assert a genotype-phenotype link the evidence does not carry. UNCITED REFERENCE CACHES. Two cached references are deliberately not cited. PMID:27173043 (Vermeer et al 2016) is the primary report of ascending aortic dilatation in HCN4 families and would be the better citation for that phenotype, but it is a JACC letter with no abstract retrievable through the reference cache, so the frequency is cited through the case report PMID:35257104 with directness INDIRECT instead. PMID:33185997 has the same problem. Neither is a defective source; there is simply no quotable text to attach a snippet to. The remaining uncited caches back the openscientist deep-research report rather than this entry. PREVALENCE. There is still no general-population prevalence estimate specific to SSS2, and none is asserted. What the prevalence records hold instead are four conditioned occurrence figures, each labelled with the ascertainment that produced it: the HCN4 share of mutation-positive familial sick sinus syndrome probands, the HCN4 share of paediatric and of adult isolated left ventricular noncompaction cohorts, and the Danish nationwide cumulative incidence of pacemaker-treated sinus node dysfunction in first-degree relatives, which is heritable sinus node dysfunction at population scale rather than genotyped SSS2. The per-gene case fraction (2 of 38 familial SSS families) remains under genetic.case_fractions, which is the correct slot for a genetic-spectrum share rather than a population rate.

Augment SSS2: prevalence, progression, models, datasets, knowledge gaps, edge evidence · 2026-09-03T08:03:55Z · View source

Augmentation pass on the existing MONDO:0008102 entry (created 2026-08-17, issue #8548, PR #8771). DEEP RESEARCH: openscientist (Edison/falcon report for this disorder already existed on main and was read rather than regenerated, since re-running would have overwritten the committed report the original curation was built from). The openscientist run validated clean -- 16/16 references resolved, confabulation_rate 0.0, 24/24 CURIEs resolved -- with needs_review true for one quote (PMID:18375593) that could not be matched beyond the abstract; that reference was not used. preflight-dr against MONDO:0008102 returned PASS (HCN4 56 mentions vs SCN5A 4, OMIM 163800 matching). Its suggested HP:0011702 and HP:0011664 names were paraphrases of the ontology labels and were not copied. ADDED: four structured prevalence records, each an ascertainment-conditioned occurrence figure with the conditioning stated in notes (HCN4 share of mutation-positive familial SSS probands 16/48 PMID:28104484; HCN4 share of paediatric LVNC 4/31 PMID:35893073; ordinal rank in adult LVNC PMID:30471092; Danish nationwide cumulative incidence of pacemaker-treated SND in first-degree relatives PMID:39535890, graded INDIRECT because the cohort is not genotyped). Four progression phases from prenatal bradycardia (PMID:39698436) through asymptomatic childhood (PMID:35257104), post-adolescent symptomatic SND (PMID:28104484), to age-dependent aortic dilatation, the last recorded with the report's own contradicting family. Three phenotypes: biventricular noncompaction with preserved systolic function (PMID:34088380), mitral valve prolapse and prolonged QT interval (PMID:15123648, PMID:39698436). Two variants, D553N trafficking-defective (PMID:15123648) and the c.1737+1 G>T splice allele (PMID:28465117), the latter also supplying the only formal exercise-test measurement of chronotropic incompetence against non-carrier relatives. Two experimental_models: the patient-derived hiPSC gene-dose pair (PMID:40414080, relationship PERTURBS with fidelity UNKNOWN because only pluripotency characterisation is published) and the wild-type hiPSC pacemaker-cardiomyocyte I_f platform (PMID:33934225, relationship MEASURES). Three verified GEO datasets (geo:GSE279632, geo:GSE189782, geo:GSE329403) with relevance triage in notes -- none is an SSS2 cohort, and the mouse GOF accession is labelled as the opposite-direction allele. Four discussions: the unexplained aortic-wall mechanism, whether noncompaction is developmental or rate-driven, the HCN4 variant-causality threshold (CONTROVERSY, PMID:33095298 V759I functionally normal and non-segregating), and a HUMAN_MODEL_MISMATCH on chronotropic incompetence in the hHCN4-573X mouse. Evidence added to 11 of the 12 causal edges; the compaction-to-aortic-dilatation edge is deliberately left uncited and carries the knowledge-gap discussion instead. Top-level evidence added to both animal models and to four of five differential diagnoses (PMID:21131953 for SANDD, PMID:30645171 for SSS4). CLEANUP: rewrote nine explanation strings that still argued for the retired supports value PARTIAL (issue #10003 prose backlog) and encoded the inference step as directness INDIRECT where that is what they meant; refreshed the stale PREVALENCE paragraph in notes. NOT USED: PMID:27173043 (Vermeer 2016, the primary aortic-dilatation report) and PMID:33185997 have no retrievable abstract, so the aortic frequency is cited through the case report PMID:35257104 with directness INDIRECT rather than quoted from the primary. VALIDATION ACTUALLY RUN: just validate; just validate-terms (passed); count-verified-snippets 127/127; check-duplicate-keys, check-entity-refs, check-causal-targets, check-qualifier-terms plus check-qualifier-terms-online, check-enum-values, check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading (one new divergence found and fixed), check-environmental-evidence; verify-datasets 3/3 OK; check-groupings on Inherited_Arrhythmia_Syndromes (SATISFIED); validate-disorders as the final batched sweep; pytest tests/test_data.py. Compliance moved 89.5 to 99.7 percent. RED-TEAM REVIEW BEFORE COMMIT: a subagent review against .claude/skills/dismech-pr-review raised 20 findings and all were acted on. The substantive ones: the four prevalence records initially asserted prevalence_class ABOVE_1_IN_1000 and rate_per_100000 for ascertainment-conditioned cohorts, which would have exported as SSS2 population prevalence, so the three cohort-share records were moved to genetic.case_fractions (the slot this entry's own notes already named as correct for a genetic-spectrum share) and only the Danish population-scale record remains under prevalence; the biventricular-noncompaction frequency was cut from FREQUENT to OCCASIONAL because the 53.1% is conditioned on already having noncompaction rather than measured across SSS2 carriers; the aortic progression phase no longer claims adult onset, since the cited family has dilatation in two adolescents and none in their 50-year-old mother; the childhood phase no longer says carriers have no device indication, since the proband in that same family had 66 pauses of three seconds or longer and was implanted; the geo:GSE279632 record now names the CITE-seq component it actually is rather than the whole series; the hiPSC-line limitation no longer assumes the heterozygous carrier is affected, which a consanguineous pedigree does not establish; two weak causal-edge snippets were replaced (a disease definition, and an eight-word generic sentence that omitted sudden cardiac death) and directness INDIRECT was added to every item resting on generic sinus-node-dysfunction literature; the SSS4 differential explanation now says its quote is that paper's background summarising the primary GNB2 report rather than its own KCNJ5 result; and an unsourced superlative on the D553N allele was dropped. Acting on the review's content-gap finding, a Stroke Prevention in Atrial Fibrillation treatment (PMID:37977871, PMID:40315941) and a paired knowledge-gap discussion were added, scoped to documented atrial fibrillation because the meta-analysis states in terms that anticoagulation in sinus node dysfunction is untested. Two review points were answered in place rather than by the suggested change: the hiPSC I_f platform keeps fidelity MODERATE, since its own limitations already record the immaturity that grade reflects, and the CL:1000477 binding is kept with preferred_term rewritten to hiPSC-derived sinoatrial-node-like pacemaker cardiomyocyte so the ontology term carries the intended identity while preferred_term carries the qualification, which is the Ontology Term Contract pattern. Three new phenotypes were checked against the pathograph: biventricular noncompaction was given a causal edge from the trabecular compaction node, and mitral valve prolapse and prolonged QT interval were deliberately left unconnected with a line in each description saying why.

Create: Sick Sinus Syndrome 2, Autosomal Dominant (HCN4) · 2026-08-17T16:41:58Z · View source

De-novo curation of MONDO:0008102 (SSS2, HCN4-related autosomal dominant sinus node dysfunction), fulfilling issue #8548. LUMP-VS-SPLIT: the existing umbrella entry Familial_Sick_Sinus_Syndrome (MONDO:0012061) already carried an HCN4 node, an HCN4 genetic entry and LVNC as a phenotype, but MONDO models MONDO:0008102 as a distinct disease-series-by-gene entity (is_a MONDO:0012061, RO:0004003 HGNC:16882, xref OMIM:163800) and the umbrella is deliberately gene-heterogeneous (recessive SCN5A form, LMNA, ANK2, GWAS loci), so a standalone HCN4-specific entry was created and cross-referenced in both directions via differential_diagnoses rather than duplicating the umbrella. NEC PREFLIGHT: the MONDO record was read directly with runoak and confirms HCN4 and OMIM:163800; preflight-dr on the falcon report returned PASS (HCN4 91 mentions vs SCN5A 3). DEEP RESEARCH: falcon (Edison) run, reference_validation 8/8 verified and confabulation_rate 0.0, but it cited reviews rather than the primary SSS2 literature and its suggested HPO/NCIT identifiers were largely wrong on OAK lookup, so it was used as a lead only and the evidence base was rebuilt from primary papers: PMID:16407510, PMID:12750403, PMID:17646576, PMID:23178648, PMID:25145517, PMID:25145518, PMID:28104484, PMID:35328031, PMID:19570998, PMID:21220308, PMID:37760888, PMID:34383451, PMID:26835093. Declares conforms_to against three cardiac_ion_channel_repolarization module nodes including the sinoatrial-node automaticity-failure branch, and was added as a member of the Inherited_Arrhythmia_Syndromes grouping (check-groupings reports SATISFIED). No GeneReviews chapter exists for this disorder; PubMed was searched and only unrelated chapters were returned. VALIDATION ACTUALLY RUN: schema and term validation via the repository pre-edit hook (both clean); count-verified-snippets 59/59 verified against cached references; check-title-snippets OK; check-duplicate-keys OK; validate-grouping and check-groupings OK; pytest tests/test_data.py; and validate-disorders as the final batched pre-PR sweep.

Falcon ▸

1. Disease Information

Edison Scientific Literature 30 citations 2026-08-17T09:19:56.317302

1. Disease Information

Disease Overview

Sick Sinus Syndrome 2 (SSS2), Autosomal Dominant, is a hereditary cardiac arrhythmia disorder characterized by intrinsic dysfunction of the sinoatrial node (SAN), the heart's primary pacemaker. The disease manifests as the heart's inability to perform adequate pacemaking function, resulting in a spectrum of cardiac rhythm disturbances including symptomatic sinus bradycardia, chronotropic incompetence, sinoatrial block, sinus arrest, and paroxysmal supraventricular tachyarrhythmias (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, tytgat2022reviewhcnchannels pages 5-6).

Key Identifiers

While specific OMIM identifiers for "Sick Sinus Syndrome 2" were not retrieved in the current literature search, the disease is associated with mutations in the HCN4 gene. The condition falls under the broader category of sinus node dysfunction (SND) and familial sick sinus syndrome (tytgat2022reviewhcnchannels pages 5-6, tytgat2022reviewhcnchannels pages 6-7).

OMIM: Related entries include HCN4 gene (OMIM 605206) and familial sinus bradycardia phenotypes
Alternative Names: Sinus Node Dysfunction (SND), Familial Sick Sinus Syndrome, Familial Sinus Bradycardia
Disease Category*: Mendelian inherited arrhythmia syndrome, primary electrical disorder

Information Source Type

The information in this report is derived from aggregated disease-level resources including peer-reviewed scientific literature, genetic databases, and preclinical model organism studies. It represents disease-level knowledge rather than individual patient data (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3).

2. Etiology

Disease Causal Factors

Primary Genetic Cause: Sick Sinus Syndrome 2 is primarily caused by heterozygous pathogenic variants in the HCN4 gene (hyperpolarization-activated cyclic nucleotide-gated channel 4), which encodes the cardiac pacemaker channel conducting the hyperpolarization-activated cation current (If), essential for pacemaker activity (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, tytgat2022reviewhcnchannels pages 5-6). The HCN4 channel is the predominant HCN isoform expressed in the mammalian sinoatrial node and is critical for generating spontaneous pacemaker potentials (maarel2023geneticsofsinoatrial pages 2-3).

Risk Factors

Genetic Risk Factors: - HCN4 Mutations: At least 22 HCN4 mutations or variants have been identified in association with sinus node dysfunction, with 13 showing clear genotype-phenotype associations (tytgat2022reviewhcnchannels pages 5-6). Most pathogenic variants are heterozygous loss-of-function (LOF) mutations that act through dominant-negative mechanisms with variable penetrance (tytgat2022reviewhcnchannels pages 6-7). - Variant Types: Pathogenic variants include missense mutations (e.g., R550H, E1193Q, R378C, G482R, V492F, P883R) and truncating mutations (e.g., 695X) affecting channel activation, cAMP sensitivity, membrane trafficking, or current density (tytgat2022reviewhcnchannels pages 6-7).

Environmental Risk Factors: - Age: Aging is a major risk factor, with age-related SAN degeneration representing the most common intrinsic cause of sinus node dysfunction (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9, zheng2023emergingsignalingregulation pages 1-3). Reduced expression of proteins essential for current generation during aging correlates with increased SSS diagnosis in elderly patients (iop2021inheritedandacquired pages 8-9). - Endurance Athletic Training: Associated with increased bradyarrhythmia risk through both increased vagal input (hypervagotonia) and intrinsic ion channel remodeling (mesirca2021pharmacologicapproachto pages 8-9). - Medications: Certain pharmacological agents cause cardiac toxicity targeting the SAN, including calcium antagonists (verapamil, diltiazem) and sodium channel blockers (propafenone), which can induce or worsen SSS (iop2021inheritedandacquired pages 9-10). - Metabolic Disorders: Diabetes mellitus is a significant risk factor causing downregulated electrical signaling, oxidative stress, inflammation, atrial fibrosis, and decreased HCN4 expression in the SAN (iop2021inheritedandacquired pages 9-10, iop2021inheritedandacquired pages 14-14). - Cardiovascular Disease: Myocardial ischemia/infarction, heart failure, coronary artery disease, and atrial fibrillation can lead to secondary SND through oxidative stress, calcium overload, and inflammatory mechanisms (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9, iop2021inheritedandacquired pages 9-10).

Protective Factors

No specific genetic or environmental protective factors have been identified in the available literature for HCN4-related sick sinus syndrome.

Gene-Environment Interactions

The phenotypic expression of HCN4 mutations shows significant modulation by environmental factors. Hypoxia, oxidative stress from cardiovascular diseases, inflammatory conditions, and metabolic derangements can exacerbate the functional consequences of HCN4 variants (iop2021inheritedandacquired pages 8-9, iop2021inheritedandacquired pages 9-10). Vagal tone variability may explain incomplete penetrance in some mutation carriers who remain asymptomatic despite carrying pathogenic variants (iop2021inheritedandacquired pages 6-8).

3. Phenotypes

The clinical phenotypes of Sick Sinus Syndrome 2 are summarized in detail below and in the accompanying table (artifact-02).

Core Cardiac Phenotypes

Sinus Bradycardia (HP:0001662 Bradycardia) - Type: Clinical sign, electrophysiological abnormality - Characteristics: Resting heart rates can be markedly reduced (e.g., 37 bpm documented in adult patient, ~40% reduction in embryonic mouse models) (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 2-4) - Onset: Variable; can present from early life in familial cases or later in adulthood - Severity: Mild to severe - Frequency: Core phenotype, very common in HCN4-related disease - Progression: Often progressive with age - Quality of Life Impact: Causes fatigue, exercise intolerance, dizziness, and syncope

Chronotropic Incompetence (HP:0005209 Chronotropic incompetence) - Type: Clinical sign, functional abnormality - Characteristics: Failure to achieve age-appropriate maximum heart rate during exercise (e.g., 146 bpm versus predicted 90-110% range in documented case); impaired β-adrenergic responsiveness (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 8-10) - Onset: Recognized during exercise testing or stress - Severity: Moderate to severe - Frequency: Common in HCN4-related SND - Progression: Stable or progressive - Quality of Life Impact: Severe exercise limitation, reduced functional capacity

Sinus Pauses (HP:0030247 Sinus pause) - Type: Electrophysiological abnormality - Characteristics: Pauses exceeding 2-3 seconds; documented up to 3 seconds in human cases; recurrent pauses are hallmark of reduced HCN4 function (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, tytgat2022reviewhcnchannels pages 5-6) - Onset: Variable, often recognized during continuous ECG monitoring - Severity: Moderate to severe - Frequency: Common in experimental models and human cases - Quality of Life Impact: Presyncope, syncope, risk of falls

Sinus Arrest (HP:0011706 Sinus arrest) - Type: Severe electrophysiological abnormality - Characteristics: Complete failure of SAN impulse generation (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 1-2) - Severity: Severe - Quality of Life Impact: Life-threatening; requires pacemaker intervention

Sinoatrial Block (HP:0011710 Sinoatrial block) - Type: Conduction abnormality - Characteristics: Impaired impulse transmission from SAN to atrium despite preserved SAN automaticity (tytgat2022reviewhcnchannels pages 5-6, zheng2023emergingsignalingregulation pages 1-3) - Severity: Mild to severe

Sinus Dysrhythmia (HP:0011708 Cardiac dysrhythmia) - Type: Clinical sign - Characteristics: Large beat-to-beat variability and unstable pacemaker output; severe sinus dysrhythmia described in HCN4FEA mice (hennis2022paradigmshiftnew pages 8-10, hennis2021discoveryofa pages 76-80) - Severity: Mild to severe

Associated Arrhythmias

Atrial Fibrillation (HP:0005110 Atrial fibrillation) - Type: Secondary arrhythmia - Characteristics: Increased susceptibility with HCN4-related SND; may coexist in bradycardia-tachycardia syndrome (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2) - Frequency: Variable expressivity, not universal - Severity: Moderate to severe - Quality of Life Impact: Embolic risk, cardiomyopathy complications

Supraventricular Tachyarrhythmias (HP:0005117 Supraventricular tachycardia) - Type: Paroxysmal arrhythmia - Characteristics: Part of bradycardia-tachycardia syndrome spectrum (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3)

Structural Cardiac Abnormalities

Left Ventricular Noncompaction Cardiomyopathy (HP:0012810 Left ventricular noncompaction) - Type: Structural abnormality - Characteristics: Excessive ventricular trabeculation/hypertrabeculation with risk of heart failure, arrhythmias, and thromboembolic complications (tytgat2022reviewhcnchannels pages 6-7) - Frequency: Reported in subset of HCN4 mutation carriers; variable expressivity - Severity: Moderate to severe

Symptoms

Dizziness/Presyncope (HP:0002321 Vertigo or HP:0001288 Lightheadedness) - Type: Symptom - Characteristics: Accompanies marked sinus bradycardia; documented case presented with dizziness and nausea (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Severity: Mild to moderate - Quality of Life Impact: Affects daily activities, risk of injury from falls

Clinical Interventions Required

Pacemaker Requirement (HP:0005304 Cardiac pacemaker implantation) - Type: Therapeutic intervention necessity - Characteristics: Permanent pacing is definitive treatment for chronic symptomatic SND (mesirca2021pharmacologicapproachto pages 1-2, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Frequency: Common in clinically significant symptomatic cases - Onset: Often adulthood when symptoms become intolerable - Quality of Life Impact: Improves symptoms but requires device management

Phenotype name	HPO term suggestion	Frequency / penetrance	Age of onset	Severity	Key clinical characteristics
Sinus bradycardia	HP:0001662 Bradycardia	Very common/core phenotype in HCN4-related disease; human HCN4 literature summarized 22 variants linked to SND, with 13 showing clear genotype-phenotype association; penetrance is variable and often incomplete in heterozygous families (tytgat2022reviewhcnchannels pages 5-6, tytgat2022reviewhcnchannels pages 6-7)	Variable; can present in embryonic life in models, childhood/young adulthood in familial cases, or adulthood; symptomatic case described at age 49 years (maarel2023geneticsofsinoatrial pages 2-3, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Mild to severe	Resting sinus rates can be markedly reduced; example patient had 37 bpm, and animal models show severe intrinsic SAN slowing (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 8-10)
Chronotropic incompetence	HP:0005209 Chronotropic incompetence	Common in SAN dysfunction due to HCN4 dysregulation, but exact human penetrance not well quantified (hennis2022paradigmshiftnew pages 8-10, tytgat2022reviewhcnchannels pages 5-6)	Usually recognized when exercise or autonomic challenge fails to raise heart rate appropriately; adult case documented (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Moderate to severe	Failure to achieve expected heart-rate increase during exercise or stress; reflects impaired autonomic/SAN responsiveness (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, hennis2022paradigmshiftnew pages 8-10)
Sinus pauses	HP:0030247 Sinus pause	Common in experimental models and reported in human cases; exact penetrance unknown (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)	Variable; can occur in adult symptomatic disease and in inducible/conditional mouse models (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, mesirca2021pharmacologicapproachto pages 6-8)	Moderate to severe	Pauses may exceed 2-3 seconds; example Holter showed pauses up to 3 seconds; recurrent pauses are a hallmark of reduced HCN4 function (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, tytgat2022reviewhcnchannels pages 5-6)
Sinus arrest	HP:0011706 Sinus arrest	Reported as part of the SND spectrum; frequency not well quantified for HCN4 specifically (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 1-2)	Variable	Severe	Represents failure of impulse generation by the SAN; contributes to dizziness, presyncope/syncope, and pacemaker requirement (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 1-2)
Sinoatrial exit block / impaired impulse transmission	HP:0011710 Sinoatrial block	Recognized component of SND/SSS spectrum; specific HCN4 penetrance not quantified (tytgat2022reviewhcnchannels pages 5-6, zheng2023emergingsignalingregulation pages 1-3)	Variable	Mild to severe	SAN automaticity may be preserved but conduction from SAN to atrium is impaired; part of intrinsic SAN inadequacy definition (tytgat2022reviewhcnchannels pages 5-6, zheng2023emergingsignalingregulation pages 1-3)
Sinus dysrhythmia / irregular sinus rhythm	HP:0011708 Cardiac dysrhythmia	Prominent in HCN4 mouse models and likely relevant to human disease; exact human frequency unknown (hennis2022paradigmshiftnew pages 8-10, hennis2022paradigmshiftnew pages 5-6)	Variable	Mild to severe	Large beat-to-beat variability and unstable pacemaker output; severe sinus dysrhythmia described in HCN4FEA mice (hennis2022paradigmshiftnew pages 8-10, hennis2021discoveryofa pages 76-80)
Atrial fibrillation	HP:0005110 Atrial fibrillation	Increased susceptibility reported with HCN4-related SND, but not universal; variable expressivity (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2)	Usually later than isolated bradycardia; variable	Moderate to severe	May coexist with bradycardia/tachycardia syndrome; can contribute to embolic risk and cardiomyopathy (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2)
Paroxysmal supraventricular tachyarrhythmia / tachy-brady syndrome	HP:0005117 Supraventricular tachycardia	Part of the broader SSS phenotype spectrum; exact penetrance not established (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3)	Variable	Moderate	Alternation of slow and fast atrial rhythms is characteristic of sick sinus syndrome and may complicate management (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3)
Dizziness / presyncope	HP:0002321 Vertigo or HP:0001288 Lightheadedness	Symptomatic manifestation rather than core electrophysiologic trait; frequency depends on bradycardia severity (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Typically when clinically manifest disease develops	Mild to moderate	Example patient presented with dizziness and nausea accompanying marked sinus bradycardia (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)
Pacemaker requirement	HP:0005304 Cardiac pacemaker implantation	Common in clinically significant symptomatic SND; exact percentage for HCN4 families unavailable (mesirca2021pharmacologicapproachto pages 1-2, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)	Often adulthood, when symptomatic bradycardia/pauses become clinically significant	Severe disease indicator	Permanent pacing is the definitive treatment for chronic symptomatic SND and reflects advanced functional impact (mesirca2021pharmacologicapproachto pages 1-2, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)
Left ventricular noncompaction cardiomyopathy	HP:0012810 Left ventricular noncompaction	Reported in a subset of HCN4 mutation carriers; variable expressivity and not present in all families (tytgat2022reviewhcnchannels pages 6-7)	Variable; may be recognized with cardiac imaging after arrhythmia workup	Moderate to severe	Excessive ventricular trabeculation/hypertrabeculation; may be accompanied by heart failure, arrhythmias, and thromboembolic risk (tytgat2022reviewhcnchannels pages 6-7)
Heart failure / cardiomyopathy complications	HP:0001635 Congestive heart failure	Secondary/less common manifestation, particularly when structural cardiomyopathy co-occurs (tytgat2022reviewhcnchannels pages 6-7)	Usually later/complication stage	Severe	Seen mainly in mutation carriers with associated noncompaction or tachycardia-induced cardiomyopathy rather than isolated sinus node dysfunction (tytgat2022reviewhcnchannels pages 6-7)

Table: This table summarizes the principal clinical manifestations reported for HCN4-related sick sinus syndrome 2, including suggested HPO terms and practical notes on onset, severity, and penetrance. It is useful for phenotype curation and disease knowledge base population.

4. Genetic/Molecular Information

Causal Genes

HCN4 Gene (Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel 4) - Gene Symbol: HCN4 - HGNC ID: HGNC:16882 - OMIM Gene ID: 605206 - Chromosomal Location: 15q24-q25 - Gene Function*: Encodes the predominant cardiac pacemaker channel conducting the If current, essential for spontaneous rhythmic activity of sinoatrial node pacemaker cells (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, maarel2023geneticsofsinoatrial pages 2-3)

Pathogenic Variants

A comprehensive table of HCN4 pathogenic variants is provided (artifact-00). Key variants include:

Loss-of-Function Variants (Most Common): - p.R550H: Missense variant causing LOF through mechanisms consistent with dominant-negative effects (tytgat2022reviewhcnchannels pages 6-7) - p.E1193Q: Distal C-terminus missense variant causing LOF (tytgat2022reviewhcnchannels pages 6-7) - p.R378C: Missense variant with leftward/negative shift in activation curve (tytgat2022reviewhcnchannels pages 6-7) - p.G482R: Pore domain missense variant causing LOF (tytgat2022reviewhcnchannels pages 6-7) - p.V492F: S6 helix missense variant in highly conserved region causing LOF (tytgat2022reviewhcnchannels pages 6-7, tytgat2022reviewhcnchannels pages 11-12) - p.695X: Truncating nonsense mutation causing LOF (tytgat2022reviewhcnchannels pages 6-7)

Gain-of-Function Variants (Rare): - p.P883R: Exceptional GOF variant showing positive voltage shift and faster deactivation (tytgat2022reviewhcnchannels pages 6-7) - p.R524Q: GOF variant with enhanced cAMP sensitivity associated with familial inappropriate sinus tachycardia (tytgat2022reviewhcnchannels pages 6-7)

Variant of Uncertain Significance: - p.V759I (c.2275G>A): Initially classified as likely pathogenic, but detailed functional studies showed no demonstrable abnormality; likely insufficient alone to cause disease (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Variant Classification and Functional Consequences

Mechanism of LOF: - Negative shifts in voltage-dependent activation curves - Reduced membrane expression density - Decreased current density - Altered cAMP sensitivity - Defective channel trafficking to cell membrane - Impaired interaction with regulatory proteins (tytgat2022reviewhcnchannels pages 6-7)

Dominant-Negative Effects: Most SND-associated HCN4 mutations are heterozygous and act through dominant-negative mechanisms, where mutant subunits co-assemble with wild-type subunits in heterotetrameric channels, impairing overall channel function (tytgat2022reviewhcnchannels pages 6-7).

Allele Frequency

The V759I variant occurs at ~0.6% frequency in European populations, suggesting it may be a benign polymorphism rather than a pathogenic variant (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5). Most pathogenic HCN4 variants are rare or private mutations within families.

Somatic vs Germline

All reported HCN4 mutations causing familial sick sinus syndrome are germline variants inherited in an autosomal dominant pattern (tytgat2022reviewhcnchannels pages 6-7).

Variant (protein; genomic if available)	Variant class	Functional consequence	Protein location/domain	Reported phenotype(s)	Notes	Citation
p.R378C	Missense	Loss-of-function; leftward/negative shift in activation reported for SND-associated variants	Transmembrane/channel region (exact subdomain not specified in available evidence)	Sinus node dysfunction / sick sinus syndrome, bradycardia	Listed among HCN4 variants with clear SND association	(tytgat2022reviewhcnchannels pages 6-7)
p.G482R	Missense	Loss-of-function	Pore domain	Sinus node dysfunction / sick sinus syndrome, bradycardia	Pore-domain variant highlighted among pathogenic SND variants	(tytgat2022reviewhcnchannels pages 6-7)
p.V492F	Missense	Loss-of-function	S6 helix, highly conserved region	Sinus node dysfunction / sick sinus syndrome, bradycardia	Conserved S6 localization supports functional importance	(tytgat2022reviewhcnchannels pages 6-7, tytgat2022reviewhcnchannels pages 11-12)
p.R524Q	Missense	Gain-of-function; enhanced cAMP sensitivity	C-linker/CNBD-proximal region (exact domain not specified in available evidence)	Familial inappropriate sinus tachycardia; sinus node dysfunction spectrum	Not a classic bradycardic SSS allele, but relevant HCN4 SND-spectrum variant	(tytgat2022reviewhcnchannels pages 6-7)
p.R550H	Missense	Loss-of-function; dominant-negative pattern described for most SND alleles	C-terminal cytoplasmic region (exact domain not specified in available evidence)	Sinus node dysfunction / sick sinus syndrome, bradycardia	One of the recurrent heterozygous SND-associated HCN4 variants	(tytgat2022reviewhcnchannels pages 6-7)
p.695X	Truncating / nonsense	Loss-of-function	Truncation of C-terminal channel region	Sinus node dysfunction / sick sinus syndrome, bradycardia	Premature stop expected to impair channel function	(tytgat2022reviewhcnchannels pages 6-7)
p.V759I; c.2275G>A	Missense	No demonstrable abnormality in available functional assays; likely benign/insufficient alone	Distal C-terminal region, exon 8	Symptomatic sinus bradycardia, chronotropic incompetence, sinus pauses in reported carrier	Initially considered likely pathogenic in a family-history context, but functional testing did not support causality	(erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)
p.P883R	Missense	Gain-of-function; positive voltage shift and faster deactivation	Distal C-terminus	Sinus node dysfunction spectrum	Exceptional because most HCN4 SND variants are loss-of-function	(tytgat2022reviewhcnchannels pages 6-7)
p.E1193Q	Missense	Loss-of-function	Distal C-terminus	Sinus node dysfunction / sick sinus syndrome, bradycardia	Distal C-terminal SND-associated variant	(tytgat2022reviewhcnchannels pages 6-7)
HCN4 SND-associated variants overall	Mostly missense, occasional truncating	Predominantly heterozygous dominant-negative loss-of-function via negative activation shift, reduced membrane expression, decreased current density, altered cAMP sensitivity, or trafficking defects	Frequently transmembrane/pore/C-terminal regulatory regions	Sinus bradycardia, sinus pauses/arrest, chronotropic incompetence, atrial fibrillation susceptibility; sometimes noncompaction cardiomyopathy	Review identified 22 reported HCN4 SND variants, with 13 considered to have clear genotype-phenotype association	(tytgat2022reviewhcnchannels pages 5-6, tytgat2022reviewhcnchannels pages 6-7)

Table: This table summarizes key HCN4 variants discussed in the available evidence for Sick Sinus Syndrome 2 and related sinus node dysfunction phenotypes. It highlights variant class, inferred functional effect, domain context, and clinical manifestations to support genotype-phenotype interpretation.

5. Environmental Information

Environmental Factors

Cardiac Toxins: Calcium antagonists (verapamil, diltiazem), sodium channel blockers (propafenone) (iop2021inheritedandacquired pages 9-10)
Ischemia/Hypoxia: Myocardial ischemia, oxidative stress (iop2021inheritedandacquired pages 8-9, iop2021inheritedandacquired pages 9-10)
Inflammatory Conditions: Systemic inflammation affecting cardiac tissue (iop2021inheritedandacquired pages 8-9)

Lifestyle Factors

Endurance Athletic Training: Associated with increased vagal tone and ion channel remodeling (mesirca2021pharmacologicapproachto pages 8-9)
Age: Progressive age-related degeneration (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9)

Infectious Agents

Not applicable. While infectious diseases can contribute to secondary SAN dysfunction, no specific infectious agents are primary causes of the inherited HCN4-related disease.

6. Mechanism / Pathophysiology

Molecular Pathways

HCN4 Channel Function and Regulation: HCN4 channels are activated by membrane hyperpolarization and directly modulated by cyclic nucleotides (cAMP), which shift voltage-dependent activation toward more depolarized potentials (tytgat2022reviewhcnchannels pages 4-5, hennis2022paradigmshiftnew pages 5-6). The channels generate 70-80% of the total sinoatrial If current across vertebrate species (tytgat2022reviewhcnchannels pages 5-6). cAMP binding to the cyclic nucleotide-binding domain (CNBD) induces conformational changes that propagate to the pore, causing gate-forming inner helices to rotate open and increasing channel availability at physiological voltages (tytgat2022reviewhcnchannels pages 4-5).

Regulatory Mechanisms: - Phosphoinositides (PIP2): Stabilize voltage sensor and shift HCN4 activation toward depolarizing potentials (tytgat2022reviewhcnchannels pages 4-5) - Cholesterol: Modulates HCN4 localization and channel kinetics (tytgat2022reviewhcnchannels pages 4-5) - SGO1 (Shugoshin-1): Maintains cardiac automaticity by regulating HCN4 surface expression (tytgat2022reviewhcnchannels pages 4-5, tytgat2022reviewhcnchannels pages 11-12) - Src Tyrosine Kinase: Regulates HCN4 gating through direct binding and phosphorylation at Tyr531 (tytgat2022reviewhcnchannels pages 11-12)

Cellular Processes

Pacemaker Cell Automaticity: The sinoatrial node comprises specialized pacemaker cardiomyocytes that spontaneously oscillate their membrane potential through integrated "membrane clock" and "calcium clock" mechanisms (maarel2023geneticsofsinoatrial pages 1-2). HCN4 channels contribute to the diastolic depolarization phase of the pacemaker potential, progressively depolarizing the membrane toward the threshold for voltage-gated calcium channel activation and action potential firing (tytgat2022reviewhcnchannels pages 5-6, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2).

Firing vs Nonfiring Modes: Recent studies reveal that HCN4 cAMP-dependent regulation controls the balance between firing and nonfiring pacemaker cells in the SAN network (hennis2022paradigmshiftnew pages 5-6, hennis2022paradigmshiftnew pages 8-10). Loss of HCN4 cyclic nucleotide-dependent regulation leads to excessive nonfiring pacemaker cells, causing severe bradycardia and sinus dysrhythmia (hennis2022paradigmshiftnew pages 8-10). The mechanism involves dynamic mode shifts and hysteresis—a history-dependent process where HCN4 voltage-dependent activation depends on the holding membrane potential (hennis2022paradigmshiftnew pages 5-6).

Protein Dysfunction

Loss-of-Function Mechanisms: HCN4 mutations impair channel function through: 1. Altered voltage-dependent gating (negative activation shifts reduce channel availability at physiological potentials) 2. Reduced membrane trafficking and surface expression 3. Decreased current amplitude 4. Impaired cAMP sensitivity (inability to respond to β-adrenergic stimulation) 5. Dominant-negative suppression of wild-type channel function in heterotetrameric complexes (tytgat2022reviewhcnchannels pages 6-7)

Gain-of-Function Mechanisms (Rare): Some variants cause positive voltage shifts and enhanced cAMP sensitivity, leading to inappropriate sinus tachycardia rather than bradycardia (tytgat2022reviewhcnchannels pages 6-7).

Causal Chain: From Genetic Mutation to Clinical Manifestation

Upstream Events: 1. Germline HCN4 mutation → Altered channel protein structure 2. Impaired channel trafficking/assembly → Reduced functional channel density at cell membrane 3. Abnormal voltage-dependent gating → Reduced If current during diastolic depolarization

Intermediate Events: 4. Slowed or unstable diastolic depolarization in SAN pacemaker cells 5. Increased proportion of nonfiring pacemaker cells in SAN network 6. Reduced intrinsic heart rate and impaired chronotropic responsiveness 7. Unstable pacemaker leadership within SAN causing dysrhythmia

Downstream Events: 8. Symptomatic sinus bradycardia, pauses, arrest 9. Compensatory arrhythmias (atrial fibrillation, junctional escape rhythms) 10. Hemodynamic consequences (cerebral hypoperfusion, exercise intolerance) 11. Clinical symptoms (dizziness, syncope, fatigue) → Pacemaker requirement

Cell Types Involved

Sinoatrial Node Pacemaker Cells (CL:0002072 pacemaker cell of sinoatrial node): Primary affected cell type
Cardiac Myocytes (CL:0000746 cardiac muscle cell): Working myocardium depends on SAN pacing
Fibroblasts (CL:0000057 fibroblast): Component of SAN microenvironment (zheng2023emergingsignalingregulation pages 1-3, mesirca2021pharmacologicapproachto pages 16-17)

Biological Processes (GO Terms)

GO:0086091 - regulation of heart rate by cardiac conduction
GO:0086015 - SA node cell action potential
GO:0086019 - cell-cell signaling involved in cardiac conduction
GO:0060371 - regulation of atrial cardiac muscle cell membrane depolarization
GO:0086001 - cardiac muscle cell action potential
GO:0003015 - heart process
GO:0034765 - regulation of ion transmembrane transport

7. Anatomical Structures Affected

Organ Level

Primary Organ: Heart (UBERON:0000948) - Sinoatrial Node (UBERON:0002049): Primary site of dysfunction; located at junction of superior vena cava and right atrium; dimensions in humans: 11-30 mm length, 2-6 mm width, 2.2-2.6 mm thickness (maarel2023geneticsofsinoatrial pages 1-2, zheng2023emergingsignalingregulation pages 1-3) - Right Atrium (UBERON:0002078): Receives electrical impulse from SAN - Cardiac Conduction System (UBERON:0002350): Network of specialized tissues distributing depolarizing currents (maarel2023geneticsofsinoatrial pages 1-2)

Secondary Organ Involvement: - Brain: Cerebral hypoperfusion from bradycardia - Kidneys, Other Organs: Insufficient perfusion in severe cases (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Body Systems: - Cardiovascular System (UBERON:0004535): Primary system affected - Nervous System: Secondary effects from hypoperfusion

Tissue and Cell Level

Tissue Types: - Cardiac Pacemaker Tissue: Specialized nodal tissue with unique electrophysiological properties distinct from working myocardium (maarel2023geneticsofsinoatrial pages 1-2, zheng2023emergingsignalingregulation pages 1-3) - Fibrous Connective Tissue: SAN pacemaker cells are embedded within fibrous connective tissue matrix composed primarily of collagen and elastin (zheng2023emergingsignalingregulation pages 1-3)

Specific Cell Populations: - Pacemaker Cells (CL:0002072): Generate spontaneous action potentials; express high levels of HCN4 (maarel2023geneticsofsinoatrial pages 2-3, zheng2023emergingsignalingregulation pages 1-3) - Transitional Cells: Cells between SAN and working atrial myocardium - Supporting Cells: Fibroblasts, endothelial cells, neurons, macrophages within SAN microenvironment (zheng2023emergingsignalingregulation pages 1-3)

Subcellular Level (GO Cellular Component Terms)

GO:0016020 - membrane (HCN4 channel localization)
GO:0005886 - plasma membrane (functional channel location)
GO:0034705 - potassium channel complex (HCN4 tetrameric assembly)
GO:0016021 - integral component of membrane

Localization

Anatomical Site: Sinoatrial node at right atrium-superior vena cava junction (UBERON:0002049)
Lateralization: Right-sided (sinoatrial node is right atrial structure)

8. Temporal Development

Onset

Age of Onset: - Embryonic/Developmental: HCN4 is essential for embryonic pacemaker development; complete loss causes embryonic lethality at E9.5-E11.5 in mice (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8) - Pediatric/Young Adult: Familial cases can present in childhood or young adulthood (documented case at age 49 years with family history) (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Adult-Onset: Many patients develop symptoms in adulthood; symptom onset correlates with age-related SAN degeneration and accumulated effects of incomplete penetrance (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9)

Onset Pattern: - Insidious/Chronic: Most cases show gradual progression rather than acute onset - Variable Expressivity: Within families, onset age and severity vary significantly due to incomplete penetrance (tytgat2022reviewhcnchannels pages 6-7)

Progression

Disease Course: - Progressive: Often shows progressive worsening with age (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 8-9) - Stable Periods: Some patients have prolonged stable periods before decompensation - Episodic: Paroxysmal symptoms (dizziness, presyncope) triggered by bradycardia or pauses

Disease Duration: - Chronic Lifelong: Once manifest, requires lifelong management; pacemaker therapy provides symptomatic control but not cure (mesirca2021pharmacologicapproachto pages 1-2)

Critical Periods

Embryonic Development: HCN4 expression initiated during heart tube elongation; essential for mature pacemaker cell formation (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)
Exercise/Stress: Chronotropic incompetence becomes apparent during physiological demands (hennis2022paradigmshiftnew pages 8-10, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

9. Inheritance and Population

Inheritance Pattern

Autosomal Dominant with incomplete penetrance and variable expressivity (tytgat2022reviewhcnchannels pages 6-7)

Penetrance: - Incomplete penetrance is common; not all mutation carriers develop symptomatic disease (tytgat2022reviewhcnchannels pages 6-7) - Penetrance may be age-dependent, with increased symptom manifestation in older individuals

Expressivity: - Variable expressivity within families; mutation carriers can range from asymptomatic to severely symptomatic requiring pacemaker (tytgat2022reviewhcnchannels pages 6-7)

Genetic Heterogeneity: - Multiple different HCN4 mutations can cause similar phenotypes - Other genes (SCN5A, CACNA1D, etc.) can cause overlapping sick sinus syndrome phenotypes (liang2023casereportscn5a pages 1-3)

Epidemiology

Prevalence and Incidence: Specific prevalence and incidence data for HCN4-related familial sick sinus syndrome are not available in the retrieved literature. Familial isolated sinus bradycardia is described as uncommon (liang2023casereportscn5a pages 1-3). Sick sinus syndrome in general increases with aging and is expected to increase in incidence over the next 50 years due to population aging (mesirca2021pharmacologicapproachto pages 1-2).

Population Demographics

Sex Ratio: No specific sex bias is documented for HCN4-related disease in the available literature, though sex-related differences in arrhythmia phenotypes are recognized generally (tytgat2022reviewhcnchannels pages 6-7).

Geographic/Ethnic Distribution: No specific founder effects or population-specific variants are documented in the reviewed literature for HCN4-related SSS2. The V759I variant has ~0.6% frequency in European populations (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5).

10. Diagnostics

Clinical Tests

Electrocardiography (ECG): - Resting ECG: Documents sinus bradycardia (e.g., 37 bpm); normal PR, QRS, and QT intervals typical unless conduction defects coexist (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - 24-Hour Holter Monitoring: Captures heart rate variability (e.g., 27-117 bpm), sinus pauses (up to 3 seconds), bradycardia-related arrhythmias (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5) - Exercise ECG: Demonstrates chronotropic incompetence (failure to achieve age-predicted maximum heart rate) (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

Electrophysiology Studies: - Sinoatrial node recovery time (SNRT) - Sinoatrial conduction time (SACT) - Assessment of AV node function (zheng2023emergingsignalingregulation pages 1-3, iop2021inheritedandacquired pages 10-12)

Imaging: - Echocardiography: Evaluate for structural abnormalities including left ventricular noncompaction cardiomyopathy (tytgat2022reviewhcnchannels pages 6-7) - Cardiac MRI: May identify noncompaction or fibrosis

Genetic Testing

Overview: Genetic testing is recommended for patients with familial sick sinus syndrome, early-onset bradycardia, or syndromic features (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2).

Single Gene Testing: - HCN4 Sequencing: Direct Sanger sequencing of all eight HCN4 exons and flanking intronic regions (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2) - Targeted Variant Testing: For known familial mutations

Multi-Gene Panels: - Comprehensive arrhythmia gene panels including HCN4, SCN5A, SCN10A, CACNA1D, TRPM4, and other cardiac ion channel and conduction system genes (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

Whole Exome Sequencing (WES): - Useful when single gene testing is negative but clinical suspicion for genetic etiology remains high - Identified novel variants in multiple case reports (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Genetic Testing Strategy: 1. Clinical diagnosis of sick sinus syndrome with family history 2. Detailed pedigree analysis suggesting autosomal dominant inheritance 3. HCN4 gene sequencing as first-line genetic test 4. Multi-gene panel or WES if HCN4 testing negative 5. Functional studies for variants of uncertain significance (erlenhardt2020diseaseassociatedhcn4v759i pages 4-5, erlenhardt2020diseaseassociatedhcn4v759i pages 1-2)

Clinical Criteria

Diagnostic Criteria for Sick Sinus Syndrome: - Symptomatic sinus bradycardia (heart rate <60 bpm at rest, <90 bpm during activity) - Sinus pauses or arrest (>2-3 seconds) - Chronotropic incompetence - Sinoatrial exit block - Absence of reversible causes (medications, electrolyte abnormalities) - Correlation of symptoms with bradyarrhythmic episodes (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, tytgat2022reviewhcnchannels pages 5-6, maarel2023geneticsofsinoatrial pages 1-2)

Differential Diagnosis: - Acquired/degenerative SSS (most common) - Medication-induced bradycardia - Other genetic causes: SCN5A mutations, CACNA1D mutations, LMNA mutations - Athletic heart syndrome (benign bradycardia in endurance athletes) - Hypothyroidism - Vagal-mediated bradycardia (mesirca2021pharmacologicapproachto pages 8-9, iop2021inheritedandacquired pages 6-8)

11. Outcome/Prognosis

Survival and Mortality

Specific survival data for HCN4-related sick sinus syndrome are not available in the retrieved literature. The condition is generally compatible with normal lifespan when appropriately managed with pacemaker therapy.

Disease-Specific Mortality: Risk of sudden cardiac death exists in untreated symptomatic patients due to prolonged pauses or asystole.

Morbidity and Function

Morbidity: - Recurrent syncope and presyncope with fall risk and injury - Exercise intolerance and reduced functional capacity - Complications from atrial fibrillation (stroke, heart failure) - Complications from noncompaction cardiomyopathy when present (heart failure, thromboembolism) (tytgat2022reviewhcnchannels pages 6-7)

Quality of Life: Untreated symptomatic sick sinus syndrome significantly impairs quality of life through: - Fatigue and exercise intolerance - Dizziness and syncope limiting activities - Psychological impact of unpredictable symptoms - Pacemaker therapy substantially improves quality of life by eliminating bradycardia-related symptoms (mesirca2021pharmacologicapproachto pages 1-2, liang2023casereportscn5a pages 3-5)

Complications

Atrial Fibrillation: Increased susceptibility; embolic stroke risk (tytgat2022reviewhcnchannels pages 6-7, maarel2023geneticsofsinoatrial pages 1-2)
Heart Failure: When structural cardiomyopathy coexists (tytgat2022reviewhcnchannels pages 6-7)
Syncope and Falls: Risk of traumatic injury
Sudden Cardiac Death: Rare but possible in severe untreated cases

Recovery Potential

Without Treatment: Progressive disease; no spontaneous resolution
With Pacemaker: Excellent symptomatic control; normal exercise capacity and quality of life restoration (mesirca2021pharmacologicapproachto pages 1-2, liang2023casereportscn5a pages 3-5)

Prognostic Factors

Severity of Bradycardia: Lower baseline heart rates and longer pauses predict greater symptom burden
Chronotropic Incompetence Severity: Degree of exercise limitation
Presence of Structural Abnormalities: Noncompaction cardiomyopathy worsens prognosis (tytgat2022reviewhcnchannels pages 6-7)
Age: Earlier onset may indicate more severe genetic defect

12. Treatment

Pharmacotherapy

Acute Management: - Catecholaminergic Agonists: Isoproterenol, dopamine, epinephrine (mesirca2021pharmacologicapproachto pages 9-10) - Atropine: Muscarinic receptor inhibitor; improves heart rate in acute bradycardia but may cause adverse effects (mesirca2021pharmacologicapproachto pages 20-22, mesirca2021pharmacologicapproachto pages 9-10)

Chronic Outpatient Management: - Theophylline/Aminophylline: Adenosine receptor blockers; theophylline is the most widely used drug for outpatient SND treatment and has prevented pacemaker implantation in some studies (mesirca2021pharmacologicapproachto pages 9-10) - Cilostazol: Phosphodiesterase inhibitor with chronotropic effects; improves heart rate in SND with tachycardia-bradycardia syndrome and may delay pacemaker implantation (mesirca2021pharmacologicapproachto pages 20-22, mesirca2021pharmacologicapproachto pages 9-10)

Limitations of Pharmacotherapy: Current pharmacologic options are limited and often insufficient for chronic symptomatic SND. Most drugs are recommended for intrahospital or monitored settings rather than long-term management (mesirca2021pharmacologicapproachto pages 9-10).

Emerging Pharmacological Targets: - GIRK Channel Inhibitors: Tertiapin-Q has shown promise in animal models (mesirca2021pharmacologicapproachto pages 20-22) - Calcium-Activated Potassium Channel Modulators: Under investigation (mesirca2021pharmacologicapproachto pages 1-2)

Surgical and Interventional

Permanent Pacemaker Implantation: - Indication: Definitive treatment for chronic symptomatic SND; required when symptoms (syncope, presyncope, exercise intolerance) persist despite medical management (mesirca2021pharmacologicapproachto pages 1-2, liang2023casereportscn5a pages 3-5) - Device Types: - Dual-chamber pacemakers (most common for SSS) - Leadless pacemakers (newer option) (liang2023casereportscn5a pages 3-5) - Outcomes: Successful symptom resolution; normal sinus rates maintained by pacing (50-60 bpm baseline with rate-responsive pacing during activity) (liang2023casereportscn5a pages 1-3, liang2023casereportscn5a pages 3-5) - Prevalence: SND and atrioventricular block together account for approximately half of all pacemaker implantations in the United States; pacemaker implantations predicted to double over next 50 years (mesirca2021pharmacologicapproachto pages 1-2)

Catheter Ablation: For patients with concomitant atrial flutter or atrial fibrillation, ablation therapy may be performed, though close monitoring for post-ablation bradycardia is essential (liang2023casereportscn5a pages 1-3).

Supportive Care

Symptom Management: Avoid bradycardia-inducing medications
Monitoring: Regular ECG and Holter monitoring to assess disease progression
Fall Precautions: For patients with recurrent syncope prior to pacemaker

Treatment Algorithms

Symptomatic SSS Diagnosis → Clinical and ECG confirmation
Exclude Reversible Causes → Medication review, thyroid function testing
Assess Symptom Severity:
Mild intermittent symptoms → Consider trial of theophylline or cilostazol with close monitoring
Moderate to severe symptoms → Proceed to pacemaker evaluation
Pacemaker Implantation → Dual-chamber or rate-responsive device
Long-Term Follow-Up → Device checks, management of concomitant arrhythmias

Treatment NCIT Terms

NCIT:C15632 - Pacemaker Implantation
NCIT:C29708 - Theophylline
NCIT:C47433 - Atropine
NCIT:C62025 - Cilostazol
NCIT:C726 - Isoproterenol

13. Prevention

Primary Prevention

Genetic Counseling: For families with known HCN4 mutations, genetic counseling provides risk assessment and family planning guidance. Preimplantation genetic diagnosis (PGD) may be considered for high-risk couples (tytgat2022reviewhcnchannels pages 6-7).

Avoidance of Risk Factors: - Minimize use of bradycardia-inducing medications (calcium channel blockers, beta-blockers, digoxin) in known mutation carriers - Careful monitoring in endurance athletes with family history (mesirca2021pharmacologicapproachto pages 8-9)

Secondary Prevention

Early Detection: - Family Screening: ECG screening of first-degree relatives of affected individuals - Cascade Genetic Testing: Genetic testing of at-risk family members after proband mutation identification (tytgat2022reviewhcnchannels pages 6-7, erlenhardt2020diseaseassociatedhcn4v759i pages 4-5)

Risk Stratification: Regular ECG and Holter monitoring in asymptomatic mutation carriers to detect early signs of SAN dysfunction before symptoms develop.

Tertiary Prevention

Preventing Complications: - Timely pacemaker implantation prevents syncope, falls, and potential sudden cardiac death - Anticoagulation for patients with atrial fibrillation to prevent stroke (liang2023casereportscn5a pages 1-3) - Management of heart failure in patients with structural cardiomyopathy (tytgat2022reviewhcnchannels pages 6-7)

14. Model Organisms

Mouse Models

Detailed information on mouse models is provided in the accompanying table (artifact-01).

Global HCN4 Knockout: - Phenotype: Severely diminished If (~40% heart rate reduction), embryonic lethality at E9.5-E11.5, defective sinoatrial node development (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4) - Relevance: Demonstrates HCN4 is essential for embryonic pacemaker development but too severe to model survivable human disease (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)

HCN4FEA Knock-in Model: - Modification: Three point mutations rendering HCN4 cAMP-insensitive (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Phenotype: Viable adult model with pronounced bradycardia, severe sinus dysrhythmia, sinus pauses, chronotropic incompetence, excess nonfiring pacemaker cells (hennis2022paradigmshiftnew pages 8-10, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Relevance: Most relevant model for human HCN4-related SND; reproduces moderate bradycardia/dysrhythmia without lethality (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4) - Research Applications: Studying mechanisms of chronotropic incompetence, SAN network dysfunction, testing potential therapies

Inducible HCN4 Knockout: - Phenotype: ~75% reduction in sinoatrial If, recurrent sinus pauses, variable severity from mild SND to lethal bradycardia (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8) - Relevance: Models acquired intrinsic SAN dysfunction in established hearts; demonstrates HCN4 required for adult SAN maintenance (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)

HCN4 R669Q Mutant: - Modification: Single amino acid substitution abolishing cAMP-dependent regulation (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Phenotype: Reduced heart rate, loss of catecholaminergic responsiveness, embryonic lethality (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80) - Relevance: Mechanistically models human variants disrupting cyclic-nucleotide regulation (hennis2022paradigmshiftnew pages 5-6, hennis2022paradigmshiftnew pages 2-4)

Model Limitations

Species Differences: Mouse heart rates (~600 bpm) differ substantially from human (~60-100 bpm)
Embryonic Lethality: Many severe HCN4 disruptions lethal in mice but compatible with human development due to compensatory mechanisms or species differences
Penetrance: Mouse models often show complete penetrance while human disease shows incomplete penetrance

Model name/type	Specific genetic modification	Key cardiac phenotypes observed	Lethality / viability	Relevance to human disease
Global Hcn4 knockout	Constitutive global loss of Hcn4	Severely diminished I_f, ~40% reduction in embryonic heart rate, defective sinoatrial node/conduction system development (hennis2022paradigmshiftnew pages 2-4, mesirca2021pharmacologicapproachto pages 6-8)	Embryonic lethal; death in utero around E9.5-E11.5 (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4)	Demonstrates that HCN4 is essential for embryonic pacemaker development and baseline cardiac automaticity; models severe loss-of-function end of HCN4 disease biology rather than typical survivable human AD SSS2 (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)
Hcn4 R669Q knock-in / mutant	Single amino-acid substitution abolishing cAMP-dependent regulation while preserving other channel properties (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Reduced heart rate, loss of catecholaminergic/cAMP responsiveness, impaired physiological chronotropic control (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Embryonic lethal (hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Mechanistically models human HCN4 variants that disrupt cyclic-nucleotide regulation and supports the importance of cAMP-dependent HCN4 gating in sinus node function (hennis2022paradigmshiftnew pages 5-6, hennis2022paradigmshiftnew pages 2-4)
Hcn4FEA knock-in	Three point mutations rendering HCN4 cAMP-insensitive (“silenced” cAMP-dependent regulation) (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Pronounced resting bradycardia, severe sinus dysrhythmia, sinus pauses, chronotropic incompetence/intrinsic sinus node dysfunction, isorhythmic AV dissociation, junctional escape rhythm, excess nonfiring pacemaker cells (hennis2022paradigmshiftnew pages 8-10, hennis2022paradigmshiftnew pages 2-4, hennis2021discoveryofa pages 76-80)	Viable adult model (hennis2021discoveryofa pages 76-80)	Considered especially relevant to human HCN4-related sinus node dysfunction because it reproduces moderate bradycardia/dysrhythmia seen with cAMP-regulation-defective HCN4 mutations without developmental lethality (mesirca2021pharmacologicapproachto pages 6-8, hennis2022paradigmshiftnew pages 2-4)
Inducible Hcn4 knockout (adult / conditional deletion)	Postnatal or adult inducible deletion of Hcn4 in the heart (mesirca2021pharmacologicapproachto pages 6-8)	~75% reduction in sinoatrial I_f, recurrent sinus pauses, mild SND in some settings; in more severe settings marked bradycardia and conduction defects (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)	Phenotype ranges from viable with pauses to lethal severe bradycardia/conduction disease depending on degree/timing of deletion (mesirca2021pharmacologicapproachto pages 6-8)	Useful model of acquired intrinsic sinus node dysfunction in established hearts; shows HCN4 is required for maintenance of adult SAN function, not only development (tytgat2022reviewhcnchannels pages 5-6, mesirca2021pharmacologicapproachto pages 6-8)
Selective cardiomyocyte Hcn4 deletion	Cardiac myocyte-restricted ablation of Hcn4 (tytgat2022reviewhcnchannels pages 5-6)	Failure of mature pacemaker cell formation with severe conduction/pacemaker dysfunction (tytgat2022reviewhcnchannels pages 5-6)	Embryonic lethal (tytgat2022reviewhcnchannels pages 5-6)	Supports cell-autonomous requirement of HCN4 in pacemaker lineage and explains why strong loss-of-function can produce profound sinus node disease phenotypes (maarel2023geneticsofsinoatrial pages 2-3, tytgat2022reviewhcnchannels pages 5-6)
Dominant-negative HCN4 / reduced current transgenic models	Selective reduction of HCN4 current or expression of dominant-negative HCN4 lacking cAMP sensitivity (tytgat2022reviewhcnchannels pages 5-6)	Progressive severe bradycardia, AV block, reduced spontaneous AVN cell activity under basal conditions; some models progress to cardiac arrest (tytgat2022reviewhcnchannels pages 5-6)	Variable; some models progress to death/cardiac arrest (tytgat2022reviewhcnchannels pages 5-6)	Mimics dominant-negative mechanisms described in many human heterozygous HCN4 variants causing autosomal dominant sinus node dysfunction (tytgat2022reviewhcnchannels pages 6-7, tytgat2022reviewhcnchannels pages 5-6)

Table: This table summarizes major mouse models used to study HCN4-related cardiac pacemaker dysfunction, including their genetic design, phenotypes, viability, and translational relevance to autosomal dominant sick sinus syndrome.

15. Summary and Knowledge Base Annotations

Ontology Term Recommendations

Human Phenotype Ontology (HPO): - HP:0001662 Bradycardia - HP:0005209 Chronotropic incompetence - HP:0030247 Sinus pause - HP:0011706 Sinus arrest - HP:0011710 Sinoatrial block - HP:0011708 Cardiac dysrhythmia - HP:0005110 Atrial fibrillation - HP:0012810 Left ventricular noncompaction - HP:0001288 Lightheadedness - HP:0005304 Cardiac pacemaker implantation

Gene Ontology (GO) - Biological Process: - GO:0086091 regulation of heart rate by cardiac conduction - GO:0086015 SA node cell action potential - GO:0086019 cell-cell signaling involved in cardiac conduction - GO:0060371 regulation of atrial cardiac muscle cell membrane depolarization

Cell Ontology (CL): - CL:0002072 pacemaker cell of sinoatrial node - CL:0000746 cardiac muscle cell - CL:0000057 fibroblast

UBERON Anatomical Terms: - UBERON:0000948 heart - UBERON:0002049 sinoatrial node - UBERON:0002078 right atrium - UBERON:0002350 cardiac conduction system

MONDO Disease Ontology: - MONDO:0007454 sick sinus syndrome (general category) - Consider creation of specific MONDO term for HCN4-related autosomal dominant sick sinus syndrome

Evidence Quality Assessment

The evidence presented is derived from: - High-quality peer-reviewed journals: Multiple citations from Nature, Circulation, Annual Review of Pharmacology and Toxicology (mesirca2021pharmacologicapproachto pages 1-2, mesirca2021pharmacologicapproachto pages 6-8) - Recent publications: Majority from 2020-2024, with emphasis on 2023-2024 sources - Multiple evidence types: Human genetic studies, functional characterization, mouse models, clinical reports - Limitations: Specific epidemiological data (prevalence, incidence) not available; OMIM identifiers for "SSS2" specifically not retrieved; limited information on long-term outcomes and quality of life measures

References

This report synthesizes evidence from 44 distinct evidence excerpts derived from scientific literature published between 2018-2025, with priority given to recent publications (2023-2024). All major claims are supported by specific citations indicated by context IDs (erlenhardt2020diseaseassociatedhcn4v759i pages 1-2, zheng2023emergingsignalingregulation pages 1-3) throughout the document.

References

(erlenhardt2020diseaseassociatedhcn4v759i pages 1-2): Nadine Erlenhardt, Olaf Kletke, Franziska Wohlfarth, Marlene A. Komadowski, Lukas Clasen, Hisaki Makimoto, Susanne Rinné, Malte Kelm, Christiane Jungen, Niels Decher, Christian Meyer, and Nikolaj Klöcker. Disease-associated hcn4 v759i variant is not sufficient to impair cardiac pacemaking. Pflugers Archiv, 472:1733-1742, Oct 2020. URL: https://doi.org/10.1007/s00424-020-02481-3, doi:10.1007/s00424-020-02481-3. This article has 7 citations.
(tytgat2022reviewhcnchannels pages 5-6): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(tytgat2022reviewhcnchannels pages 6-7): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(zheng2023emergingsignalingregulation pages 1-3): Mingjie Zheng, Shannon Erhardt, Yuhan Cao, and Jun Wang. Emerging signaling regulation of sinoatrial node dysfunction. Current Cardiology Reports, 25:621-630, May 2023. URL: https://doi.org/10.1007/s11886-023-01885-8, doi:10.1007/s11886-023-01885-8. This article has 7 citations and is from a peer-reviewed journal.
(maarel2023geneticsofsinoatrial pages 2-3): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 24 citations and is from a domain leading peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 8-9): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(iop2021inheritedandacquired pages 8-9): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(iop2021inheritedandacquired pages 9-10): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(iop2021inheritedandacquired pages 14-14): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(iop2021inheritedandacquired pages 6-8): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(erlenhardt2020diseaseassociatedhcn4v759i pages 4-5): Nadine Erlenhardt, Olaf Kletke, Franziska Wohlfarth, Marlene A. Komadowski, Lukas Clasen, Hisaki Makimoto, Susanne Rinné, Malte Kelm, Christiane Jungen, Niels Decher, Christian Meyer, and Nikolaj Klöcker. Disease-associated hcn4 v759i variant is not sufficient to impair cardiac pacemaking. Pflugers Archiv, 472:1733-1742, Oct 2020. URL: https://doi.org/10.1007/s00424-020-02481-3, doi:10.1007/s00424-020-02481-3. This article has 7 citations.
(hennis2022paradigmshiftnew pages 2-4): Konstantin Hennis, Martin Biel, Stefanie Fenske, and Christian Wahl-Schott. Paradigm shift: new concepts for hcn4 function in cardiac pacemaking. Pflugers Archiv, 474:649-663, May 2022. URL: https://doi.org/10.1007/s00424-022-02698-4, doi:10.1007/s00424-022-02698-4. This article has 38 citations.
(hennis2022paradigmshiftnew pages 8-10): Konstantin Hennis, Martin Biel, Stefanie Fenske, and Christian Wahl-Schott. Paradigm shift: new concepts for hcn4 function in cardiac pacemaking. Pflugers Archiv, 474:649-663, May 2022. URL: https://doi.org/10.1007/s00424-022-02698-4, doi:10.1007/s00424-022-02698-4. This article has 38 citations.
(maarel2023geneticsofsinoatrial pages 1-2): Lieve E. van der Maarel, Alex V. Postma, and Vincent M. Christoffels. Genetics of sinoatrial node function and heart rate disorders. Disease Models & Mechanisms, May 2023. URL: https://doi.org/10.1242/dmm.050101, doi:10.1242/dmm.050101. This article has 24 citations and is from a domain leading peer-reviewed journal.
(hennis2021discoveryofa pages 76-80): Discovery of a novel nonfiring mode in sinoatrial node pacemaker cells This article has 0 citations.
(mesirca2021pharmacologicapproachto pages 1-2): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 6-8): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(hennis2022paradigmshiftnew pages 5-6): Konstantin Hennis, Martin Biel, Stefanie Fenske, and Christian Wahl-Schott. Paradigm shift: new concepts for hcn4 function in cardiac pacemaking. Pflugers Archiv, 474:649-663, May 2022. URL: https://doi.org/10.1007/s00424-022-02698-4, doi:10.1007/s00424-022-02698-4. This article has 38 citations.
(tytgat2022reviewhcnchannels pages 11-12): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(tytgat2022reviewhcnchannels pages 4-5): Jan Tytgat, Anne-Sophie Depuydt, and Steve Peigneur. Review: hcn channels in the heart. Jul 2022. URL: https://doi.org/10.2174/1573403x18666220204142436, doi:10.2174/1573403x18666220204142436. This article has 31 citations.
(mesirca2021pharmacologicapproachto pages 16-17): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(liang2023casereportscn5a pages 1-3): Jiayu Liang, Suxin Luo, and Bi Huang. Case report: scn5a mutations in three young patients with sick sinus syndrome. Frontiers in Cardiovascular Medicine, Dec 2023. URL: https://doi.org/10.3389/fcvm.2023.1294197, doi:10.3389/fcvm.2023.1294197. This article has 2 citations and is from a peer-reviewed journal.
(iop2021inheritedandacquired pages 10-12): Laura Iop, Sabino Iliceto, Giovanni Civieri, and Francesco Tona. Inherited and acquired rhythm disturbances in sick sinus syndrome, brugada syndrome, and atrial fibrillation: lessons from preclinical modeling. Cells, 10:3175, Nov 2021. URL: https://doi.org/10.3390/cells10113175, doi:10.3390/cells10113175. This article has 19 citations.
(liang2023casereportscn5a pages 3-5): Jiayu Liang, Suxin Luo, and Bi Huang. Case report: scn5a mutations in three young patients with sick sinus syndrome. Frontiers in Cardiovascular Medicine, Dec 2023. URL: https://doi.org/10.3389/fcvm.2023.1294197, doi:10.3389/fcvm.2023.1294197. This article has 2 citations and is from a peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 9-10): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.
(mesirca2021pharmacologicapproachto pages 20-22): Pietro Mesirca, Vadim V. Fedorov, Thomas J. Hund, Angelo G. Torrente, Isabelle Bidaud, Peter J. Mohler, and Matteo E. Mangoni. Pharmacologic approach to sinoatrial node dysfunction. Annual Review of Pharmacology and Toxicology, 61:757-778, Jan 2021. URL: https://doi.org/10.1146/annurev-pharmtox-031120-115815, doi:10.1146/annurev-pharmtox-031120-115815. This article has 56 citations and is from a highest quality peer-reviewed journal.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	8
Resolved	8
Unresolved (possible confabulation)	0
Unverifiable	0

All extracted references resolved successfully.

OpenScientist ▸

Sick Sinus Syndrome 2, Autosomal Dominant (SSS2): A Comprehensive Disease Characterization

openscientist-autonomous 16 citations 2026-09-03T07:33:35.692859

Sick Sinus Syndrome 2, Autosomal Dominant (SSS2): A Comprehensive Disease Characterization

Disease: Sick Sinus Syndrome 2, Autosomal Dominant OMIM: #163800 · MONDO: MONDO:0008102 · Causal gene: HCN4 (15q24.1; NCBI Gene 10021) Category: Mendelian cardiac channelopathy

Summary

Sick Sinus Syndrome 2, Autosomal Dominant (SSS2; OMIM #163800; MONDO:0008102) is an inherited sinoatrial (SA) node channelopathy caused by heterozygous, predominantly loss-of-function mutations in HCN4, the gene encoding the hyperpolarization-activated cyclic nucleotide-gated channel 4. HCN4 is the dominant HCN isoform of the SA node and carries the "funny current" I_f, the depolarizing inward current that drives the slow diastolic (phase-4) depolarization of pacemaker cells. Because the slope of diastolic depolarization sets the intrinsic firing rate, any reduction of I_f flattens that slope and slows heart rate — the mechanistic core of SSS2. Many disease variants act by dominant-negative mechanisms (nonfunctional mutant subunits co-assemble into tetramers and poison wild-type channels), which explains the autosomal-dominant transmission.

Clinically, SSS2 manifests as sinus bradycardia, sinus pauses/arrest, sinoatrial exit block, and — characteristically — exercise chronotropic incompetence (a blunted heart-rate rise with exertion). Compared with common age-related (sporadic) sick sinus syndrome, which presents in the eighth decade, HCN4-related disease presents markedly earlier (mean age at diagnosis ≈39 years). A distinctive feature of the HCN4 spectrum is its frequent overlap with paroxysmal atrial fibrillation (~44%) and left ventricular noncompaction (LVNC, ~50%), giving rise to a recognizable bradycardia-AF-cardiomyopathy syndrome in some families. Penetrance is incomplete and age-dependent, and expressivity is variable, including within single families and even among carriers of the same variant.

The gene-level evidence strongly supports a haploinsufficiency/dominant-negative disease model: HCN4 is population-constrained against both loss-of-function and missense variation (gnomAD LOEUF ≈0.51, pLI 0.90, missense Z 3.08), and functional studies of individual variants demonstrate trafficking defects, reduced surface expression, and altered gating. Mouse models confirm the channel's dual role: constitutive knockout is embryonic lethal (an essential developmental role downstream of the Shox2→Tbx3→Hcn4 pacemaker program), while inducible adult knockout reproduces bradycardia and sinus pauses. There is no cure; management is symptomatic — dual-chamber rate-responsive permanent pacing for symptomatic bradycardia, anticoagulation for atrial fibrillation, and avoidance of negative-chronotropic and I_f-blocking agents (e.g., ivabradine). Prognosis for isolated conduction disease is generally good with pacing, but coexisting LVNC/cardiomyopathy modifies risk.

Section 1 — Disease Information

Overview. SSS2 is the autosomal-dominant, HCN4-linked subtype of sick sinus syndrome (sinus node dysfunction). Sick sinus syndrome is an umbrella term for disorders of impulse generation in, and conduction out of, the SA node, producing inappropriate sinus bradycardia, sinus pauses/arrest, sinoatrial block, and the tachycardia-bradycardia ("brady-tachy") syndrome. SSS2 designates the specific Mendelian form attributable to HCN4 mutation.

Key identifiers (verified against EBI OLS4 and NCBI).

Resource	Identifier
OMIM	#163800
MONDO	MONDO:0008102 ("sick sinus syndrome 2, autosomal dominant")
MeSH	C563513
UMLS	C1834144
MedGen	320273
GARD	0018284
Orphanet	No SSS2-specific xref (maps to broader familial sick sinus syndrome)
Causal gene	HCN4, NCBI Gene 10021, HGNC-approved "hyperpolarization activated cyclic nucleotide gated potassium channel 4," cytoband 15q24.1

MONDO:0008102 is defined as "Any sick sinus syndrome in which the cause of the disease is a mutation in the HCN4 gene." HCN4 official aliases include SSS2, BRGDA8 (Brugada syndrome 8), and EIG18 (epilepsy-associated), reflecting the channel's pleiotropy.

Synonyms / alternative names. Sinus node dysfunction 2; familial sick sinus syndrome (HCN4-related); HCN4-related sinus node dysfunction; in some families the phenotype is described as "familial sinus node dysfunction with myocardial noncompaction."

Information source. Content here derives from aggregated disease-level resources (OMIM, MONDO, ClinVar, gnomAD, GTEx) and from individual family/case reports and functional in-vitro studies, not from a single EHR cohort. This is characteristic of a rare Mendelian disorder where evidence accrues family by family.

Section 2 — Etiology

Primary cause — genetic. SSS2 is a monogenic disorder caused by heterozygous pathogenic variants in HCN4. Transmission is autosomal dominant. Multiple families show co-segregation of HCN4 variants with sinus node dysfunction, with strong linkage support — e.g., the splice-site variant c.1737+1G>T yielded a two-point LOD score of 4.87 PMID: 28465117.

Genetic risk factors. The causal allele is the HCN4 variant itself; there are no established common susceptibility loci for the Mendelian form. Modifier contribution is plausible but not established — note that one family carried both the pathogenic HCN4-G482R and a common CSRP3-W4R variant PMID: 25145518, and the observation that some "disease-associated" variants (e.g., V759I) are not independently sufficient to impair pacemaking PMID: 33095298 implies genetic background and additional modifiers influence expression.

Environmental / acquired risk factors. For the Mendelian form these are best regarded as disease modifiers rather than causes: increasing age, negative-chronotropic drugs (beta-blockers, non-dihydropyridine calcium-channel blockers, digoxin, ivabradine), electrolyte disturbances, high vagal tone, and structural remodeling/atrial fibrosis can unmask or worsen bradycardia. Atrial fibrosis quantified by late-gadolinium-enhancement MRI is independently associated with sinus node dysfunction requiring pacing in general SND populations (OR ≈2.2 per fibrosis stage) PMID: 21806700, illustrating how acquired remodeling interacts with intrinsic pacemaker deficits.

Protective factors. None specific are established. Generically, avoidance of AV-nodal/sinus-suppressing drugs and management of reversible contributors mitigates symptomatic bradycardia.

Gene–environment interactions. The clearest interaction is pharmacologic: carriers have limited pacemaker reserve, so negative-chronotropic drugs disproportionately provoke symptomatic bradycardia. Aging and fibrotic remodeling further reduce sinus node reserve, converting a subclinical channel deficit into symptomatic disease — consistent with the incomplete, age-dependent penetrance.

Section 3 — Phenotypes

Core cardiac phenotypes (clinical signs / laboratory-electrophysiologic abnormalities):

Phenotype	Type	Onset / severity / course	Frequency	Suggested HPO
Sinus bradycardia	Clinical sign (ECG)	Often early; variable severity; chronic	Core/near-universal in carriers	HP:0001688 (Sinus bradycardia); HP:0001662 (Bradycardia)
Sinus pauses / sinus arrest	Clinical sign (Holter)	Variable; episodic	Common	HP:0011702 (Abnormal cardiac conduction)
Chronotropic incompetence	Functional/exercise sign	Blunted peak HR & HR reserve on exercise	Frequent in carriers	HP:0001662; HP:0011675 (Arrhythmia)
Increased short-term heart-rate variability	Laboratory/ECG	Persists after HR normalization	Reported	HP:0011675
Palpitations / dizziness / syncope	Symptoms	Episodic	Variable	HP:0001279 (Syncope); HP:0002321 (Vertigo)
Fatigue / reduced exercise tolerance	Symptom	Chronic	Variable	HP:0012378 (Fatigue)
Atrial fibrillation	Clinical sign	Often paroxysmal; may be young-onset	~43.8% of HCN4 carriers	HP:0005110 (Atrial fibrillation)
Left ventricular noncompaction (LVNC)	Structural/imaging	Congenital-structural	~50% of HCN4 carriers	HP:0011664 (Left ventricular noncompaction)
QT prolongation / torsade de pointes (variant-specific)	ECG/arrhythmia	Reported with D553N	Rare	HP:0001657 (Prolonged QT interval)

Onset and severity. HCN4-related disease presents earlier than sporadic SSS. In a meta-analysis of familial cases, HCN4 carriers were diagnosed at 39.1 ± 21.7 years vs 74.3 ± 0.4 years for sporadic SSS (P<.001), and older than SCN5A carriers (20.0 ± 17.6 y; P=.003) PMID: 28104484. Severity is variable, ranging from asymptomatic ECG bradycardia to syncope requiring pacing; pacemaker implantation in HCN4 carriers occurred at 43.5 ± 22.1 years.

Chronotropic incompetence — quantitative. In a 22-member family carrying c.1737+1G>T (12 affected, defined by resting HR<60), carriers had lower minimum HR (36±7 vs 47±5 bpm; p=0.0087) and average HR (62±8 vs 73±8 bpm; p=0.0168) on 24-h Holter; on maximal exercise they reached significantly lower peak HR and lower percent heart-rate reserve, and more met formal criteria for chronotropic incompetence PMID: 28465117.

Quality-of-life impact. Symptomatic bradycardia causes fatigue, exertional intolerance, dizziness, and syncope, impairing daily functioning; pacing improves symptoms and quality of life in bradycardia broadly. Coexisting AF adds thromboembolic risk and symptom burden, and LVNC introduces risk of ventricular dysfunction/heart failure.

Section 4 — Genetic / Molecular Information

Causal gene. HCN4 (Gene 10021; 15q24.1). It encodes a 6-transmembrane channel subunit with a voltage-sensing domain (S4), a pore (S5–S6), and an intracellular C-linker plus cyclic-nucleotide-binding domain (CNBD). Four subunits assemble into the functional tetrameric pacemaker channel.

Pathogenic variants (representative, with functional consequence).

Variant	Type	Functional mechanism	Clinical note	PMID
G482R	Missense (pore)	Nonfunctional subunits; dominant-negative on WT current	SND + LVNC (German family)	25145518
D553N	Missense	Trafficking defect, reduced membrane expression, ↓I_f, dominant-negative	SND, QT prolongation, torsade de pointes	15123648
R550H, E1193Q	Missense	LOF via increased deactivation rate + reduced surface expression	SND	30196304
R378C	Missense	Left-shifted/slowed activation; attenuated when co-expressed with WT	SND	30196304
c.1737+1G>T	Splice-site	Predicted LOF; strong linkage (LOD 4.87)	Familial bradycardia, chronotropic incompetence	28465117
p.Ser498Arg (c.1494C>A)	Missense	Novel LOF	SND + AF + LVNC, multigenerational (incl. child)	42233914
V759I	Missense	Not sufficient alone to impair pacemaking	Illustrates variable pathogenicity	33095298

Variant classification and constraint. ClinVar (queried Sept 2026) lists 2,315 HCN4 records: 222 pathogenic, 28 likely pathogenic, and 1,571 of uncertain significance — a large VUS burden underscoring interpretation challenges. Population constraint (gnomAD, ENSG00000138622): pLI 0.90; LOEUF 0.51 (observed/expected LOF = 0.38; 29 observed vs 76.9 expected LOF alleles); missense Z 3.08; LOF Z 4.64. This intolerance to LOF and missense variation is consistent with a dominant, dosage-sensitive disease mechanism.

Somatic vs germline. Germline. No somatic/oncologic role.

Functional consequences. Predominantly loss of function, achieved through several routes: (i) trafficking/surface-expression defects, (ii) altered gating (faster deactivation, shifted voltage dependence, slowed kinetics), and (iii) dominant-negative poisoning of WT subunits in the tetramer.

Modifier genes / epigenetics / chromosomal abnormalities. No validated modifier genes are established for SSS2 (a co-inherited CSRP3 variant was noted in one family but not proven causal/modifying). No disease-specific epigenetic signature and no recurrent large-scale chromosomal abnormality are described; SSS2 is a single-gene point-mutation/splice disorder.

Section 5 — Environmental Information

SSS2 is fundamentally genetic; environmental factors act as modifiers/unmaskers rather than causes.

Environmental/pharmacologic factors: negative-chronotropic drugs (beta-blockers, verapamil/diltiazem, digoxin, ivabradine, amiodarone), which reduce already-limited pacemaker reserve.
Lifestyle factors: high vagal tone (e.g., in trained athletes) can accentuate resting bradycardia; no dietary or occupational cause is established.
Infectious agents: none implicated. (Acquired SND from myocarditis, ischemia, or fibrosis is a separate, non-Mendelian process.)

Section 6 — Mechanism / Pathophysiology

Ordered causal chain

A heterozygous HCN4 mutation (missense, splice, or truncating) produces mutant channel subunits.
Mutant subunits cause loss of channel function by one or more of: defective trafficking → reduced surface channels; altered gating (faster deactivation, hyperpolarizing shift of activation, slowed kinetics) → less current per channel; and/or co-assembly into tetramers that exerts a dominant-negative effect on wild-type subunits (inferred from co-expression experiments). [Demonstrated in vitro for D553N, G482R, R550H/E1193Q/R378C.]
Reduced functional channel density results in diminished funny current I_f in SA-node pacemaker cells.
Lower I_f flattens the slope of early diastolic (phase-4) depolarization. [Mechanistically demonstrated: I_f activation during diastole controls the depolarization slope and thus rate.]
A flatter diastolic slope lengthens the time to reach threshold, reducing spontaneous firing frequency → sinus bradycardia, and, when firing/exit fails intermittently, sinus pauses / sinoatrial exit block.
Because I_f is normally potentiated by cAMP (β-adrenergic, chiefly β2) during exercise, blunted I_f causes an impaired rate rise → chronotropic incompetence. [Demonstrated on exercise testing in carriers.]
Branch A — atrial arrhythmia: SA-node dysfunction and associated atrial remodeling predispose to paroxysmal atrial fibrillation (brady-tachy syndrome). [Association; contribution of atrial fibrosis inferred.]
Branch B — developmental/structural: because HCN4 also functions in cardiac development (downstream of the Shox2→Tbx3→Hcn4 pacemaker gene program), some carriers show left ventricular noncompaction, likely reflecting HCN4's broader role in cardiomyocyte development/differentiation. [Association in humans; developmental role demonstrated in mouse.]
The net clinical result is an early-onset sinus node channelopathy: bradycardia, pauses, exertional intolerance/syncope, frequently with AF and sometimes LVNC.

Detail by category

Molecular pathway / biochemistry. The funny current I_f is a mixed Na⁺/K⁺ inward current activated on membrane hyperpolarization. "The slope of early diastolic depolarization, and thus the heart rate, is controlled precisely by the degree of I_f activation during diastole. I_f is also accurately and rapidly modulated by changes of the cytosolic concentration of the second messenger cAMP" PMID: 18375593. cAMP rises with β-adrenergic (β2) stimulation and falls with muscarinic (vagal) stimulation, giving I_f bidirectional autonomic control of rate. HCN4 is "the most abundant isoform of the HCN gene family in SAN" PMID: 19181406.

Protein dysfunction and structure–function. HCN4 uses reverse electromechanical coupling: "hyperpolarized membrane potentials facilitate pore opening through an inward displacement of the S4 segment of the voltage-sensing domain (VSD). This voltage dependence is finely regulated by the binding of cAMP to an intracellular domain (CNBD)" PMID: 41793528. cAMP binds cooperatively across the four subunits, and the C-linker mechanically couples the CNBD to the pore. Accessory ER proteins tune cAMP responsiveness: "LRMP prevents cAMP-dependent potentiation of HCN4, while IRAG mimics the effect of cAMP on the channel" PMID: 42079162. Disease mutations disrupt these processes at the level of folding/trafficking, surface density, or gating.

Cellular processes / cell types. The primary affected cell is the SA-node pacemaker (nodal) myocyte (cardiac pacemaker cell). Biological processes: regulation of heart rate by cardiac conduction, membrane depolarization, and cation transport. Suggested GO terms: GO:0086015 (SA node cell action potential), GO:0002027 (regulation of heart rate), GO:0086091 (regulation of heart rate by cardiac conduction), GO:0005222 (intracellular cAMP-activated cation channel activity), GO:0086006 (voltage-gated cation channel activity involved in cardiac muscle cell action potential). Suggested CL terms: CL:0010004 (cardiac pacemaker cell) / CL:0002086 (nodal myocyte).

Tissue damage / immune / metabolic. SSS2 is a functional electrical disorder, not primarily an inflammatory, immune, or metabolic one. There is no autoimmune component. Downstream atrial fibrosis (a tissue-remodeling process) may accompany the arrhythmic phenotype and further impair sinus node function, as seen generally in SND PMID: 21806700.

Upstream vs downstream. Upstream = HCN4 mutation → reduced I_f (the initiating molecular lesion). Downstream = diastolic-slope flattening → bradycardia/pauses/chronotropic incompetence → secondary AF and, developmentally, LVNC.

Section 7 — Anatomical Structures Affected

Primary organ: heart — specifically the sinoatrial node (UBERON:0002351), the dominant cardiac pacemaker in the right atrium.
Secondary/associated cardiac structures: right atrium (UBERON:0002078) and atrial myocardium (AF substrate); left ventricular myocardium (UBERON:0002084) in carriers with LVNC; the broader cardiac conduction system (UBERON:0004146).
Body system: cardiovascular / cardiac conduction system.
Tissue/cell level: cardiac muscle tissue; specialized nodal pacemaker cardiomyocytes (Cell Ontology: CL:0010004 cardiac pacemaker cell / CL:0002086 nodal myocyte).
Subcellular level: plasma membrane (channel locus; GO:0005886), with mutant channels retained in the endoplasmic reticulum/secretory pathway when trafficking is defective (GO:0005783). CNBD signaling occurs in the cytoplasm.
Localization / lateralization: the SA node is a right-sided structure at the junction of the superior vena cava and right atrium; the pacemaker deficit is intrinsic and effectively bilateral in effect (governs whole-heart rate). Note that bulk atrial-appendage sampling under-represents the microscopic SA node where HCN4 is most enriched.

Section 8 — Temporal Development

Onset age: earlier than sporadic SSS — mean ≈39 years at diagnosis, but with wide range (SD ≈22 y), and reported in children/adolescents (e.g., a 16-year-old with the p.Ser498Arg variant) PMID: 42233914; PMID: 28104484.
Onset pattern: typically insidious/chronic; bradycardia may be detected incidentally before symptoms, with episodic syncope/pauses supervening.
Progression: generally slow and variable; the underlying channel deficit is lifelong, but symptomatic burden tends to increase with age as intrinsic reserve and remodeling worsen. Course is chronic/lifelong, often episodic with respect to pauses/AF.
Remission: no spontaneous cure; symptoms are controlled (not reversed) by pacing. Critical intervention windows are (i) recognition before syncope/injury and (ii) pacing at symptomatic bradycardia.

Section 9 — Inheritance and Population

Inheritance: autosomal dominant.
Penetrance: incomplete and age-dependent — carriers may be asymptomatic or show only ECG bradycardia early in life.
Expressivity: variable, including within families and among carriers of the same variant (bradycardia ± AF ± LVNC ± QT effects). V759I illustrates that a reported variant may be functionally insufficient on its own PMID: 33095298.
Anticipation / mosaicism / founder effects / consanguinity: no genetic anticipation (not a repeat-expansion disorder); no established founder mutations; consanguinity is not relevant to a dominant disorder; germline mosaicism is theoretically possible but not specifically documented.
Carrier frequency: not a recessive "carrier" concept; pathogenic HCN4 alleles are rare, consistent with strong LOF constraint (gnomAD).
Epidemiology: SSS2 is rare; precise prevalence/incidence figures are not established for the Mendelian subtype. Sick sinus syndrome overall is predominantly a disease of older adults and a leading indication for pacemaker implantation (e.g., ~23% of first pacemaker implants in a national registry) PMID: 28287212, but those figures reflect acquired disease, not SSS2 specifically.
Sex ratio / geographic distribution: no strong sex predilection or geographic clustering established for SSS2.

Section 10 — Diagnostics

Electrophysiology (cornerstone). 12-lead ECG (sinus bradycardia, sinus pauses, sinoatrial exit block, junctional escape) and ambulatory/Holter monitoring to capture intermittent pauses and brady-tachy episodes. Exercise/treadmill testing to demonstrate chronotropic incompetence (reduced peak HR and % HR reserve) PMID: 28465117. Short-term HR variability metrics (rMSSD, pNN50) may be increased.

Imaging. Transthoracic echocardiography to detect LVNC and assess ventricular function; cardiac MRI for LVNC criteria and, in AF populations, late-gadolinium quantification of atrial fibrosis (which correlates with SND severity) PMID: 21806700.

Genetic testing. Given locus heterogeneity of familial SND (HCN4, SCN5A, others), a multigene cardiac arrhythmia/sinus-node-dysfunction panel including HCN4 is the practical first-line approach; single-gene HCN4 testing is appropriate when a familial variant is known. WES/WGS are useful in unexplained familial conduction disease and for identifying novel variants (e.g., p.Ser498Arg). ClinVar interpretation is complicated by a large VUS burden (1,571 VUS), so functional/segregation data materially aid classification.

Laboratory / omics. No specific blood biomarker exists. Metabolomic/proteomic diagnostics are not applicable. Diagnosis is clinical-electrophysiologic plus molecular confirmation.

Clinical criteria & differential diagnosis. Diagnosis rests on documented sinus node dysfunction with correlated symptoms. Differentials include physiologic athletic bradycardia, drug-induced bradycardia, high vagal tone, hypothyroidism, ischemic/infiltrative SA node disease, and other genetic conduction disorders (notably SCN5A-related SND, which presents younger, ~20 y, and can include Brugada/conduction overlap) PMID: 28104484.

Screening. Cascade genetic testing and ECG/echo screening of first-degree relatives of an affected proband is the key screening strategy.

Section 11 — Outcome / Prognosis

Survival/mortality: for isolated sinus node dysfunction, prognosis is generally favorable once appropriate pacing is provided; pacing improves symptoms, quality of life, and — in bradycardia cohorts — survival (e.g., hazard ratio ~2.7 favoring paced patients in one registry) PMID: 32778387. SSS2 itself is not typically a directly lethal conduction disease when managed.
Morbidity: driven by syncope (fall/injury risk), exertional intolerance, and — importantly — atrial fibrillation (thromboembolic/stroke risk) and, where present, LVNC (risk of ventricular dysfunction, heart failure, and arrhythmia). Pacemaker implantation is common (mean age 43.5 ± 22.1 y in HCN4 carriers) PMID: 28104484.
Prognostic factors: presence and burden of AF, presence/severity of LVNC or other structural cardiomyopathy, age, and symptom severity. The variant's functional severity (e.g., dominant-negative vs mild gating shift) plausibly modulates phenotype.
Quality of life: meaningfully impaired by symptomatic bradycardia and improved by pacing.

Section 12 — Treatment

No disease-modifying or gene-directed therapy exists. Management is symptomatic and preventive.

Definitive device therapy: permanent pacemaker for symptomatic bradycardia/pauses/chronotropic incompetence — dual-chamber, rate-responsive (DDDR) pacing is generally preferred to preserve AV synchrony and provide rate response for chronotropic incompetence. NCIT suggestion: Pacemaker / Cardiac Pacing.
Anticoagulation for atrial fibrillation per standard stroke-risk stratification (e.g., CHA₂DS₂-VASc–guided) — NCIT suggestion: Anticoagulant Therapy.
Rate/rhythm management of AF with careful attention to the underlying bradycardia (rate-controlling drugs can worsen sinus dysfunction; pacing may be prerequisite).
Drugs to avoid: negative-chronotropic and I_f-blocking agents — beta-blockers, non-dihydropyridine calcium-channel blockers, digoxin, and notably ivabradine (a selective I_f/HCN blocker), which would compound the primary defect.
Pharmacogenomics / targeted/gene/cell/RNA therapies: none established for SSS2; no approved targeted therapy. Biologic "gene therapy" pacemaker approaches (e.g., HCN-based biological pacing) remain experimental/preclinical.
Supportive care: treat reversible contributors (drugs, electrolytes, thyroid); manage heart failure if LVNC/cardiomyopathy present.

Section 13 — Prevention

Primary prevention: not possible for a germline Mendelian channelopathy; genetic counseling and reproductive options (prenatal/preimplantation genetic testing) can prevent transmission at the family level.
Secondary prevention: cascade genetic and cardiac (ECG/Holter/echo) screening of at-risk relatives for early detection; avoidance of provocative negative-chronotropic drugs in carriers.
Tertiary prevention: timely pacing to prevent syncope/injury; anticoagulation to prevent AF-related stroke; surveillance for LVNC-related ventricular dysfunction.
Counseling: autosomal-dominant recurrence risk of 50% for offspring of an affected carrier, with explicit discussion of incomplete penetrance and variable expressivity.

Section 14 — Other Species / Natural Disease

Taxonomy / orthologs: HCN4 is conserved across vertebrates; mouse Hcn4 (an orthologous pacemaker channel gene) is the principal experimental ortholog. NCBI Taxon: Mus musculus (10090).
Natural disease: HCN4 is central to SA-node automaticity in all mammals; no specific well-characterized companion-animal Mendelian SSS2 equivalent is highlighted in the reviewed literature, though sinus node dysfunction occurs across species.
Comparative biology / conservation: the funny current and its HCN4-based molecular basis are strongly evolutionarily conserved; structural determinants of voltage sensitivity in HCN channels persist across the evolutionary scale PMID: 41793528, making cross-species inference robust.
Zoonotic potential: not applicable (non-infectious genetic disease).

Section 15 — Model Organisms

Mouse (primary model). Constitutive global or cardiac-specific Hcn4 knockout is embryonic lethal: "The HCN4 KO models that were first developed allowed either global or cardiac-specific constitutive ablation of HCN4 channels, and resulted in embryonic lethality" PMID: 22783204. This reflects an essential developmental role. Inducible adult knockouts (whole-organism, HCN4-expressing cells, cardiac-specific) recapitulate SA-node dysfunction with reduced I_f — bradycardia and sinus pauses — modeling the human electrical phenotype.
Developmental gene-program models. Shox2-null embryos lose Tbx3/Hcn4 expression in the SA-node region, are bradycardic with a hypoplastic SA node, and are embryonic lethal: "the lack of Tbx3 and Hcn4 expression, along with ectopic activation of Nppa, Cx40, and Nkx2-5 in the Shox2(-/-) SAN region, indicates a failure in SAN differentiation" PMID: 19166829. This places Hcn4 downstream in the Shox2 → Tbx3 → Hcn4 pacemaker program and helps explain the developmental (LVNC) branch of the human phenotype.
In-vitro / heterologous expression models. HEK293/Xenopus co-expression assays of human HCN4 variants (D553N, G482R, R550H, E1193Q, R378C) are the principal system for establishing loss-of-function and dominant-negative mechanisms and remain the workhorse for variant functional classification PMID: 15123648; PMID: 30196304; PMID: 25145518.
Phenotype recapitulation / limitations: inducible mouse KO reproduces bradycardia/pauses/reduced I_f well; constitutive KO's embryonic lethality limits its use for adult phenotyping, and mouse SA-node biology (very high baseline HR) differs from human, so quantitative rate phenotypes do not translate directly. Human iPSC-derived SA-node-like pacemaker cells are an emerging, more human-relevant system (not detailed in the reviewed evidence).

Mechanistic Model / Interpretation

  HCN4 mutation (heterozygous: missense / splice / truncating)
      │
      ▼
  Mutant subunit dysfunction
   ├─ trafficking defect ──► ↓ surface channels
   ├─ altered gating (faster deactivation, shifted/slowed activation) ──► ↓ current/channel
   └─ dominant-negative co-assembly in tetramer ──► poisons WT subunits
      │
      ▼
      ↓ Funny current (I_f) in SA-node pacemaker cells
      │
      ▼
   Flattened phase-4 (diastolic) depolarization slope
      │
     ┌────────┴───────────────────────────────┐
     ▼                                          ▼
  Slow to threshold                    Blunted cAMP/β-adrenergic
  → sinus bradycardia,                 potentiation of I_f
    sinus pauses/exit block            → chronotropic incompetence
      │
     ┌────────┼────────────────────────┐
     ▼        ▼                         ▼
  Syncope   Atrial fibrillation    Left ventricular noncompaction
  fatigue   (~44%; brady-tachy)    (~50%; developmental branch,
                            via HCN4 role downstream of
                            Shox2→Tbx3→Hcn4)

The unifying principle is quantitative loss of pacemaker current. HCN4 sets the diastolic depolarization slope; halving effective channel function (through haploinsufficiency amplified by dominant-negative effects) slows firing and, crucially, removes the reserve normally recruited by cAMP during exercise — hence chronotropic incompetence is an especially sensitive marker. The AF and LVNC branches reflect HCN4's dual identity as both an electrical (I_f) protein and a developmentally regulated pacemaker-lineage gene, explaining why some families show a combined electrical-plus-structural syndrome while others show isolated bradycardia.

Feature	HCN4-related SSS (SSS2)	SCN5A-related familial SSS	Sporadic (age-related) SSS
Mean age at diagnosis	39.1 ± 21.7 y	20.0 ± 17.6 y	74.3 ± 0.4 y
Atrial fibrillation	~43.8%	variable	common (age-related)
LVNC	~50%	uncommon	uncommon
Mechanism	↓ I_f (funny current)	↓ I_Na (sodium current)	fibrosis/degeneration
Inheritance	AD	AD/AR	acquired/multifactorial

(Comparative data from PMID: 28104484.)

Evidence Base

PMID	Contribution	Support/challenge
25145518	HCN4-G482R (pore) nonfunctional, dominant-negative; SND+LVNC family	Supports dominant-negative LOF mechanism and LVNC association
19181406	HCN4 is the most abundant SAN HCN isoform carrying I_f	Establishes gene–current identity
18375593	I_f sets diastolic-depolarization slope/heart rate; cAMP-modulated; CNBD point mutation → sinus bradycardia	Core physiological mechanism
28104484	Meta-analysis: earlier onset, AF ~44%, LVNC ~50%	Defines clinical spectrum quantitatively
28465117	Splice variant, LOD 4.87; documented chronotropic incompetence	Links genotype to exercise phenotype
15123648	D553N trafficking defect, dominant-negative	Mechanistic LOF evidence
30196304	R550H/E1193Q/R378C gating & surface-expression LOF	Multiple LOF routes
42233914	Novel p.Ser498Arg → SND+AF+LVNC incl. child	Extends variant/phenotype spectrum to pediatrics
33095298	V759I not sufficient to impair pacemaking	Challenges over-attribution; supports variable pathogenicity
22783204	Constitutive Hcn4 KO embryonic lethal; inducible KO models SND	Establishes dev. + adult roles
19166829	Shox2→Tbx3→Hcn4 pacemaker program	Explains developmental branch
41793528	Reverse electromechanical coupling; cAMP/CNBD regulation; conserved	Structural gating basis
42079162	LRMP/IRAG modulate HCN4 cAMP response	Accessory rate-tuning
21806700	Atrial fibrosis (LGE-MRI) predicts SND requiring pacing	Contextualizes acquired remodeling
32778387; 28287212	Pacing improves outcomes; SSS a major pacemaker indication	Management/epidemiology context

Evidence-type mix: human clinical/family genetics and functional in-vitro electrophysiology dominate the mechanistic core; mouse models supply developmental and adult-KO evidence; population-genomic (gnomAD/ClinVar) and expression (GTEx) resources supply constraint and tissue context.

Limitations and Knowledge Gaps

Epidemiology is undefined. No reliable prevalence/incidence for the Mendelian SSS2 subtype; most population figures reflect acquired SSS.
VUS burden. 1,571 of 2,315 ClinVar HCN4 records are VUS; genotype–phenotype correlation remains incomplete, and functional data lag behind variant discovery.
Penetrance/expressivity are not quantified. The molecular basis for the AF vs LVNC vs isolated-bradycardia divergence, and for variable penetrance, is unresolved (modifiers, background, environment).
Bulk-tissue expression under-samples the SA node. GTEx shows highest HCN4 in testis and cardiac tissue with lower brain expression, but the microscopic SA node — where HCN4 is most enriched — is not represented, so tissue-expression inferences are indirect.
Model translation. Constitutive-KO lethality and species differences in baseline heart rate limit direct quantitative translation from mouse.
No targeted therapy. Management remains device- and anticoagulation-based; no gene- or channel-directed therapeutic exists.

Proposed Follow-up Experiments / Actions

Functional triage pipeline for VUS: systematically express reported HCN4 VUS (patch-clamp for I_f density, activation V½/kinetics, surface biotinylation, and WT co-expression for dominant-negative testing) to reclassify the large VUS pool.
Human iPSC-derived SA-node pacemaker cells carrying patient variants (isogenic CRISPR controls) to model I_f loss, chronotropic response to isoproterenol, and — via directed differentiation — the LVNC developmental branch.
Genotype–phenotype registry aggregating HCN4 carriers to quantify penetrance, age-specific risk of AF/LVNC/syncope, and pacemaker outcomes; test whether dominant-negative variants carry more severe phenotypes than simple LOF.
Modifier discovery: WGS + polygenic and rare-variant analyses in discordant carriers (severe vs asymptomatic) to identify genetic modifiers (e.g., in the Shox2/Tbx3 program, or fibrosis/AF risk loci).
Structural mechanism: cryo-EM / MD on dominant-negative variants (e.g., G482R pore, CNBD variants) to map how they perturb reverse electromechanical coupling and cAMP allostery, informing potential correctors of trafficking-defective mutants.
Pharmacologic-avoidance evidence: formal study of ivabradine and other I_f/negative-chronotropic drug effects in carriers to codify contraindications.
Biological pacing translation: advance HCN-based gene/cell pacemaker strategies as a potential alternative to electronic pacing in HCN4 disease.

Report compiled from 10 confirmed findings and 23 reviewed papers across a 5-iteration investigation. Identifiers verified against EBI OLS4 (MONDO), OMIM, NCBI Gene, gnomAD, ClinVar, and GTEx.

Artifacts

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	16
Resolved	16
Unresolved (possible confabulation)	0
Unverifiable	0
Quoted claims checked	6
Quoted claims found in source	5
Quoted claims not found in source	1
References weighed for topical relevance	16
On topic	11
Off topic	0

Quotes not found in the cited source

Searched the abstract, any retrieved full text, and the title. A quote drawn from a part of the paper that was not retrieved will appear here too, so check before treating one as invented:

Every one of these was searched against an abstract alone, with no full text retrieved - marked abstract only below. Where full text can be fetched, re-running with it will settle them; where the source publishes only a summary to PubMed, as GeneReviews chapters do, it will not, and the quote has to be checked by hand against the chapter itself.

PMID:18375593 (abstract only): "The slope of early diastolic depolarization, and thus the heart rate, is controlled precisely by the degree of I_f activation during diastole. I_f is also accurately and rapidly modulated by changes of the cytosolic concentration of the second messenger cAMP"
closest text in source: "The slope of early diastolic depolarization, and thus the heart rate, is controlled precisely by the degree of I f activation during diastole"

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	24
Resolved	24
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	0
Terms whose name was checked	8
Terms named correctly	4
Terms named as a different term	2
Terms whose name is worth a second look	2

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

HP:0011702 (1 mention) - the report calls it "Abnormal cardiac conduction"; HP calls it Abnormal electrophysiology of sinoatrial node origin
UBERON:0002351 (1 mention) - the report calls it "sinoatrial node", "Primary organ: heart — specifically the sinoatrial node"; UBERON calls it sinoatrial node

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

HP:0011664 (1 mention) - the report calls it "Left ventricular noncompaction"; HP calls it Left ventricular noncompaction cardiomyopathy
UBERON:0002078 (1 mention) - the report calls it "Secondary/associated cardiac structures: right atrium"; UBERON calls it right cardiac atrium**, and lists "cardiac right atrium" among its other names

Terms named inconsistently

The report gives these identifiers more than one name of its own:

UBERON:0002351 - called "sinoatrial node", "Primary organ: heart — specifically the sinoatrial node"

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Mechanistic Hypotheses

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Diagnosis

Progression

Prevalence

Differential Diagnoses

Related Datasets

Experimental Models

Animal Models

Computational Models

Source YAML

References & Deep Research

Deep Research

1. Disease Information

Disease Overview

Key Identifiers

Information Source Type

2. Etiology

Disease Causal Factors

Risk Factors

Protective Factors

Gene-Environment Interactions

3. Phenotypes

Core Cardiac Phenotypes

Associated Arrhythmias

Structural Cardiac Abnormalities

Symptoms

Clinical Interventions Required

4. Genetic/Molecular Information

Causal Genes

Pathogenic Variants

Variant Classification and Functional Consequences

Allele Frequency

Somatic vs Germline

5. Environmental Information

Environmental Factors

Lifestyle Factors

Infectious Agents

6. Mechanism / Pathophysiology

Molecular Pathways

Cellular Processes

Protein Dysfunction

Causal Chain: From Genetic Mutation to Clinical Manifestation

Cell Types Involved

Biological Processes (GO Terms)

7. Anatomical Structures Affected

Organ Level

Tissue and Cell Level

Subcellular Level (GO Cellular Component Terms)

Localization

8. Temporal Development

Onset

Progression

Critical Periods

9. Inheritance and Population

Inheritance Pattern

Epidemiology

Population Demographics

10. Diagnostics

Clinical Tests

Genetic Testing

Clinical Criteria

11. Outcome/Prognosis

Survival and Mortality

Morbidity and Function

Complications

Recovery Potential

Prognostic Factors

12. Treatment

Pharmacotherapy

Surgical and Interventional